
<html lang="en"     class="pb-page"  data-request-id="2edf7fe0-0199-4f60-a3ed-fed15cf50364"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.9b01681;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2020.63.issue-5"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Discovery and Optimization of Novel Pyrazolopyrimidines as Potent and Orally Bioavailable Allosteric HIV-1 Integrase Inhibitors" /></meta><meta name="dc.Creator" content="Guo  Li" /></meta><meta name="dc.Creator" content="Nicholas A.  Meanwell" /></meta><meta name="dc.Creator" content="Mark R.  Krystal" /></meta><meta name="dc.Creator" content="David R.  Langley" /></meta><meta name="dc.Creator" content="B. Narasimhulu  Naidu" /></meta><meta name="dc.Creator" content="Prasanna  Sivaprakasam" /></meta><meta name="dc.Creator" content="Hal  Lewis" /></meta><meta name="dc.Creator" content="Kevin  Kish" /></meta><meta name="dc.Creator" content="Javed A.  Khan" /></meta><meta name="dc.Creator" content="Alicia  Ng" /></meta><meta name="dc.Creator" content="George L.  Trainor" /></meta><meta name="dc.Creator" content="Christopher  Cianci" /></meta><meta name="dc.Creator" content="Ira B.  Dicker" /></meta><meta name="dc.Creator" content="Michael A.  Walker" /></meta><meta name="dc.Creator" content="Zeyu  Lin" /></meta><meta name="dc.Creator" content="Tricia  Protack" /></meta><meta name="dc.Creator" content="Linda  Discotto" /></meta><meta name="dc.Creator" content="Susan  Jenkins" /></meta><meta name="dc.Creator" content="Samuel W.  Gerritz" /></meta><meta name="dc.Creator" content="Annapurna  Pendri" /></meta><meta name="dc.Description" content="The standard of care for HIV-1 infection, highly active antiretroviral therapy (HAART), combines two or more drugs from at least two classes. Even with the success of HAART, new drugs with novel me..." /></meta><meta name="Description" content="The standard of care for HIV-1 infection, highly active antiretroviral therapy (HAART), combines two or more drugs from at least two classes. Even with the success of HAART, new drugs with novel me..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="February 21, 2020" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b01681" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2020 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01681" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b01681" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01681" /></link>
        
    
    

<title>Discovery and Optimization of Novel Pyrazolopyrimidines as Potent and Orally Bioavailable Allosteric HIV-1 Integrase Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b01681" /></meta><meta property="og:title" content="Discovery and Optimization of Novel Pyrazolopyrimidines as Potent and Orally Bioavailable Allosteric HIV-1 Integrase Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01681/20200306/images/large/jm9b01681_0016.jpeg" /></meta><meta property="og:description" content="The standard of care for HIV-1 infection, highly active antiretroviral therapy (HAART), combines two or more drugs from at least two classes. Even with the success of HAART, new drugs with novel mechanisms are needed to combat viral resistance, improve adherence, and mitigate toxicities. Active site inhibitors of HIV-1 integrase are clinically validated for the treatment of HIV-1 infection. Here we describe allosteric inhibitors of HIV-1 integrase that bind to the LEDGF/p75 interaction site and disrupt the structure of the integrase multimer that is required for the HIV-1 maturation. A series of pyrazolopyrimidine-based inhibitors was developed with a vector in the 2-position that was optimized by structure-guided compound design. This resulted in the discovery of pyrazolopyrimidine 3, which was optimized at the 2- and 7-positions to afford 26 and 29 as potent allosteric inhibitors of HIV-1 integrase that exhibited low nanomolar antiviral potency in cell culture and encouraging PK properties." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b01681"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01681">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b01681&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b01681&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b01681&amp;href=/doi/10.1021/acs.jmedchem.9b01681" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 5</span><span class="cit-fg-pageRange">, 2620-2637</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/5" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b01526" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.9b01752" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery and Optimization of Novel Pyrazolopyrimidines as Potent and Orally Bioavailable Allosteric HIV-1 Integrase Inhibitors</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Guo Li</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Guo Li</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Early Discovery Chemistry, Bristol-Myers Squibb Research and Development, Wallingford, Connecticut 06492, United States</div></div><span class="conrtib-corresp"><strong>*</strong>G.L.: e-mail, <a href="/cdn-cgi/l/email-protection#a0c7d5cf8eccc9e0c2cdd38ec3cfcd"><span class="__cf_email__" data-cfemail="8becfee4a5e7e2cbe9e6f8a5e8e4e6">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Guo++Li">Guo Li</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Nicholas A. Meanwell</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Nicholas A. Meanwell</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, Bristol-Myers Squibb Research and Development, Wallingford, Connecticut 06492, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Nicholas+A.++Meanwell">Nicholas A. Meanwell</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-8857-1515" title="Orcid link">http://orcid.org/0000-0002-8857-1515</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Mark R. Krystal</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mark R. Krystal</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Virology Discovery Biology, Bristol-Myers Squibb Research and Development, Wallingford, Connecticut 06492, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mark+R.++Krystal">Mark R. Krystal</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">David R. Langley</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">David R. Langley</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Computer-Aided Drug Design & Molecular Analytics, Bristol-Myers Squibb Research and Development, Princeton, New Jersey 08543-4000, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=David+R.++Langley">David R. Langley</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">B. Narasimhulu Naidu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">B. Narasimhulu Naidu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, Bristol-Myers Squibb Research and Development, Wallingford, Connecticut 06492, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=B.+Narasimhulu++Naidu">B. Narasimhulu Naidu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Prasanna Sivaprakasam</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Prasanna Sivaprakasam</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Computer-Aided Drug Design & Molecular Analytics, Bristol-Myers Squibb Research and Development, Princeton, New Jersey 08543-4000, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Prasanna++Sivaprakasam">Prasanna Sivaprakasam</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hal Lewis</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hal Lewis</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Molecular Structure and Design, Bristol-Myers Squibb Research and Development, Princeton, New Jersey 08543-4000, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hal++Lewis">Hal Lewis</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kevin Kish</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kevin Kish</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Molecular Structure and Design, Bristol-Myers Squibb Research and Development, Princeton, New Jersey 08543-4000, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kevin++Kish">Kevin Kish</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Javed A. Khan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Javed A. Khan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Molecular Structure and Design, Bristol-Myers Squibb Research and Development, Princeton, New Jersey 08543-4000, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Javed+A.++Khan">Javed A. Khan</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Alicia Ng</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Alicia Ng</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Materials Science, Bristol-Myers Squibb Research and Development, Wallingford, Connecticut 06492, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Alicia++Ng">Alicia Ng</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">George L. Trainor</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">George L. Trainor</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, Bristol-Myers Squibb Research and Development, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=George+L.++Trainor">George L. Trainor</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Christopher Cianci</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Christopher Cianci</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Virology Discovery Biology, Bristol-Myers Squibb Research and Development, Wallingford, Connecticut 06492, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Christopher++Cianci">Christopher Cianci</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ira B. Dicker</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ira B. Dicker</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Virology Discovery Biology, Bristol-Myers Squibb Research and Development, Wallingford, Connecticut 06492, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ira+B.++Dicker">Ira B. Dicker</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Michael A. Walker</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Michael A. Walker</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, Bristol-Myers Squibb Research and Development, Wallingford, Connecticut 06492, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Michael+A.++Walker">Michael A. Walker</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Zeyu Lin</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Zeyu Lin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Virology Discovery Biology, Bristol-Myers Squibb Research and Development, Wallingford, Connecticut 06492, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Zeyu++Lin">Zeyu Lin</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Tricia Protack</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Tricia Protack</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Virology Discovery Biology, Bristol-Myers Squibb Research and Development, Wallingford, Connecticut 06492, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Tricia++Protack">Tricia Protack</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Linda Discotto</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Linda Discotto</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Virology Discovery Biology, Bristol-Myers Squibb Research and Development, Wallingford, Connecticut 06492, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Linda++Discotto">Linda Discotto</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Susan Jenkins</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Susan Jenkins</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Research and Development, Wallingford, Connecticut 06492, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Susan++Jenkins">Susan Jenkins</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Samuel W. Gerritz</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Samuel W. Gerritz</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Early Discovery Chemistry, Bristol-Myers Squibb Research and Development, Wallingford, Connecticut 06492, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Samuel+W.++Gerritz">Samuel W. Gerritz</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Annapurna Pendri</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Annapurna Pendri</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Early Discovery Chemistry, Bristol-Myers Squibb Research and Development, Wallingford, Connecticut 06492, United States</div></div><span class="conrtib-corresp"><strong>*</strong>A.P.: e-mail, <a href="/cdn-cgi/l/email-protection#b6d7d8d8d7c6c3c4d8d798c6d3d8d2c4dff6d4dbc598d5d9db"><span class="__cf_email__" data-cfemail="99f8f7f7f8e9ecebf7f8b7e9fcf7fdebf0d9fbf4eab7faf6f4">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Annapurna++Pendri">Annapurna Pendri</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6070-5171" title="Orcid link">http://orcid.org/0000-0002-6070-5171</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01681&amp;href=/doi/10.1021%2Facs.jmedchem.9b01681" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 5</span><span class="cit-pageRange">, 2620–2637</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">February 21, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>10 October 2019</li><li><span class="item_label"><b>Published</b> online</span>21 February 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 12 March 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b01681" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01681</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2620%26pageCount%3D18%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DGuo%2BLi%252C%2BNicholas%2BA.%2BMeanwell%252C%2BMark%2BR.%2BKrystal%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D5%26contentID%3Dacs.jmedchem.9b01681%26title%3DDiscovery%2Band%2BOptimization%2Bof%2BNovel%2BPyrazolopyrimidines%2Bas%2BPotent%2Band%2BOrally%2BBioavailable%2BAllosteric%2BHIV-1%2BIntegrase%2BInhibitors%26numPages%3D18%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D2637%26publicationDate%3DMarch%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b01681"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1361</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">7</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b01681" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery and Optimization of Novel Pyrazolopyrimidines as Potent and Orally Bioavailable Allosteric HIV-1 Integrase Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Guo&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Nicholas&quot;,&quot;last_name&quot;:&quot;A. Meanwell&quot;},{&quot;first_name&quot;:&quot;Mark&quot;,&quot;last_name&quot;:&quot;R. Krystal&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;R. Langley&quot;},{&quot;first_name&quot;:&quot;B.&quot;,&quot;last_name&quot;:&quot;Narasimhulu Naidu&quot;},{&quot;first_name&quot;:&quot;Prasanna&quot;,&quot;last_name&quot;:&quot;Sivaprakasam&quot;},{&quot;first_name&quot;:&quot;Hal&quot;,&quot;last_name&quot;:&quot;Lewis&quot;},{&quot;first_name&quot;:&quot;Kevin&quot;,&quot;last_name&quot;:&quot;Kish&quot;},{&quot;first_name&quot;:&quot;Javed&quot;,&quot;last_name&quot;:&quot;A. Khan&quot;},{&quot;first_name&quot;:&quot;Alicia&quot;,&quot;last_name&quot;:&quot;Ng&quot;},{&quot;first_name&quot;:&quot;George&quot;,&quot;last_name&quot;:&quot;L. Trainor&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;Cianci&quot;},{&quot;first_name&quot;:&quot;Ira&quot;,&quot;last_name&quot;:&quot;B. Dicker&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;A. Walker&quot;},{&quot;first_name&quot;:&quot;Zeyu&quot;,&quot;last_name&quot;:&quot;Lin&quot;},{&quot;first_name&quot;:&quot;Tricia&quot;,&quot;last_name&quot;:&quot;Protack&quot;},{&quot;first_name&quot;:&quot;Linda&quot;,&quot;last_name&quot;:&quot;Discotto&quot;},{&quot;first_name&quot;:&quot;Susan&quot;,&quot;last_name&quot;:&quot;Jenkins&quot;},{&quot;first_name&quot;:&quot;Samuel&quot;,&quot;last_name&quot;:&quot;W. Gerritz&quot;},{&quot;first_name&quot;:&quot;Annapurna&quot;,&quot;last_name&quot;:&quot;Pendri&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;02&quot;,&quot;day&quot;:&quot;21&quot;,&quot;issue&quot;:&quot;5&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;2620-2637&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b01681&quot;},&quot;abstract&quot;:&quot;The standard of care for HIV-1 infection, highly active antiretroviral therapy (HAART), combines two or more drugs from at least two classes. Even with the success of HAART, new drugs with novel mechanisms are needed to combat viral resistance, improve adherence, and mitigate toxicities. Active site inhibitors of HIV-1 integrase are clinically validated for the treatment of HIV-1 infection. Here we describe allosteric inhibitors of HIV-1 integrase that bind to the LEDGF/p75 interaction site and disrupt the structure of the integrase multimer that is required for the HIV-1 maturation. A series of pyrazolopyrimidine-based inhibitors was developed with a vector in the 2-position that was optimized by structure-guided compound design. This resulted in the discovery of pyrazolopyrimidine 3, which was optimized at the 2- and 7-positions to afford 26 and 29 as potent allosteric inhibitors of HIV-1 integrase that exhibited low nanomolar antiviral potency in cell culture and encouraging PK properties.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01681&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01681" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01681&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01681" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01681&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01681" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01681&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01681&amp;href=/doi/10.1021/acs.jmedchem.9b01681" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b01681" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b01681" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01681&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b01681%26sid%3Dliteratum%253Aachs%26pmid%3D32081010%26genre%3Darticle%26aulast%3DLi%26date%3D2020%26atitle%3DDiscovery%2Band%2BOptimization%2Bof%2BNovel%2BPyrazolopyrimidines%2Bas%2BPotent%2Band%2BOrally%2BBioavailable%2BAllosteric%2BHIV-1%2BIntegrase%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D5%26spage%3D2620%26epage%3D2637%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291362" title="Antimicrobial agents">Antimicrobial agents</a>,</li><li><a href="/action/doSearch?ConceptID=290676" title="Substituents">Substituents</a>,</li><li><a href="/action/doSearch?ConceptID=291316" title="Mixtures">Mixtures</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/5" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/jmcmar.2020.63.issue-5/20200312/jmcmar.2020.63.issue-5.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01681/20200306/images/medium/jm9b01681_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01681/20200306/images/large/jm9b01681_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01681&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The standard of care for HIV-1 infection, highly active antiretroviral therapy (HAART), combines two or more drugs from at least two classes. Even with the success of HAART, new drugs with novel mechanisms are needed to combat viral resistance, improve adherence, and mitigate toxicities. Active site inhibitors of HIV-1 integrase are clinically validated for the treatment of HIV-1 infection. Here we describe allosteric inhibitors of HIV-1 integrase that bind to the LEDGF/p75 interaction site and disrupt the structure of the integrase multimer that is required for the HIV-1 maturation. A series of pyrazolopyrimidine-based inhibitors was developed with a vector in the 2-position that was optimized by structure-guided compound design. This resulted in the discovery of pyrazolopyrimidine <b>3</b>, which was optimized at the 2- and 7-positions to afford <b>26</b> and <b>29</b> as potent allosteric inhibitors of HIV-1 integrase that exhibited low nanomolar antiviral potency in cell culture and encouraging PK properties.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="specialIssueNotice" class="extra-info-sec articleNote"><h4>SPECIAL ISSUE</h4><p class="last">This article is part of the <a href="/toc/jmcmar/63/5"><issue-title>Women in Medicinal Chemistry</issue-title></a> special issue.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50651" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50651" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Human immunodeficiency virus type 1 (HIV-1) is the etiologic agent underlying acquired immunodeficiency syndrome (AIDS) and was first recognized and diagnosed in the early 1980s. After more than 30 years, HIV-1 infection remains a significant medical problem and is now a global epidemic that infects 37 million people worldwide. At present, more than 40 drugs have been approved for the treatment of HIV-1/AIDS and these are used to create combination regimens designed to mitigate the emergence of resistance. These drugs belong mainly to four classes: nucleoside and non-nucleoside inhibitors of reverse transcriptase, integrase (IN) inhibitors, and inhibitors of HIV-1 protease.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> In addition, the HIV-1 entry inhibitors maraviroc (a CCR5 co-receptor antagonist), enfuvirtide (a peptidic inhibitor of gp41 fusion), and ibalizumab (a nonimmunosuppressive monoclonal antibody that binds to the host cell receptor CD4) are available for later lines of therapy. Key challenges have been the continued emergence of resistance and the long-term toxicity associated with approved anti-HIV-1 drugs. The identification of additional viral targets and the development of new classes of antiviral compounds are essential in the continued fight against HIV/AIDS.</div><div class="NLM_p">HIV-1 integrase is the enzyme responsible for integrating viral DNA into the host cell genome. Active site-targeted integrase strand transfer inhibitors (INSTIs) are clinically useful therapeutics that include raltegravir, elvitegravir, dolutegravir, and bictegravir (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> These inhibitors bind to the active site of the integrase enzyme, forming a ternary complex with 3′ processed proviral DNA that impairs strand transfer activity, the step that initiates the integration of viral DNA into host DNA. In contrast, the allosteric integrase inhibitors (ALLINIs) bind to a site located at the HIV-1 integrase dimer interface that is recognized by the host cell transcription factor lens epithelium-derived growth factor (LEDGF/p75).<a onclick="showRef(event, 'ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref5">(3−5)</a> The important role of LEDGF/p75 in HIV-1 integration has been validated in vitro by site-directed mutagenesis studies,<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6,7)</a> RNAi knockdown experiments, and cellular expression of the integrase binding domain (IBD) of LEDGF that inhibits HIV-1 replication in cell culture.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8,9)</a> Recent studies showed that the multifunctional ALLINIs not only inhibit IN binding to its cofactor LEDGF/p75 but also promote aberrant IN multimerization to block viral maturation, leading to the production of structurally defective, noninfectious virions.<a onclick="showRef(event, 'ref10 ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12 ref13">(10−13)</a> The pleiotropic effects of ALLINIs suggest considerable promise as antiviral agents for the development of HIV-1 therapeutics.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> The potential of this new class of inhibitor led us to explore compounds that bind to the novel dimer interface pocket.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01681/20200306/images/medium/jm9b01681_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01681/20200306/images/large/jm9b01681_0001.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of Food and Drug Administration (FDA)-approved HIV-1 active site-targeted integrase strand transfer inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01681/20200306/images/large/jm9b01681_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01681&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38226" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38226" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The 2-(quinolin-3-yl)acetic acid derivative <b>1</b> was shown to bind to the ALLINI site on HIV-1 integrase, presenting rudimentary elements of a pharmacophore that were more fully appreciated in the context of a cocrystal structure of the compound bound to the integrase CCD dimer interface.<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14,15)</a> This structure revealed a well-defined binding pocket that could accommodate small molecules and indicated the importance of both the <i>tert</i>-butoxyacetic acid moiety and the quinoline 4-substituent as key recognition elements.<a onclick="showRef(event, 'ref14 ref15 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref14 ref15 ref16 ref17">(14−17)</a> The analysis of the structure focused attention on exploring alternatives to the quinoline scaffold that would offer opportunities for unique substituent vector presentation and which may lead to improved potency and enhanced drug-like properties. The initial screening strategy relied upon evaluation of test compounds in a binding assay in which displacement of a tritiated version of <b>1</b> was monitored to provide <i>K</i><sub>i</sub> values. Antiviral activity was assessed in a cell culture replication assay using a fully replicating NL<sub>4–3</sub> virus containing the <i>Renilla</i> luciferase gene in place of nef (WT EC<sub>50</sub>), with the cytotoxicity (CC<sub>50</sub>) of test compounds toward the host MT-2 cells determined in parallel.</div><div class="NLM_p">A computer-aided drug design (CADD) approach based on careful analysis of the cocrystal structure allowed an in silico assessment of the potential of a series of scaffolds that were scored by a best fit analysis for their complementarity to the pocket formed by the integrase dimer. To aid in this analysis, the biphenyl derivative <b>2</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>) was prepared as an abbreviated model system for <b>1</b> and found to be poorly active in the displacement assay with a <i>K</i><sub>i</sub> value of 67 μM, although the compound exhibited weak but detectable antiviral activity in cell culture (WT EC<sub>50</sub> = 16 μM, CC<sub>50</sub> = 127 μM)). Several additional scaffolds were investigated for their potential to bind to the pocket, and the pyrazolopyrimidine derivative <b>3</b> emerged as a compound with a <i>K</i><sub>i</sub> value of 2 μM in the binding assay that inhibited WT virus in cell culture with an EC<sub>50</sub> value of 4.5 μM, a promising preliminary profile. Structural modification of the unsaturated 6,6-fused ring system found in <b>1</b> to the 5,6-scaffold of <b>3</b> provided an alternative core system that reduced the aromatic nature of the fused heterocyclic ring while offering topologically distinct vectors for structural exploration and elaboration, particularly at the C-2 position which bisects the vectors offered by <b>1</b>. Indeed, the introduction of a phenyl substituent at the 2-position of <b>3</b> afforded <b>4</b> as a compound with improved potency in the binding assay (<i>K</i><sub>i</sub> = 700 nM) which translated to enhanced antiviral activity, WT EC<sub>50</sub> = 620 nM, CC<sub>50</sub> = 77 μM. Consistent with the emerging structure–activity relationships (SARs) for ALLINI inhibitors, the carboxamide <b>5</b> and alcohol <b>6</b> were considerably less potent than <b>4</b>, with WT EC<sub>50</sub> values of 18 and >40 μM, respectively. As a consequence, <b>4</b> was adopted as a promising lead structure suitable for further optimization.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01681/20200306/images/medium/jm9b01681_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01681/20200306/images/large/jm9b01681_0002.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Scaffold modification and preliminary SAR exploration associated with ALLINIs <b>2</b>–<b>6</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01681/20200306/images/large/jm9b01681_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01681&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The initial phase of study with <b>4</b> explored the effect of variation of the C-7 substituent, with the results compiled in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>. Removal of the <i>para</i>-CH<sub>3</sub> substituent from the 7-phenyl moiety of <b>4</b> resulted in <b>7</b>, which exhibited 5-fold reduced potency in the binding assay while failing to significantly inhibit virus replication in cell culture. However, the 4-OCH<sub>3</sub> analogue <b>8</b> offered improved potency in the binding assay, although this compound was less active than <b>4</b> in the cell-based assay. Installation of CH<sub>3</sub> or OCH<sub>3</sub> substituents at the <i>meta</i>- and <i>ortho</i>- positions of the C-7 phenyl ring, explored in <b>9</b>-<b>12</b>, led to reduced activity in both assays. However, the incorporation of a combination of <i>para</i>-alkoxy and <i>meta</i>-alkyl substitution in the context of the chromane ring<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> of <b>13</b> resulted in a 10-fold increase in potency in the binding assay, although the magnitude did not fully translate to antiviral activity in cell culture. Substitution of the chromane ring led to the production of separable atropisomers of which the major isomer <b>14</b> was more potent than the minor isomer <b>15</b>. The identity of the atropisomers was established by single crystal X-ray structure determination which revealed <b>14</b> to be a mixture of two enantiomers, assigned as (<i>S</i>,<i>S</i>) and (<i>R</i>,<i>R</i>) (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>), while <b>15</b> was a mixture of the (<i>S</i>,<i>R</i>) and (<i>R</i>,<i>S</i>) isomers (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). The separated diastereomers <b>14</b> and <b>15</b> showed no interconversion at temperatures ranging from 30 to 100 °C in NMR experiments conducted in DMSO-<i>d</i><sub>6</sub>, with configurational stability attributed to the presence of the adjacent bulky <i>tert</i>-butoxy moiety.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Effect of Substituent Variation at the 7-Position of Pyrazolopyrimidine <b>4</b> on Binding Potency and Antiviral Activity As Explored with <b>7</b>–<b>19</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01681/20200306/images/medium/jm9b01681_0011.gif" alt="" id="fx1" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last"><i>K</i><sub>i</sub> and EC<sub>50</sub> values were the result of multiple determinations (<i>n</i> ≥ 2).</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last"><i>K</i><sub>i</sub> and EC<sub>50</sub> values were obtained after single determinations (<i>n</i> = 1).</p></div></div><div></div></div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01681/20200306/images/medium/jm9b01681_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01681/20200306/images/large/jm9b01681_0003.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Single crystal X-ray structure of (<i>S</i>,<i>S</i> and <i>R</i>,<i>R</i>)-<b>14</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01681/20200306/images/large/jm9b01681_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01681&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01681/20200306/images/medium/jm9b01681_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01681/20200306/images/large/jm9b01681_0004.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Single crystal X-ray structure of (<i>S</i>,<i>R</i> and <i>R</i>,<i>S</i>)-<b>15</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01681/20200306/images/large/jm9b01681_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01681&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Both binding and antiviral activity were dependent on the identity of the substituent at C-7, since the simple CH<sub>3</sub>-substituted analogue <b>16</b> was poorly active in both assays, as was the substituted aniline <b>17</b>. However, cyclic amine-based substituents at C-7 were tolerated, as exemplified by <b>18</b> and <b>19</b>, with the latter compound exhibiting antiviral activity in cell culture that was comparable to <b>4</b>.</div><div class="NLM_p">The (<i>S</i>,<i>S</i>)- and (<i>R</i>,<i>R</i>)-enantiomers of <b>14</b> were successfully separated by chromatography using a chiral column, with the (<i>S</i>,<i>S</i>)-enantiomer <b>14</b> found to be ∼100-fold more potent (<i>K</i><sub>i</sub> = 0.09 ± 0.02 μM, WT EC<sub>50</sub> = 0.11 ± 0.06 μM) than the (<i>R</i>,<i>R</i>)-enantiomer (<i>K</i><sub>i</sub> > 53 μM, WT EC<sub>50</sub> = 13 μM). Similarly, compound <b>15</b> was successfully resolved by chiral column chromatography; however, both enantiomers were inactive in the cell culture antiviral assay. A single crystal X-ray structure of racemic <b>14</b> (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>) revealed the presence of the <i>S</i>,<i>S</i>- and <i>R</i>,<i>R</i>-enantiomers in one unit cell. In both configurations, the methyl group on the phenyl and the <i>tert</i>-butoxy group on the acid-containing side chain project in opposite directions, while the C-2 phenyl and pyrazolopyrimidine rings are coplanar and the plane of the chromane heterocycle is almost perpendicular to the core (the dihedral angle between the two planes is ∼74°). In contrast to <b>14</b>, the phenyl and the pyrazolopyrimidine elements of <b>15</b> do not approach coplanarity (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). However, the bicyclic chromane ring adopts a dihedral angle relative to the plane of the pyrimidine of ∼66°. Thus, the major difference between <b>14</b> and <b>15</b> is the conformation of the distal phenyl ring, while the elements proximal to the carboxylic acid moiety differ only slightly in their disposition.</div><div class="NLM_p">In order to obtain further insight into the binding interactions between <b>14</b> and the enzyme, a cocrystal structure of the racemic compound and the dimeric HIV-1 integrase catalytic core domain (CCD) was determined (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). A full view of the HIV-1 integrase CCD dimer cocrystallized with two molecules of (<i>S</i>,<i>S</i>)-<b>14</b> is shown in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>a. The structure demonstrated that the inhibitor occupied the same binding pocket as the LEDGF IBD and that the binding is preferential for the more potent (<i>S</i>,<i>S</i>)-enantiomer [the (<i>R</i>,<i>R</i>)-isomer was not observed]. A magnified view of one of the inhibitor binding pockets at the dimer interface is shown in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>b. The carboxylic acid group of (<i>S</i>,<i>S</i>)-<b>14</b> makes a bidentate hydrogen-bonding interaction with the backbone amide NHs of Glu170 and His171 of subunit 2 of the enzyme. In addition, the side chain hydroxyl group of Thr174 of subunit 2 makes a hydrogen-bonding interaction with one of the carboxylic acid oxygen atoms. The <i>tert</i>-butoxy group occupies a hydrophobic pocket created by Thr125, Gln95, Tyr99, and Thr174, while the C7-chromane ring sculpts into another hydrophobic pocket formed by Leu102, Ala129, Thr174, Met178, Trp132, and Ala169. The interactions observed with respect to the carboxylic acid, <i>tert</i>-butoxy, and chromane moieties are consistent with what has been observed in the crystal structures of other ALLINIs bound to HIV-1 integrase CCD dimers.<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18,19)</a> The pyrazolopyrimidine core of (<i>S</i>,<i>S</i>)-<b>14</b> and the 2-phenyl substituent lie on the hydrophobic surface of the subunit 1, and the molecule exhibits tight van der Waals contact with Ala128 in the α3-helix(124–133) of subunit 1. The dihedral angle between the core heterocycle and 2-phenyl ring is ∼30°, which contrasts with the nearly coplanar arrangement observed in the single crystal X-ray structure of (<i>S</i>,<i>S</i>)-<b>14</b> (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>), reflecting the conformational mobility of the substituent. An overlay of the previously solved ALLINI-bound crystal structures of HIV-1 integrase CCD dimers revealed an interesting slight shift in the α3-helix(124–133), presumably to maximize the hydrophobic contacts between Ala128 and the 2-phenyl ring of (<i>S</i>,<i>S</i>)-<b>14</b>. Two crystallographic water molecules bridge the N4 nitrogen atom of the pyrazolopyrimidine core of (<i>S</i>,<i>S</i>)-<b>14</b> with protein residues. An image of <i>F</i><sub>o</sub> – <i>F</i><sub>c</sub> electron density for (<i>S</i>,<i>S</i>)-<b>14</b> and surrounding water molecules contoured at 3σ is shown in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>c. Interestingly, a polyethylene glycol fragment was found to occupy a site just above the ligand. Its positioning corresponds to the positioning of the side chains of Tyr226, Trp235, and Lys266 in the carboxyl terminal domain (CTD) of the CCD–CTD interface discerned in the full length crystal structure of HIV-1 integrase solved by Gupta and colleagues.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Manual docking of (<i>S</i>,<i>S</i>)-<b>14</b> into this full length crystal structure of HIV-1 integrase reveals a snug fit of the 2-phenyl group in an invagination created at the CTD–CCD interface.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01681/20200306/images/medium/jm9b01681_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01681/20200306/images/large/jm9b01681_0005.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (a) Snapshot of the cocrystal structure of (<i>S</i>,<i>S</i>)-<b>14</b> bound to the HIV-1 integrase CCD dimer. Subunits 1 and 2 of the dimer are colored cyan and green, respectively, and (<i>S</i>,<i>S</i>)-<b>14</b> is colored orange. The catalytic domain of HIV-1 integrase that contains the DDE triad is highlighted in purple patches for comparison to the LEDGF binding site where (<i>S</i>,<i>S</i>)-<b>14</b> binds crystallographically. (b) Close-up view of the binding interactions of (<i>S</i>,<i>S</i>)-<b>14</b> in one of the two LEDGF binding pockets at the dimer interface. Hydrogen atoms were added in silico followed by a restrained minimization of the X-ray structure. (c) <i>F</i><sub>o</sub> – <i>F</i><sub>c</sub> electron density map for (<i>S</i>,<i>S</i>)-<b>14</b> and surrounding water molecules contoured at 3σ.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01681/20200306/images/large/jm9b01681_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01681&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Comparison of the cocrystal structures of the dimeric HIV-1 integrase CCD bound to the LEDGF IBD<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>a) and (<i>S</i>,<i>S</i>)-<b>14</b> (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>b) revealed some interesting insights into binding interactions. The carboxylic acid moiety of (<i>S</i>,<i>S</i>)-<b>14</b> engages the backbone amide groups of HIV-1 integrase via two hydrogen-bonding interactions, while the pyrazolopyrimidine core packs into the hydrophobic pocket by relying primarily on van der Waals interactions. The carboxylic acid moiety of (<i>S</i>,<i>S</i>)-<b>14</b> mimics Asp366 of LEDGF, while the chromane group at C-7 mimics the hydrophobic side chain of Ile365. However, (<i>S</i>,<i>S</i>)-<b>14</b> does not take advantage of the interactions availed by Val408 and Phe406 in LEDGF with the integrase protein. Molecular modeling (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>b) suggested that substituents at the <i>meta</i>-position of the 2-phenyl ring of (<i>S</i>,<i>S</i>)-<b>14</b> would extend deeper into the LEDGF binding pocket in a fashion that would more effectively mimic the contacts made by Val408 and Phe406 of the IBD of LEDGF. Consequently, this was viewed as a useful avenue for additional structural elaboration that may lead to improved antiviral activity and the possibility of a higher genetic barrier to the emergence of resistance.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01681/20200306/images/medium/jm9b01681_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01681/20200306/images/large/jm9b01681_0006.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (a) Cocrystal structures of the dimeric HIV-1 integrase CCD bound to the LEDGF IBD. (b) Molecular modeling of substitution at the <i>meta</i>-position of the 2-phenyl group of (<i>S</i>,<i>S</i>)-<b>14</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01681/20200306/images/large/jm9b01681_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01681&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">This phase of the SAR survey is compiled in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a> and revealed that the judicious introduction of substituents to the 2-phenyl ring does indeed lead to enhanced antiviral activity in cell culture. The 4-CH<sub>3</sub> substituent in <b>20</b> improved antiviral potency by a modest 2-fold. That potency was only marginally affected by the introduction of the much larger 4-benzyloxy moiety in <b>21</b>. Further improvements were obtained with <i>meta</i>-substitutions, as explored with <b>22</b>–<b>24</b>, of which the 3-phenyl derivative <b>24</b> offered a 10-fold improvement over prototype <b>14</b>, exhibiting a WT EC<sub>50</sub> value of 15 nM, CC<sub>50</sub> = 10 μM. The biphenyl derivative <b>24</b> was 4-fold more potent than the phenoxy homologue <b>23</b> and comparable to the 3-benzyloxy analogue <b>22</b>. In parallel with optimization of antiviral potency, these inhibitors were profiled in a parallel artificial membrane permeability assay (PAMPA) and evaluated for metabolic stability in rat and human liver microsomal preparations. Analogues <b>20</b>–<b>24</b> exhibited uniformly high permeability in a parallel artificial membrane permeability assay (PAMPA) and generally showed good metabolic stability in the microsomal assays, suggestive of the potential to demonstrate bioavailability following oral administration.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Effect of Structural Modification of the 2-Aryl Moiety on the Antiviral Activity, PAMPA Permeability, and Metabolic Stability in Human and Rat Liver Microsomes of Pyrazolopyrimidines <b>20</b>–<b>24</b> Compared to <b>14</b><a class="ref internalNav" href="#t2fn1" aria-label="f">f</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01681/20200306/images/medium/jm9b01681_0012.gif" alt="" id="fx3" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn2"><div class="footnote" id="t2fn2"><sup><sup>a</sup></sup><p class="last">EC<sub>50</sub> values were obtained by multiple determinations (<i>n</i> ≥ 2).</p></div><div class="footnote" id="t2fn3"><sup><sup>b</sup></sup><p class="last">EC<sub>50</sub> value was obtained after a single determination (<i>n</i> = 1).</p></div><div class="footnote" id="t2fn4"><sup><sup>c</sup></sup><p class="last">PAMPA values were averaged from triplicate determinations (<i>n</i> = 3).</p></div><div class="footnote" id="t2fn5"><sup><sup>d</sup></sup><p class="last">HLM/RLM denotes human and rat liver microsomes, respectively.</p></div><div class="footnote" id="t2fn6"><sup><sup>e</sup></sup><p class="last">Metabolic stability % remaining values were averaged from duplicate experiments (<i>n</i> = 2).</p></div><div class="footnote" id="t2fn1"><sup><sup>f</sup></sup><p class="last">All compounds were screened as a mixture of the (<i>S</i>,<i>S</i>)- and (<i>R</i>,<i>R</i>)-isomers.</p></div></div><div></div></div><div class="NLM_p">A select set of pyrazolopyrimidines was evaluated for antiviral efficacy toward the double mutant G140S/Q148H virus strain that confers resistance to some of the active site-targeting INSTIs. GQ EC<sub>50</sub> values are shown in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a> where the GQ mutant inhibitory activity is compared to that toward WT virus. (<i>S</i>,<i>S</i> and <i>R</i>,<i>R</i>)-<b>14</b>, (<i>S</i>,<i>S</i>)-<b>14</b>, and (<i>S</i>,<i>S</i> and <i>R</i>,<i>R</i>)-<b>24</b> fully retained potency toward the resistant virus strain, whereas the EC<sub>50</sub> value for the INSTI raltegravir shifted by over 1000-fold compared to its inhibitory effect toward WT virus.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Antiviral Activity of the Pyrazolopyrimidine Inhibitors against the INSTI-Resistant G140S/Q148H HIV-1 Strain (GQ EC<sub>50</sub>) Compared to Raltegravir</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01681/20200306/images/medium/jm9b01681_0013.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">EC<sub>50</sub> values were obtained by multiple determinations (<i>n</i> ≥ 2).</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">EC<sub>50</sub> value was obtained by single determination (<i>n</i> = 1).</p></div></div><div></div></div><div class="NLM_p">The beneficial effects of <i>meta</i>-substitutions of the C-2 phenyl moiety in <b>22</b>–<b>24</b> prompted an examination of this structural modification in the context of the C-7 piperidine <b>19</b>, with the result that both the phenyl and benzyloxy derivatives <b>25</b> and <b>26</b>, respectively, were more potent antiviral agents (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). Both <b>19</b> and <b>26</b> exhibited good PAMPA permeability and high microsomal stability in both HLM and RLM.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Effect of Structural Modification of the 2-Aryl Moiety on the Antiviral Activity, PAMPA Permeability, and Metabolic Stability in Human and Rat Liver Microsomes of C-7 Piperidine-Substituted Pyrazolopyrimidines <b>25</b> and <b>26</b> Compared to Prototype <b>19</b><a class="ref internalNav" href="#t4fn1" aria-label="d">d</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01681/20200306/images/medium/jm9b01681_0014.gif" alt="" id="fx6" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn2"><div class="footnote" id="t4fn2"><sup><sup>a</sup></sup><p class="last">EC<sub>50</sub> values were obtained by multiple determinations (<i>n</i> ≥ 2).</p></div><div class="footnote" id="t4fn3"><sup><sup>b</sup></sup><p class="last">PAMPA values were averaged from multiple replicates (<i>n</i> = 3).</p></div><div class="footnote" id="t4fn4"><sup><sup>c</sup></sup><p class="last">Metabolic stability % remaining values were averaged from duplicate experiments (<i>n</i> = 2).</p></div><div class="footnote" id="t4fn1"><sup><sup>d</sup></sup><p class="last">All compounds were screened as a mixture of the <i>S</i>- and R-isomers.</p></div></div><div></div></div><div class="NLM_p">Several of the compounds in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Tables <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a> combined potent antiviral activity with good membrane permeability and high microsomal stability, which suggested that they could be candidates for in vivo pharmacokinetic (PK) studies in the rat to determine the potential for exposure following oral administration. However, as a prelude to these studies, compounds were evaluated in the antiviral cell culture assay in the presence of human serum albumin (HSA EC<sub>50</sub>) since these data would provide a target trough concentration of drug based on the assumption that in vivo activity would be dependent on maintaining drug levels above the protein binding-adjusted EC<sub>90</sub> value. These data were obtained on the more active (<i>S</i>,<i>S</i>)-isomers. The potency of (<i>S</i>,<i>S</i>)-<b>24</b>, the prototype for the series presented in <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>, was increased compared to the racemic mixture with an EC<sub>50</sub> value of 6 nM. However, in the presence of 45 mg/mL of HSA, the approximate concentration of this plasma protein in humans, the EC<sub>50</sub> value for (<i>S</i>,<i>S</i>)-<b>24</b> was 110 nM, an 18-fold attenuation. In an effort to probe this aspect of the profile of the inhibitors, analogues <b>27</b>–<b>31</b> were prepared and the (<i>S</i>,<i>S</i>)-enantiomers evaluated. As summarized in <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>, analogues (<i>S</i>,<i>S</i>)-<b>27</b>–<b>31</b> exhibited excellent antiviral potency in the absence of HSA, with WT EC<sub>50</sub> values ranging from 3 to 6 nM, while all compounds demonstrated a reduced fold-shift in the presence of HSA (5- to 6-fold) compared to (<i>S</i>,<i>S</i>)-<b>24</b>, with the notable exception of the pyridine derivative (<i>S</i>,<i>S</i>)-<b>30</b>, which experienced a similar ∼20-fold shift. The therapeutic index (TI) for this series of compounds is also captured in <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a> and was found to range from 1098 to 6360, with (<i>S</i>,<i>S</i>)-<b>29</b>, one of the more potent inhibitors in the series, exhibiting a TI value of 6360, which compares with a TI value of 66 783 recorded for BI-224436<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> when tested under these assay conditions. The overall profiles of these compounds reflect a combination of good membrane permeability and reasonable metabolic stability, and those compounds with good HSA EC<sub>50</sub> values, (<i>S</i>,<i>S</i>)-<b>27</b>–<b>29</b>, were advanced into rat PK studies.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Antiviral Activity in the Absence and Presence of 45 mg/mL HSA, Fold Shift in Potency, Therapeutic Index, PAMPA Permeability, and Metabolic Stability Associated with Pyrazolopyrimidine Derivatives (<i>S</i>,<i>S</i>)-<b>24</b> and (<i>S</i>,<i>S</i>)-<b>27</b>–<b>31</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01681/20200306/images/medium/jm9b01681_0015.gif" alt="" id="fx7" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">EC<sub>50</sub> or CC<sub>50</sub> values were obtained by multiple determinations (<i>n</i> ≥ 2).</p></div><div class="footnote" id="t5fn2"><sup><sup>b</sup></sup><p class="last">EC<sub>50</sub> or CC<sub>50</sub> value was obtained by single determination (<i>n</i> = 1).</p></div><div class="footnote" id="t5fn3"><sup><sup>c</sup></sup><p class="last">PAMPA values were averaged from multiple replicates (<i>n</i> = 3).</p></div><div class="footnote" id="t5fn4"><sup><sup>d</sup></sup><p class="last">Metabolic stability % remaining values were averaged from duplicate experiments (<i>n</i> = 2).</p></div></div><div></div></div><div class="NLM_p">Rat PK studies monitored drug levels in plasma for 24 h following oral administration of a 5 mg/kg dose. Results are compiled in <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>. All three compounds demonstrated low to moderate clearance and low volumes of distribution. The <i>ortho</i>-methyl (<i>S</i>,<i>S</i>)-<b>27</b> and <i>ortho-</i>fluoro (<i>S</i>,<i>S</i>)-<b>29</b> derivatives exhibited lower clearance than the <i>ortho</i>-methoxy analogue (<i>S</i>,<i>S</i>)-<b>28</b>, although the latter demonstrated the highest oral bioavailability of this short series of compounds. These results indicate that the series offers promising PK profiles.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Rat PK Data for (<i>S</i>,<i>S</i>)-<b>27</b>–<b>29</b><a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>max</sub> ± SD (nM)</th><th class="colsep0 rowsep0" align="center"><i>t</i><sub>max</sub> ± SD (h)</th><th class="colsep0 rowsep0" align="center">AUC<sub>0–24h</sub> ± SD (nM·h)</th><th class="colsep0 rowsep0" align="center"><i>t</i><sub>1/2</sub> ± SD (h)</th><th class="colsep0 rowsep0" align="center">clearance ± SD (mL min<sup>–1</sup> kg<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center"><i>V</i><sub>ss</sub> ± SD (L/kg)</th><th class="colsep0 rowsep0" align="center"><i>F</i> (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>S</i>,<i>S</i>)-<b>27</b></td><td class="colsep0 rowsep0" align="left">1292 ± 1062</td><td class="colsep0 rowsep0" align="left">3 ± 0</td><td class="colsep0 rowsep0" align="left">6300 ± 2532</td><td class="colsep0 rowsep0" align="left">4.1 ± 0.1</td><td class="colsep0 rowsep0" align="left">7.1 ± 0.3</td><td class="colsep0 rowsep0" align="left">0.5 ± 0.1</td><td class="colsep0 rowsep0" align="left">32</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>S</i>,<i>S</i>)-<b>28</b></td><td class="colsep0 rowsep0" align="left">1106 ± 697</td><td class="colsep0 rowsep0" align="left">2.3 ± 1.3</td><td class="colsep0 rowsep0" align="left">2991 ± 958</td><td class="colsep0 rowsep0" align="left">3 ± 1</td><td class="colsep0 rowsep0" align="left">28 ± 5.7</td><td class="colsep0 rowsep0" align="left">1.8 ± 1.8</td><td class="colsep0 rowsep0" align="left">59</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>S</i>,<i>S</i>)-<b>29</b></td><td class="colsep0 rowsep0" align="left">803 ± 0</td><td class="colsep0 rowsep0" align="left">2.7 ± 3.8</td><td class="colsep0 rowsep0" align="left">4733 ± 0</td><td class="colsep0 rowsep0" align="left">2 ± 0</td><td class="colsep0 rowsep0" align="left">13 ± 0</td><td class="colsep0 rowsep0" align="left">0.7 ± 0.0</td><td class="colsep0 rowsep0" align="left">44</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup><sup>a</sup></sup><p class="last">All compounds were dosed at 1 mpk (iv) and 5 mpk (po). All values were obtained from multiple determinations (<i>n</i> = 3) for both iv and po.</p></div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22445" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22445" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The initial synthetic route to pyrazolopyrimidine <b>4</b> originated with the condensation of commercially available benzaldehyde <b>32</b>, 3-aminopyrazole <b>33</b>, and methyl acetoacetate in a three component, one-pot reaction that was followed by oxidation with DDQ to form the pyrazolopyrimidine core <b>34</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). The methyl ester of <b>34</b> was transformed into the aldehyde <b>35</b>, which was directly converted to the cyanohydrin <b>36</b>. <i>tert</i>-Butyl ether formation using HClO<sub>4</sub> and <i>tert</i>-butyl acetate resulted in partial hydrolysis of the nitrile moiety of <b>36</b> to give the carboxamide <b>5</b>. Alternatively, the hydrolysis of <b>36</b> under strongly acidic conditions provided the desired acid <b>6</b>. Esterification of the acid <b>6</b> and subsequent treatment with HClO<sub>4</sub> and <i>tert</i>-butyl acetate in CH<sub>2</sub>Cl<sub>2</sub> installed the <i>tert</i>-butyl ether followed by saponification to yield the pyrazolopyrimidine acid <b>4</b>.</div><figure id="sch1" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01681/20200306/images/medium/jm9b01681_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01681/20200306/images/large/jm9b01681_0007.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Pyrazolopyrimidine <b>4</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01681/20200306/images/large/jm9b01681_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01681&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (i) Methyl acetoacetate, THF, heptane, piperidine, reflux; (ii) DDQ, CH<sub>2</sub>Cl<sub>2</sub>; (b) (i) DIBAL, THF, CH<sub>2</sub>Cl<sub>2</sub>; (ii) PCC, CH<sub>2</sub>Cl<sub>2</sub>; (c) ZnI<sub>2</sub>, TMSCN, CH<sub>2</sub>Cl<sub>2</sub>; (d) HCl (conc), 90 °C; (e) (i) SOCl<sub>2</sub>, MeOH; (ii) HClO<sub>4</sub>, <i>tert</i>-butyl acetate, CH<sub>2</sub>Cl<sub>2</sub>; (iii) LiOH, 1,4-dioxane; (f) HClO<sub>4</sub>, <i>tert</i>-butyl acetate, CH<sub>2</sub>Cl<sub>2</sub>.</p></p></figure><div class="NLM_p">The synthetic route to access compounds with structural variation at the C-7 position is exemplified in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a> and utilized <b>41</b> as a common intermediate for C-7 modification. Reaction of aminopyrazole <b>33</b> with dimethyl 2-acetylsuccinate (<b>37</b>) afforded pyrazolopyrimidine <b>38</b>, which was converted to the chloride <b>39</b> using POCl<sub>3</sub>. The benzylic hydroxyl group on <b>40</b> was introduced by deprotonation followed by treatment with the Davis reagent<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> to give <b>40</b> as a racemic mixture. Alcohol <b>40</b> was treated with HClO<sub>4</sub> and <i>tert</i>-butyl acetate in CH<sub>2</sub>Cl<sub>2</sub> to afford the <i>tert</i>-butyl ether <b>41</b>, a versatile intermediate. Subjecting <b>41</b> to a Suzuki–Miyaura coupling at C-7 with arylboronic acids allowed the introduction of a diverse set of aryl substituents. A Negishi coupling reaction was used to introduce C-7 alkyl groups, while a nucleophilic displacement reaction with different amines or anilines resulted in a series of C-7 amino-substituted analogs.</div><figure id="sch2" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01681/20200306/images/medium/jm9b01681_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01681/20200306/images/large/jm9b01681_0008.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Pyrazolopyrimidine <b>14</b>, <b>15</b>, <b>16</b>, and <b>19</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01681/20200306/images/large/jm9b01681_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01681&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <i>p</i>-TsOH·H<sub>2</sub>O, xylene, reflux; (b) POCl<sub>3</sub>, reflux; (c) (i) KHMDS, THF, −78 °C; (ii) 2-(phenylsulfonyl)-3-phenyloxaziridine (Davis reagent); (d) HClO<sub>4</sub>, <i>tert</i>-butylacetate, CH<sub>2</sub>Cl<sub>2</sub>; (e) (i) 2-(8-fluoro-5-methylchroman-6-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, DMF, microwave, 130 °C; (ii) LiOH, 1,4-dioxane; (f) (i) Pd(PPh<sub>3</sub>)<sub>4</sub>, MeZnCl, THF; (ii) LiOH, 1,4-dioxane; (g) (i) 4,4-dimethylpiperidine, HCl salt, DIEA, NMP, 50 °C; (ii) LiOH.</p></p></figure><div class="NLM_p">An alternative synthetic route was developed to introduce modifications at C-2 and began with condensation of 5-bromo-3-aminopyrazole (<b>42</b>) with <b>37</b> afforded pyrazolopyrimidine <b>43</b>, which was converted to the chloride <b>44</b> using POCl<sub>3</sub>. The benzylic hydroxyl group on <b>45</b> was introduced by deprotonation followed by treatment with Davis reagent to give <b>45</b> as a racemic mixture. Alcohol <b>45</b> was then treated with HClO<sub>4</sub> and <i>t</i>-butyl acetate in CH<sub>2</sub>Cl<sub>2</sub> to procure the key intermediate <b>46</b> (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). A selective Suzuki–Miyaura coupling at the C-2 position of <b>46</b> was realized by controlling the reaction temperature and varying the base (70 °C, K<sub>2</sub>CO<sub>3</sub>). After completion of the Suzuki–Miyaura coupling at the 2-position, the 7-chloro was subjected to a second Suzuki–Miyaura coupling that was conducted at 130 °C using K<sub>3</sub>PO<sub>4</sub> as the base. Alternatively, the C-7 chlorine could be displaced by amines. A final hydrolysis afforded acids <b>20</b> and <b>25</b>.</div><figure id="sch3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01681/20200306/images/medium/jm9b01681_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01681/20200306/images/large/jm9b01681_0009.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Pyrazolopyrimidine (<i>S</i>,<i>S</i>)- and (<i>R</i>,<i>R</i>)-<b>20</b> and -<b>25</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01681/20200306/images/large/jm9b01681_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01681&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <i>p</i>-TsOH·H<sub>2</sub>O, xylene, reflux; (b) POCl<sub>3</sub>, reflux; (c) (i) KHMDS, THF, −78 °C; (ii) 2-(phenylsulfonyl)-3-phenyloxaziridine (Davis reagent); (d) HClO<sub>4</sub>, <i>tert</i>-butyl acetate, DCM; (e) (i) <i>p</i>-tolylboronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub> (2M), DMF, microwave, 70 °C; (f) (i) 2-(8-fluoro-5-methylchroman-6-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>3</sub>PO<sub>4</sub> (2M), DMF, microwave, 130 °C; (ii) LiOH 1,4-dioxane; (g) (i) 2-([1,1′-biphenyl]-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub> (2 M), DMF, microwave, 70 °C; (ii) 4,4-dimethylpiperidine, HCl salt, DIEA, NMP, 50 °C; (iii) LiOH, 1,4-dioxane.</p></p></figure><div class="NLM_p">Although the active chiral compound (<i>S</i>,<i>S</i>)-<b>14</b> and the less active enantiomer (<i>R</i>,<i>R</i>)-<b>14</b> could be separated by chiral column chromatography, the yield of the active enantiomer was low and the separation was time-consuming. To alleviate this problem, an efficient chiral synthetic route was developed to make the (<i>S</i>,<i>S</i>)-isomer of the biarylpyrazolopyrimidines starting from aminopyrazole <b>48</b> (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>). The racemic alcohol <b>51</b> was oxidized to the corresponding ketone using the Dess–Martin reagent, setting the stage for an enantioselective reduction using catecholborane in the presence of a chiral oxazaborolidine,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> which resulted in the isolation of (<i>S</i>)-<b>53</b> with 96% ee. Compound <b>53</b> was treated with HClO<sub>4</sub> and <i>tert</i>-butyl acetate to afford the corresponding <i>tert</i>-butyl ether <b>54</b>, which was subjected to two consecutive Suzuki–Miyaura coupling reactions. The phenyl-based chlorine is much less reactive than the chlorine attached to the pyrimidine ring, allowing for excellent selectivity and directing the first Suzuki–Miyaura coupling to C-7. The second Suzuki–Miyaura coupling was achieved in the presence of Pd(OAc)<sub>2</sub> using the S-Phos ligand, and hydrolysis of <b>55</b> gave the targeted chiral pyrazolopyrimidine (<i>S</i>,<i>S</i>)-<b>27</b>.</div><figure id="sch4" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01681/20200306/images/medium/jm9b01681_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01681/20200306/images/large/jm9b01681_0010.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Chiral Synthesis of Pyrazolopyrimidine (<i>S</i>,<i>S</i>)-<b>27</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01681/20200306/images/large/jm9b01681_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01681&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <i>p</i>-TsOH·H<sub>2</sub>O, xylene, reflux; (b) POCl<sub>3</sub>, reflux; (c) (i) KHMDS, THF, −78 °C; (ii) 2-(phenylsulfonyl)-3-phenyloxaziridine (Davis reagent); (d) Dess–Martin periodinane, CH<sub>2</sub>Cl<sub>2</sub>; (e) (<i>R</i>)-1-methyl-3,3-diphenyltetrahydro-1<i>H</i>,3<i>H</i>-pyrrolo[1,2-<i>c</i>][1,3,2]oxazaborole, catecholborane, toluene; (f) HClO<sub>4</sub>, <i>tert</i>-butyl acetate, CH<sub>2</sub>Cl<sub>2</sub>; (g) 2-(8-fluoro-5-methylchroman-6-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>3</sub>PO<sub>4</sub> (2 M), DMF, microwave, 130 °C; (h) (i) <i>o</i>-tolylboronic acid, Pd(OAc)<sub>2</sub>, S-Phos, K<sub>3</sub>PO<sub>4</sub> (2M), DMF, microwave, 130 °C; (ii) LiOH, 1,4-dioxane.</p></p></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11325" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11325" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">This manuscript describes the design, synthesis, and biological activities of a series of novel pyrazolopyrimidines that act as potent allosteric inhibitors of HIV-1 integrase and exhibit drug-like properties. Separation, characterization, and screening of four diastereomers (<i>S</i>,<i>S</i>)-<b>14</b>, (<i>R</i>,<i>R</i>)-<b>14</b>, (<i>S</i>,<i>R</i>)-<b>15</b>, and (<i>R</i>,<i>S</i>)-<b>15</b> provided interesting SARs and demonstrated an impact of conformational differences between atropisomers. A cocrystal structure of (<i>S</i>,<i>S</i>)-<b>14</b> with the dimeric HIV-1 integrase CCD revealed that the inhibitor occupied the same binding pocket as LEDGF. Molecular modeling based on the crystal structure data predicted that substituents incorporated at the <i>meta</i>-position of 2-phenyl group would extend deeper into the ALLINI binding pocket, modifications postulated to lead to increased binding affinity and antiviral activity. This vector proved to be a useful avenue for structural elaboration and resulted in inhibitors with excellent antiviral activity in cell culture. The most potent compound <b>29</b> exhibited a WT EC<sub>50</sub> value of 0.003 μM, while <b>26</b>, which incorporates a dimethylpiperidine substituent at the 7- position, resulted in a WT EC<sub>50</sub> value of 0.06 μM. Both the vector on the 2-position and the amino substituent at the 7-position of the core offer unique SARs for allosteric integrase inhibitors, unprecedented based on prior patent publications<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> and literature articles.<a onclick="showRef(event, 'ref14 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref14 ref16 ref17">(14,16,17)</a> Three compounds, <b>27</b>–<b>29</b>, that exhibited good overall profiles in the in vitro antiviral and PK screening assays, including minimal potency shifts in the presence of HSA, were advanced into rat PK studies and showed promising PK profiles with good oral bioavailability. Further studies based on this chemotype led to allosteric HIV-1 IN inhibitors with excellent cellular potency.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58274" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58274" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Chemistry Information</h3><div class="NLM_p last">Solvents and reagents were used directly as obtained from commercial sources. Flash chromatography was performed on silica gel 60 (0.040–0.063 particle size; EM Science supply). <sup>1</sup>H NMR spectra were recorded on a Bruker DRX-500f spectrometer at 500 MHz (or Bruker AV 400 MHz, Bruker DPX-300B, or Varian Gemini 300 at 300 MHz as stated). The chemical shifts are reported in ppm on the δ scale relative to δTMS = 0. The following internal references were used for the residual protons in the following solvents: CDCl<sub>3</sub> (δ<sub>H</sub> 7.26), CD<sub>3</sub>OD (δ<sub>H</sub> 3.30), acetic-<i>d</i><sub>4</sub> (acetic acid-<i>d</i><sub>4</sub>) (δ<sub>H</sub> 11.6, 2.07), DMSOmix or DMSO-<i>d</i><sub>6</sub> CDCl<sub>3</sub> (δ<sub>H</sub> 2.50 and 8.25) (ratio 75%:25%), and DMSO-<i>d</i><sub>6</sub> (δ<sub>H</sub> 2.50). Standard abbreviations were employed to describe the multiplicity patterns: s (singlet), br s (broad singlet), d (doublet), t (triplet), q (quartet), m (multiplet), b (broad), app (apparent). The coupling constants (<i>J</i>) are reported in hertz. All liquid chromatography (LC) data were recorded on a Shimadzu LC-10AS liquid chromatograph using a SPD-10AV UV–vis detector with mass spectrometry (MS) data determined using a Micromass Platform for LC in electrospray mode. The purity of the final compounds was determined by HPLC as described above and is 95% or higher unless specified otherwise.</div></div><div id="sec5_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> 2-(<i>tert</i>-Butoxy)-2-(4′-methyl-[1,1′-biphenyl]-2-yl)acetic Acid (<b>2</b>)</h3><div class="NLM_p last">Di-<i>tert</i>-butyl dicarbonate (4.453 g, 20.40 mmol) was added to a mixture of methyl 2-(2-bromophenyl)-2-hydroxyacetate (2000 mg, 8.16 mmol), Mg(ClO<sub>4</sub>)<sub>2</sub> (273 mg, 1.224 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (12 mL) and stirred for 72 h at room temperature. The solvent was evaporated and the residue purified by silica gel chromatography to provide methyl 2-(2-bromophenyl)-2-(<i>tert</i>-butoxy)acetate (1000 g, 40.7%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ (ppm): 7.66 (d, 2H), 7.54 (d, 2H), 7.36–7.15 (m, 2 H), 6.93 (s, 1 H), 5.50 (s, 1 H), 3.70 (s, 3 H), 1.25 (s, 9 H). MS (C<sub>13</sub>H<sub>17</sub>BrO<sub>3</sub>): <i>m</i>/<i>z</i> 323 (M + Na)<sup>+</sup>. A mixture of methyl 2-(2-bromophenyl)-2-(<i>tert</i>-butoxy)acetate (30 mg, 0.100 mmol), <i>p</i>-tolylboronic acid (20.3 mg, 0.149 mmol), Pd(Ph<sub>3</sub>P)<sub>4</sub> (17.3 mg, 0.015 mmol), 2 M K<sub>3</sub>PO<sub>4</sub> (200 μL) in DMF (2 mL) was heated in a microwave reactor at 130 °C for 10 min. The reaction mixture was filtered and the filtrate was purified by preparative HPLC to give methyl 2-(<i>tert</i>-butoxy)-2-(4′-methyl-[1,1′-biphenyl]-2-yl)acetate (22 mg, 70.7%). <sup>1</sup>H NMR (400 MHz, MeOD) δ (ppm): 7.58–7.56 (m, 1 H), 7.36–7.20 (m, 7 H), 5.24 (s, 1 H), 3.68 (s, 3 H), 2.42 (s, 3 H), 0.95 (s, 9 H). MS (C<sub>20</sub>H<sub>24</sub>O<sub>3</sub>): <i>m</i>/<i>z</i> 335 (M + Na)<sup>+</sup>. 1 N LiOH aqueous solution (0.6 mL, 0.6 mmol was added to a solution of methyl 2-(<i>tert</i>-butoxy)-2-(4′-methyl-[1,1′-biphenyl]-2-yl)acetate (22 mg, 0.070 mmol) in dioxane (0.6 mL), and the mixture was stirred at room temperature for 2 h. The reaction mixture was filtered and the filtrate was purified by preparative HPLC to afford <b>2</b> (15.7 mg, 74.0%). <sup>1</sup>H NMR (400 MHz, MeOD) δ (ppm): 7.60–7.58 (m, 1 H), 7.38–7.22 (m, 7 H), 5.22 (s, 1 H), 2.42 (s, 3 H), 0.93 (s, 9 H). MS (C<sub>19</sub>H<sub>22</sub>O<sub>3</sub>): <i>m</i>/<i>z</i> 321 (M + Na)<sup>+</sup>.</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> 2-<i>tert</i>-Butoxy-2-(5-methyl-7-<i>p</i>-tolylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)acetic Acid, TFA Salt (<b>3</b>)</h3><div class="NLM_p last">Compound <b>3</b> was prepared from 1<i>H</i>-pyrazol-3-amine in a manner similar to that described for compound <b>4</b>. <sup>1</sup>H NMR (500 MHz, MeOD) δ (ppm): 8.03 (d, <i>J</i> = 2.4 Hz, 1H), 7.66–7.42 (m, 4 H), 6.63 (d, <i>J</i> = 2.4 Hz, 1H), 5.16 (s, 1 H), 2.70 (s, 3 H), 2.52 (s, 3 H), 0.98 (s, 9 H). MS (C<sub>20</sub>H<sub>23</sub>N<sub>3</sub>O<sub>3</sub>): <i>m</i>/<i>z</i> 354 (M + H)<sup>+</sup>. HRMS calcd for C<sub>20</sub>H<sub>23</sub>N<sub>3</sub>O<sub>3</sub> 354.1812 (MH<sup>+</sup>); found 354.1819.</div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> 2-<i>tert</i>-Butoxy-2-(5-methyl-2-phenyl-7-<i>p</i>-tolylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)acetic Acid, TFA Salt (<b>4</b>)</h3><div class="NLM_p last">SOCl<sub>2</sub> (0.0023 mL, 0.032 mmol) was added to a solution of <b>6</b> (6 mg, 0.016 mmol) in MeOH (2 mL) and the reaction mixture stirred at 40 °C for 16 h. The solvent was evaporated to give methyl 2-hydroxy-2-(5-methyl-2-phenyl-7-<i>p</i>-tolylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)acetate. The crude product was used directly for next step. MS (C<sub>23</sub>H<sub>21</sub>N<sub>3</sub>O<sub>3</sub>): <i>m</i>/<i>z</i> 388 (M + H)<sup>+</sup>. Perchloric acid (0.008 mL, 0.128 mmol) was added to a solution of methyl 2-hydroxy-2-(5-methyl-2-phenyl-7-<i>p</i>-tolylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)acetate (6.20 mg, 0.016 mmol) in <i>tert</i>-butyl acetate (0.3 mL) and the reaction mixture stirred for 2 h at room temperature. The reaction mixture was quenched with H<sub>2</sub>O and diluted with EtOAc. The organic phase was washed with saturated NaHCO<sub>3</sub> and dried over Na<sub>2</sub>SO<sub>4</sub>. The solvent was evaporated to give methyl 2-<i>tert</i>-butoxy-2-(5-methyl-2-phenyl-7-<i>p</i>-tolylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)acetate. The crude product was used directly for the next step. MS (C<sub>27</sub>H<sub>29</sub>N<sub>3</sub>O<sub>3</sub>): <i>m</i>/<i>z</i> 444 (M + H)<sup>+</sup>. 1.5 N LiOH aqueous solution (0.5 mL, 0.750 mmol) was added to a solution of methyl 2-<i>tert</i>-butoxy-2-(5-methyl-2-phenyl-7-<i>p</i>-tolylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)acetate (7.10 mg, 0.016 mmol) in dioxane (0.5 mL) and the mixture stirred at 50 °C for 2 h. The reaction mixture was filtered and the filtrate was purified by preparative HPLC to afford <b>4</b> as TFA salt (4 mg, 43.7% for 3 steps). <sup>1</sup>H NMR (400 MHz, MeOD) δ (ppm): 7.91–7.82 (m, 2 H), 7.67 (dd, <i>J</i> = 7.8, 2.8 Hz, 2H), 7.49 (d, <i>J</i> = 8.0 Hz, 2H), 7.43–7.28 (m, 3 H), 6.94 (s, 1 H), 5.19 (s, 1 H), 2.69 (s, 3 H), 2.53 (s, 3 H), 0.97 (s, 9 H). MS (C<sub>26</sub>H<sub>27</sub>N<sub>3</sub>O<sub>3</sub>): <i>m</i>/<i>z</i> 430 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> 2-(<i>tert</i>-Butoxy)-2-(5-methyl-2-phenyl-7-(<i>p</i>-tolyl)pyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)acetamide, TFA Salt (<b>5</b>)</h3><div class="NLM_p last">Perchloric acid (0.008 mL, 0.128 mmol) was added to a solution of <b>36</b> (3 mg, 8.46 μmol) in <i>tert</i>-butyl acetate (0.3 mL) and the mixture stirred for 3 h at room temperature. The reaction mixture was quenched with H<sub>2</sub>O and diluted with EtOAc. The solvent was evaporated and the residue was purified by preparative HPLC to afford <b>5</b> as TFA salt (2 mg, 52.4%). <sup>1</sup>H NMR (400 MHz, MeOD) δ (ppm): 7.87–7.85 (m, 2 H), 7.62–7.58 (m, 2 H), 7.45–7.36 (m, 5 H), 6.93 (s, 1 H), 5.05 (s, 1 H), 2.66 (s, 3 H), 2.50 (s, 3 H), 1.40 (s, 9 H). MS (C<sub>26</sub>H<sub>28</sub>N<sub>4</sub>O<sub>2</sub>): <i>m</i>/<i>z</i> 429 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> 2-Hydroxy-2-(5-methyl-2-phenyl-7-<i>p</i>-tolylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)acetic Acid (<b>6</b>)</h3><div class="NLM_p last">A solution of <b>36</b> (28 mg, 0.079 mmol) in conc HCl (400 μL, 4.87 mmol) was heated at 90 °C for 3 h. The solvent was evaporated and the residue was purified by preparative HPLC to afford <b>6</b> (14 mg, 47.5%). <sup>1</sup>H NMR (400 MHz, MeOD) δ (ppm): 7.93–7.80 (m, 2 H), 7.57 (d, <i>J</i> = 8.3 Hz, 2H), 7.51–7.29 (m, 5 H), 6.95 (s, 1 H), 5.19 (s, 1 H), 2.67 (s, 3 H), 2.51 (s, 3 H). MS (C<sub>22</sub>H<sub>19</sub>N<sub>3</sub>O<sub>3</sub>): <i>m</i>/<i>z</i> 374 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> 2-(<i>tert</i>-Butoxy)-2-(5-methyl-2,7-diphenylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)acetic Acid (<b>7</b>)</h3><div class="NLM_p last">The title compound was prepared from methyl 2-<i>tert</i>-butoxy-2-(7-chloro-5-methyl-2-phenylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)acetate in a manner similar to that described for <b>14</b>. <sup>1</sup>H NMR (600 MHz, DMSO/CDCl<sub>3</sub>) δ (ppm): 7.84 (d, <i>J</i> = 7.6 Hz, 2H), 7.76–7.67 (m, 5 H), 7.42–7.34 (m, 3 H), 7.06 (s, 1 H), 4.97 (s, 1 H), 2.53 (s, 3 H), 0.91 (s, 9 H). MS (C<sub>25</sub>H<sub>25</sub>N<sub>3</sub>O<sub>3</sub>): <i>m</i>/<i>z</i> 416 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 2-(<i>tert</i>-Butoxy)-2-(7-(4-methoxyphenyl)-5-methyl-2-phenylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)acetic Acid, TFA Salt (<b>8</b>)</h3><div class="NLM_p last">The title compound was prepared from methyl 2-<i>tert</i>-butoxy-2-(7-chloro-5-methyl-2-phenylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)acetate in a manner similar to that described for <b>14</b>. <sup>1</sup>H NMR (600 MHz, DMSO/CDCl<sub>3</sub>) δ (ppm): 7.86 (d, <i>J</i> = 8.2 Hz, 2H), 7.75–7.65 (m, 2 H), 7.43–7.35 (m, 3 H), 7.20 (d, <i>J</i> = 8.8 Hz, 2H), 7.03 (s, 1 H), 5.05 (s, 1 H), 3.92 (s, 3 H), 2.53 (s, 3 H), 0.92 (s, 9 H). MS (C<sub>26</sub>H<sub>27</sub>N<sub>3</sub>O<sub>4</sub>): <i>m</i>/<i>z</i> 446 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> 2-(<i>tert</i>-Butoxy)-2-(5-methyl-2-phenyl-7-(<i>m</i>-tolyl)pyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)acetic Acid (<b>9</b>)</h3><div class="NLM_p last">The title compound was prepared from methyl 2-<i>tert</i>-butoxy-2-(7-chloro-5-methyl-2-phenylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)acetate in a manner similar to that described for <b>14</b>. <sup>1</sup>H NMR (600 MHz, DMSO/CDCl<sub>3</sub>) δ (ppm): 7.84 (d, <i>J</i> = 7.0 Hz, 2H), 7.55–7.47 (m, 4 H), 7.44–7.35 (m, 3 H), 7.05 (s, 1 H), 4.97 (s, 1 H), 2.53 (s, 3 H), 2.45 (s, 3 H), 0.92 (s, 9 H). MS (C<sub>26</sub>H<sub>27</sub>N<sub>3</sub>O<sub>3</sub>): <i>m</i>/<i>z</i> 430 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 2-(<i>tert</i>-Butoxy)-2-(7-(3-methoxyphenyl)-5-methyl-2-phenylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)acetic Acid (<b>10</b>)</h3><div class="NLM_p last">The title compound was prepared from methyl 2-<i>tert</i>-butoxy-2-(7-chloro-5-methyl-2-phenylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)acetate in a manner similar to that described for <b>14</b>. <sup>1</sup>H NMR (600 MHz, DMSO/CDCl<sub>3</sub>) δ (ppm): 7.85 (d, <i>J</i> = 7.0 Hz, 2H), 7.59–7.56 (m, 1 H), 7.42–7.21 (m, 6 H), 7.05 (s, 1 H), 5.02 (s, 1 H), 3.84 (s, 3 H), 2.53 (s, 3 H), 0.93 (s, 9 H). MS (C<sub>26</sub>H<sub>27</sub>N<sub>3</sub>O<sub>4</sub>): <i>m</i>/<i>z</i> 446 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 2-(<i>tert</i>-Butoxy)-2-(5-methyl-2-phenyl-7-(<i>o</i>-tolyl)pyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)acetic Acid (<b>11</b>)</h3><div class="NLM_p last">The title compound was prepared from methyl 2-<i>tert</i>-butoxy-2-(7-chloro-5-methyl-2-phenylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)acetate in a manner similar to that described for <b>14</b>. <sup>1</sup>H NMR (600 MHz, DMSO/CDCl<sub>3</sub>) δ (ppm): 7.79 (d, <i>J</i> = 7.6 Hz, 2H), 7.54–7.46 (m, 2 H), 7.41–7.33 (m, 5 H), 7.04 (s, 1 H), 4.81 (s, 1 H), 2.73 (s, 3 H), 2.53 (s, 3 H), 1.11 (s, 9 H). MS (C<sub>26</sub>H<sub>27</sub>N<sub>3</sub>O<sub>3</sub>): <i>m</i>/<i>z</i> 430 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 2-(<i>tert</i>-Butoxy)-2-(7-(2-methoxyphenyl)-5-methyl-2-phenylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)acetic Acid (<b>12</b>)</h3><div class="NLM_p last">The title compound was prepared from methyl 2-<i>tert</i>-butoxy-2-(7-chloro-5-methyl-2-phenylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)acetate in a manner similar to that described for <b>14</b>. <sup>1</sup>H NMR (600 MHz, DMSO/CDCl<sub>3</sub>) δ (ppm): 7.82 (d, <i>J</i> = 7.6 Hz, 2H), 7.67–7.64 (m, 1 H), 7.52–7.18 (m, 6 H), 7.00 (s, 1 H), 4.94 (s, 1 H), 3.68 (s, 3 H), 2.53 (s, 3 H), 0.94 (s, 9 H). MS (C<sub>26</sub>H<sub>27</sub>N<sub>3</sub>O<sub>4</sub>): <i>m</i>/<i>z</i> 446 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 2-(<i>tert</i>-Butoxy)-2-(7-(chroman-6-yl)-5-methyl-2-phenylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)acetic Acid (<b>13</b>)</h3><div class="NLM_p last">The title compound was prepared from methyl 2-<i>tert</i>-butoxy-2-(7-chloro-5-methyl-2-phenylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)acetate in a manner similar to that described for <b>14</b>. <sup>1</sup>H NMR (600 MHz, DMSO/CDCl<sub>3</sub>) δ (ppm): 7.96 (s, 1H), 7.87 (d, <i>J</i> = 7.0 Hz, 2H), 7.60–7.30 (m, 4 H), 7.02 (s, 1 H), 6.98 (d, <i>J</i> = 8.8 Hz, 1H), 5.07 (s, 1 H), 4.29 (br s, 2H), 2.84 (s, 2H), 2.61 (s, 3 H), 2.04 (br s, 2H), 0.93 (9 H, s). MS (C<sub>28</sub>H<sub>29</sub>N<sub>3</sub>O<sub>4</sub>): <i>m</i>/<i>z</i> 472 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 2-(<i>tert</i>-Butoxy)-2-(7-(8-fluoro-5-methylchroman-6-yl)-5-methyl-2-phenylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)acetic Acid, TFA Salt (<i>S</i>,<i>S</i> and <i>R</i>,<i>R</i>)-<b>14</b> and (<i>S</i>,<i>R</i> and <i>R</i>,<i>S</i>)-<b>15</b></h3><div class="NLM_p last">A mixture of <b>41</b> (50 mg, 0.1 mmol), Pd(PPh<sub>3</sub>)<sub>4</sub> (17.27 mg, 0.015 mmol), 2-(8-fluoro-5-methylchroman-6-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (58.2 mg, 0.199 mmol), and 2 M K<sub>3</sub>PO<sub>4</sub> solution (300 μL) in DMF (4 mL) was heated in a microwave reactor at 130 °C for 15 min. The reaction mixture was filtered and the filtrate purified by preparative HPLC to afford (<i>S</i>,<i>S</i> and <i>R</i>,<i>R</i>)-methyl 2-(<i>tert</i>-butoxy)-2-(7-(8-fluoro-5-methylchroman-6-yl)-5-methyl-2-phenylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)acetate (30 mg, 54.3%) and (<i>S</i>,<i>R</i> and <i>R</i>,<i>S</i>) isomer (1.6 mg, 2.9%) as TFA salt. (<i>S</i>,<i>S</i> and <i>R</i>,<i>R</i>)-Methyl 2-(<i>tert</i>-butoxy)-2-(7-(8-fluoro-5-methylchroman-6-yl)-5-methyl-2-phenylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)acetate. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ (ppm): 7.83 (dd, <i>J</i> = 8.2, 1.6 Hz, 2H), 7.48–7.27 (m, 3 H), 7.04–6.85 (m, 2 H), 5.08 (s, 1 H), 4.33–4.30 (m, 2 H), 3.68 (s, 3 H), 2.81 (t, <i>J</i> = 6.5 Hz, 2H), 2.75 (s, 3 H), 2.20–2.14 (m, 2 H), 1.87 (s, 3 H), 1.17 (s, 9 H). MS (C<sub>30</sub>H<sub>32</sub>FN<sub>3</sub>O<sub>4</sub>): <i>m</i>/<i>z</i> 518 (M + H)<sup>+</sup>. (<i>S</i>,<i>R</i> and <i>R</i>,<i>S</i>)-Methyl 2-(<i>tert</i>-butoxy)-2-(7-(8-fluoro-5-methylchroman-6-yl)-5-methyl-2-phenylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)acetate. MS (C<sub>30</sub>H<sub>32</sub>FN<sub>3</sub>O<sub>4</sub>): <i>m</i>/<i>z</i> 518 (M + H)<sup>+</sup>. Hydrolysis of these esters as described for <b>4</b> gave the title compounds (<i>S</i>,<i>S</i> and <i>R</i>,<i>R</i>)-<b>14</b> and (<i>S</i>,<i>R</i> and <i>R</i>,<i>S</i>)-<b>15</b>. (<i>S</i>,<i>S</i> and <i>R</i>,<i>R</i>)-<b>14</b>. <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ (ppm): 7.83 (d, <i>J</i> = 7.2 Hz, 2H), 7.42–7.34 (m, 3H), 6.96 (d, <i>J</i> = 10.99 Hz, 1H), 6.90 (s, 1H), 4.58 (s, 1H), 4.41–4.23 (m, 2H), 2.85–2.80 (m, 5H), 2.18–2.14 (m, 2H), 1.97 (s, 3H), 1.17 (s, 9H). MS (C<sub>29</sub>H<sub>30</sub>FN<sub>3</sub>O<sub>4</sub>): <i>m</i>/<i>z</i> 504 (M + H)<sup>+</sup>. (<i>S</i>,<i>R</i> and <i>R</i>,<i>S</i>)-<b>15</b>. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 13.26 (br s, 1H), 7.87 (d, J = 7.4 Hz, 2H), 7.49–7.37 (m, 3H), 7.20 (d, J = 11.2 Hz, 1H), 7.14 (s, 1H), 4.93 (s, 1H), 4.24–4.38 (m, 2H), 2.84–2.66 (m, 2H), 2.64 (s, 3H, s), 2.16–2.04 (m, 2H), 1.78 (s, 3H), 0.96 (s, 9H). MS (C<sub>29</sub>H<sub>30</sub>FN<sub>3</sub>O<sub>4</sub>): <i>m</i>/<i>z</i> 504 (M + H)<sup>+</sup>. Single crystal structures for (<i>S</i>,<i>S</i> and <i>R</i>,<i>R</i>)-<b>14</b> and (<i>S</i>,<i>R</i> and <i>R</i>,<i>S</i>)-<b>15</b> have been deposited in the CCDC database under CCDC deposition numbers 1862636 and 1862637, respectively.</div></div><div id="sec5_1_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 2-<i>tert</i>-Butoxy-2-(7-(8-fluoro-5-methylchroman-6-yl)-5-methyl-2-phenylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)acetic Acid (<i>S</i>,<i>S</i>)-<b>14</b> and 2-<i>tert</i>-butoxy-2-(7-(8-fluoro-5-methylchroman-6-yl)-5-methyl-2-phenylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)acetic Acid (<i>R</i>,<i>R</i>)-<b>14</b></h3><div class="NLM_p last">The title compounds were synthesized using a two-step method starting from the racemic ester precursor for compound (<i>S</i>,<i>S</i> and <i>R</i>,<i>R</i>)-<b>14</b>. The racemic ester was separated into two enantiomers using a chiral column to give (<i>S</i>,<i>S</i>)-methyl 2-<i>tert</i>-butoxy-2-(7-(8-fluoro-5-methylchroman-6-yl)-5-methyl-2-phenylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)acetate and (<i>R</i>,<i>R</i>)-methyl 2-<i>tert</i>-butoxy-2-(7-(8-fluoro-5-methylchroman-6-yl)-5-methyl-2-phenylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)acetate. Chiral separation method: Chiralpak AD-H preparative column, 20 mm × 250 mm, 5 μm. Mobile phase: 15% MeOH in CO<sub>2</sub> at 150 bar. Temp: 35 °C. Flow rate: 45.0 mL/min for 14 min. UV was monitored at 254 nm. Hydrolysis of these esters as described for compound <b>4</b> gave the title compounds (<i>S</i>,<i>S</i>)-<b>14</b> and (<i>R</i>,<i>R</i>)-<b>14</b>.</div></div><div id="sec5_1_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 2-<i>tert</i>-Butoxy-2-(5,7-dimethyl-2-phenylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)acetic Acid, TFA Salt (<b>16</b>)</h3><div class="NLM_p last">A mixture of <b>41</b> (20 mg, 0.052 mmol), Pd(PPh<sub>3</sub>)<sub>4</sub> (20 mg, 0.017 mmol), methylzinc(II) chloride (0.5 mL, 1.000 mmol), and THF (0.8 mL) was heated in a microwave reactor at 130 °C for 15 min. The reaction mixture was quenched with H<sub>2</sub>O, extracted with EtOAc, and the combined organic layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The residue was purified by preparative HPLC to give methyl 2-<i>tert</i>-butoxy-2-(5,7-dimethyl-2-phenylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)acetate as the TFA salt (15 mg, 60.4%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ (ppm): 8.04–8.02 (m, 2 H), 7.56–7.38 (m, 3 H), 7.06 (s, 1 H), 5.41 (s, 1 H), 3.75 (s, 3 H), 3.10 (s, 3 H), 2.85 (s, 3 H), 1.28 (s, 9 H). MS (C<sub>21</sub>H<sub>25</sub>N<sub>3</sub>O<sub>3</sub>): <i>m</i>/<i>z</i> 368 (M + H)<sup>+</sup>. An aqueous solution of 1.5 N LiOH (0.5 mL, 0.750 mmol) was added to a solution of the TFA salt of methyl 2-<i>tert</i>-butoxy-2-(5,7-dimethyl-2-phenylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)acetate (15 mg, 0.031 mmol) in dioxane (0.5 mL) and the mixture stirred at room temperature for 4 h. The reaction mixture was filtered and the filtrate was purified by preparative HPLC to afford the TFA salt of <b>16</b> (13 mg, 89%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ (ppm): 9.92 (br s, 1H), 8.06–7.89 (m, 2 H), 7.55–7.34 (m, 3 H), 7.07 (s, 1 H), 5.41 (s, 1 H), 3.10 (s, 3 H), 2.85 (s, 3 H), 1.27 (s, 9 H). MS (C<sub>20</sub>H<sub>23</sub>N<sub>3</sub>O<sub>3</sub>): <i>m</i>/<i>z</i> 354 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 2-(<i>tert</i>-Butoxy)-2-(5-methyl-2-phenyl-7-(<i>p</i>-tolylamino)pyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)acetic Acid (<b>17</b>)</h3><div class="NLM_p last">The title compound was prepared from methyl 2-<i>tert</i>-butoxy-2-(7-chloro-5-methyl-2-phenylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)acetate in a manner similar to that described for <b>19</b>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 7.84–7.83 (m, 2 H), 7.43–7.35 (m, 4H), 7.10 (d, <i>J</i> = 7.9 Hz, 2H), 6.92 (s, 1H), 6.87 (br s, 1H), 5.29 (s, 1H), 2.54 (s, 3H), 2.30 (s, 3H), 1.08 (s, 9H). MS (C<sub>26</sub>H<sub>28</sub>N<sub>4</sub>O<sub>3</sub>): <i>m</i>/<i>z</i> 445 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 2-(7-(Azepan-1-yl)-5-methyl-2-phenylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)-2-(<i>tert</i>-butoxy)acetic Acid (<b>18</b>)</h3><div class="NLM_p last">The title compound was prepared from methyl 2-<i>tert</i>-butoxy-2-(7-chloro-5-methyl-2-phenylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)acetate in a manner similar to that described for <b>19</b>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 8.06 (d, <i>J</i> = 7.5 Hz, 2H), 7.54–7.48 (m, 2 H), 7.45–7.41 (m, 1 H), 7.06 (s, 1 H), 5.88 (s, 1 H), 2.55 (s, 3 H), 1.92–1.79 (m, 8 H), 1.22 (s, 9 H). MS (C<sub>25</sub>H<sub>32</sub>N<sub>4</sub>O<sub>3</sub>): <i>m</i>/<i>z</i> 437 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 2-(<i>tert</i>-Butoxy)-2-(7-(4,4-dimethylpiperidin-1-yl)-5-methyl-2-phenylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)acetic Acid (<b>19</b>)</h3><div class="NLM_p last">DIEA (0.047 mL, 0.272 mmol) was added to a mixture of <b>41</b> (40 mg, 0.091 mmol) and 4,4-dimethylpiperidine, HCl salt (13.55 mg, 0.091 mmol) in NMP (1 mL) and heated at 50°C for 2 h. 1 N LiOH (0.272 mL, 0.272 mmol) was added to the reaction mixture, and the contents were heated at 50°C for 2 h. The reaction mixture was filtered and the filtrate purified by preparative HPLC to afford <b>19</b> as TFA salt (13.5 mg, 30%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 8.05 (d, <i>J</i> = 7.8 Hz, 2H). 7.54–7.48 (m, 2 H), 7.45–7.41 (m, 1 H), 7.03 (s, 1 H), 5.77 (s, 1 H), 2.53 (s, 3 H), 1.65–1.52 (m, 4 H), 1.20 (s, 9 H), 1.12 (br s, 6H). MS (C<sub>26</sub>H<sub>34</sub>N<sub>4</sub>O<sub>3</sub>): <i>m</i>/<i>z</i> 451 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 2-<i>tert</i>-Butoxy-2-(7-(8-fluoro-5-methylchroman-6-yl)-5-methyl-2-<i>p</i>-tolylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)acetic Acid, TFA Salt (<i>S</i>,<i>S</i> and <i>R</i>,<i>R</i>)-<b>20</b></h3><div class="NLM_p last">A mixture of the TFA salt of <b>47</b> (8 mg, 0.016 mmol), Pd(PPh<sub>3</sub>)<sub>4</sub> (2.69 mg, 2.326 μmol), 2-(8-fluoro-5-methylchroman-6-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (9.06 mg, 0.031 mmol), 2 M K<sub>3</sub>PO<sub>4</sub> solution (50 μL), and DMF (0.7 mL) was heated in a microwave reactor at 130 °C for 15 min. The reaction mixture was filtered and the filtrate purified by preparative HPLC to afford methyl 2-<i>tert</i>-butoxy-2-(7-(8-fluoro-5-methylchroman-6-yl)-5-methyl-2-<i>p</i>-tolylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)acetate as the TFA salt (5 mg, 49.9%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ (ppm): 7.72 (d, <i>J</i> = 8.0 Hz, 2H), 7.21 (d, <i>J</i> = 8.0 Hz, 2H), 7.01 (s, 1 H), 6.89 (d, <i>J</i> = 10.5 Hz, 1H), 5.06 (s, 1 H), 4.40–4.33 (m, 2 H), 3.68 (s, 3 H), 2.86 (s, 3 H), 2.81–2.76 (m, 2 H), 2.38 (s, 3 H), 2.23–2.16 (m, 2 H), 1.86 (s, 3 H), 1.19 (s, 9 H). MS (C<sub>31</sub>H<sub>34</sub>FN<sub>3</sub>O<sub>4</sub>): <i>m</i>/<i>z</i> 532 (M + H)<sup>+</sup>. A mixture of 1 N LiOH aqueous solution (0.5 mL, 0.5 mmol) and methyl 2-<i>tert</i>-butoxy-2-(7-(8-fluoro-5-methylchroman-6-yl)-5-methyl-2-<i>p</i>-tolylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)acetate, TFA salt (5 mg, 7.74 μmol) in dioxane (0.5 mL) was stirred at 50 °C for 1 h. The mixture was filtered and the filtrate purified by preparative HPLC to afford (<i>S</i>,<i>S</i> and <i>R</i>,<i>R</i>)-<b>20</b> (4 mg, 82%) as the TFA salt. <sup>1</sup>H NMR (500 MHz, MeOD) δ (ppm): 7.71 (d, <i>J</i> = 8.2 Hz, 2H), 7.21 (d, <i>J</i> = 7.9 Hz, 2H), 6.94 (d, <i>J</i> = 10.7 Hz, 1H), 6.88 (s, 1 H), 5.01 (s, 1 H), 4.40–4.24 (m, 2 H), 2.86–2.78 (m, 2 H), 2.76 (s, 3 H), 2.35 (s, 3 H), 2.22–2.10 (m, 2 H), 1.87 (s, 3 H), 1.17 (s, 9 H). MS (C<sub>30</sub>H<sub>32</sub>FN<sub>3</sub>O<sub>4</sub>): <i>m</i>/<i>z</i> 518 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 2-(2-(4-(Benzyloxy)phenyl)-7-(8-fluoro-5-methylchroman-6-yl)-5-methylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)-2-<i>tert</i>-butoxyacetic Acid, TFA Salt ((<i>S</i>,<i>S</i> and <i>R</i>,<i>R</i>)-<b>21</b>)</h3><div class="NLM_p last">The title compound was prepared from methyl 2-(2-bromo-7-chloro-5-methylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)-2-<i>tert</i>-butoxyacetate in a manner similar to that described for compound (<i>S</i>,<i>S</i> and <i>R</i>,<i>R</i>)-<b>20</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ (ppm): 7.76 (d, <i>J</i> = 8.8 Hz, 2H), 7.47–7.32 (m, 5H), 7.04–6.95 (m, 3H), 6.91 (d, <i>J</i> = 10.5 Hz, 1H), 5.11 (d, <i>J</i> = 2.0 Hz, 3H), 4.44–4.25 (m, 2H), 2.92–2.59 (m, 5H), 2.28–2.10 (m, 2H), 1.89 (s, 3H), 1.22 (s, 9H). MS (C<sub>36</sub>H<sub>36</sub>FN<sub>3</sub>O<sub>5</sub>): <i>m</i>/<i>z</i> 610 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 2-(2-(3-(Benzyloxy)phenyl)-7-(8-fluoro-5-methylchroman-6-yl)-5-methylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)-2-<i>tert</i>-butoxyacetic Acid, TFA Salt ((<i>S</i>,<i>S</i> and <i>R</i>,<i>R</i>)-<b>22</b>)</h3><div class="NLM_p last">The title compound was prepared from methyl 2-(2-bromo-7-chloro-5-methylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)-2-<i>tert</i>-butoxyacetate in a manner similar to that described for compound (<i>S</i>,<i>S</i> and <i>R</i>,<i>R</i>)-<b>20</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ (ppm): 7.48–7.27 (m, 8H), 6.96 (dd, <i>J</i> = 8.2, 1.8 Hz, 1H), 6.93–6.88 (m, 2H), 5.08 (s, 3H), 4.46–4.12 (m, 2H), 2.92–2.73 (m, 5H), 2.26–2.08 (m, 2H), 1.91 (s, 3H), 1.20 (s, 9H). MS (C<sub>36</sub>H<sub>36</sub>FN<sub>3</sub>O<sub>5</sub>): <i>m</i>/<i>z</i> 610 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 2-<i>tert</i>-Butoxy-2-(7-(8-fluoro-5-methylchroman-6-yl)-5-methyl-2-(3-phenoxyphenyl)pyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)acetic Acid, TFA Salt ((<i>S</i>,<i>S</i> and <i>R</i>,<i>R</i>)-<b>23</b>)</h3><div class="NLM_p last">The title compound was prepared from methyl 2-(2-bromo-7-chloro-5-methylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)-2-<i>tert</i>-butoxyacetate in a manner similar to that described for (<i>S</i>,<i>S</i> and <i>R</i>,<i>R</i>)-<b>20</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ (ppm): 7.62–7.49 (m, 2H), 7.41–7.31 (m, 3H), 7.17–6.95 (m, 5H), 6.90 (d, <i>J</i> = 10.8 Hz, 1H), 5.12 (s, 1H), 4.50–4.22 (m, 2H), 2.89–2.66 (m, 5H), 2.17 (dd, <i>J</i> = 6.0, 4.0 Hz, 2H), 1.90 (s, 3H), 1.28–1.09 (m, 9H). MS (C<sub>35</sub>H<sub>34</sub>FN<sub>3</sub>O<sub>5</sub>): <i>m</i>/<i>z</i> 596 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 2-(2-([1,1′-Biphenyl]-3-yl)-7-(8-fluoro-5-methylchroman-6-yl)-5-methylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)-2-(<i>tert</i>-butoxy)acetic Acid, TFA Salt ((<i>S</i>,<i>S</i> and <i>R</i>,<i>R</i>)-<b>24</b>)</h3><div class="NLM_p last">The title compound was prepared from methyl 2-(2-bromo-7-chloro-5-methylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)-2-<i>tert</i>-butoxyacetate in a manner similar to that described for (<i>S</i>,<i>S</i> and <i>R</i>,<i>R</i>)-<b>20</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ (ppm): 8.05–7.98 (m, 1H), 7.81 (d, <i>J</i> = 7.6 Hz, 1H), 7.65–7.58 (m, 2H), 7.55 (d, <i>J</i> = 7.6 Hz, 1H), 7.46 (t, <i>J</i> = 7.5 Hz, 3H), 7.40–7.33 (m, 1H), 6.98–6.90 (m, 2H), 5.09 (s, 1H), 4.38–4.27 (m, 2H), 2.82–2.66 (m, 5H), 2.15 (d, <i>J</i> = 6.1 Hz, 2H), 1.93 (s, 3H), 1.21 (s, 9H). MS (C<sub>35</sub>H<sub>34</sub>FN<sub>3</sub>O<sub>4</sub>): <i>m</i>/<i>z</i> 580 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> (2<i>S</i>)-2-(2-([1,1′-Biphenyl]-3-yl)-7-(8-fluoro-5-methylchroman-6-yl)-5-methylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)-2-(<i>tert</i>-butoxy)acetic Acid ((<i>S</i>,<i>S</i>)-<b>24</b>)</h3><div class="NLM_p last">The title compound was prepared from (2S)-methyl 2-(<i>tert</i>-butoxy)-2-(2-(3-chlorophenyl)-7-(8-fluoro-5-methylchroman-6-yl)-5-methylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)acetate in a manner similar to that described for (<i>S</i>,<i>S</i>)-<b>27</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ (ppm): 8.05–7.98 (m, 1H), 7.81 (d, <i>J</i> = 7.6 Hz, 1H), 7.65–7.58 (m, 2H), 7.55 (d, <i>J</i> = 7.6 Hz, 1H), 7.46 (t, <i>J</i> = 7.5 Hz, 3H), 7.40–7.33 (m, 1H), 6.98–6.90 (m, 2H), 5.09 (s, 1H), 4.38–4.27 (m, 2H), 2.82–2.66 (m, 5H), 2.15 (d, <i>J</i> = 6.1 Hz, 2H), 1.93 (s, 3H), 1.21 (s, 9H). MS (C<sub>35</sub>H<sub>34</sub>FN<sub>3</sub>O<sub>4</sub>): <i>m</i>/<i>z</i> 580 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 2-(2-([1,1′-Biphenyl]-3-yl)-7-(4,4-dimethylpiperidin-1-yl)-5-methylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)-2-(<i>tert</i>-butoxy)acetic Acid ((<i>S</i> and <i>R</i>)-<b>25</b>)</h3><div class="NLM_p last">A mixture of <b>46</b> (90 mg, 0.230 mmol), Pd(PPh<sub>3</sub>)<sub>4</sub> (40 mg, 0.035 mmol), [1,1′-biphenyl]-3-ylboronic acid (45.6 mg, 0.230 mmol), 2 M K<sub>2</sub>CO<sub>3</sub> solution (300 μL), and DMF (4 mL) was heated in a microwave reactor at 70 °C for 60 min. The mixture was filtered and the filtrate purified by preparative HPLC to afford methyl 2-(2-([1,1′-biphenyl]-3-yl)-7-chloro-5-methylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)-2-(<i>tert</i>-butoxy)acetate as the TFA salt (47 mg, 35.3%). MS (C<sub>26</sub>H<sub>26</sub>ClN<sub>3</sub>O<sub>3</sub>): <i>m</i>/<i>z</i> 464 (M + H)<sup>+</sup>. A mixture of methyl 2-(2-([1,1′-biphenyl]-3-yl)-7-chloro-5-methylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)-2-(<i>tert</i>-butoxy)acetate, TFA salt (25 mg, 0.043 mmol), 4,4-dimethylpiperidine HCl salt (16.13 mg, 0.108 mmol), and DIEA (0.038 mL, 0.216 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (3 mL) was stirred at rt for 18 h. The solvent was evaporated, dioxane (1 mL) and NaOH (1 mL, 1.0 mmol) added and the mixture heated at 50 °C for 1 h. The mixture was filtered and the filtrate was purified by preparative HPLC to afford (<i>S</i> and <i>R</i>)-<b>25</b> as the TFA salt (1.5 mg, 6.7%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 8.36 (s, 1H), 8.04 (d, <i>J</i> = 7.6 Hz, 1H), 7.79–7.71 (m, 3H), 7.61 (t, <i>J</i> = 7.63 Hz, 1H), 7.52 (t, <i>J</i> = 7.27 Hz, 2H), 7.44–7.41 (m, 1H), 7.11 (s, 1H), 5.63 (br s, 1H), 3.48–3.26 (m, 4H), 2.54 (s, 3H), 1.67–1.51 (m, 4H), 1.18 (s, 9H), 1.12 (br s, 6H). MS (C<sub>32</sub>H<sub>38</sub>N<sub>4</sub>O<sub>3</sub>): <i>m</i>/<i>z</i> 527 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 2-(2-(3-(Benzyloxy)phenyl)-7-(4,4-dimethylpiperidin-1-yl)-5-methylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)-2-(<i>tert</i>-butoxy)acetic Acid ((<i>S</i> and <i>R</i>)-<b>26</b>)</h3><div class="NLM_p last">The title compound was prepared from methyl 2-(2-bromo-7-chloro-5-methylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)-2-<i>tert</i>-butoxyacetate in a manner similar to that described for (<i>S</i> and <i>R</i>)-<b>25</b>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 7.72–7.67 (m, 1H), 7.63 (d, <i>J</i> = 7.6 Hz, 1H), 7.51 (d, <i>J</i> = 7.2 Hz, 2H), 7.44–7.41 (m, 3H), 7.37–7.34 (m, 1H), 7.07 (dd, J = 8.2, 1.8 Hz, 1H), 7.03 (s, 1H), 5.71 (s, 1H), 5.21 (s, 2H), 3.36 (br s, 4H), 2.52 (s, 3H), 1.51–1.67 (m, 4H), 1.19 (s, 9H), 1.11 (br s, 6H). MS (C<sub>33</sub>H<sub>40</sub>N<sub>4</sub>O<sub>4</sub>): <i>m</i>/<i>z</i> 557 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> (2<i>S</i>)-2-(<i>tert</i>-Butoxy)-2-(7-(8-fluoro-5-methylchroman-6-yl)-5-methyl-2-(2′-methyl-[1,1′-biphenyl]-3-yl)pyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)acetic Acid ((<i>S</i>,<i>S</i>)-<b>27</b>)</h3><div class="NLM_p last">A mixture of dicyclohexyl(2′,6′-dimethoxy-[1,1′-biphenyl]-2-yl)phosphine (595 mg, 1.449 mmol), Pd(OAc)<sub>2</sub> (163 mg, 0.725 mmol), <i>o</i>-tolylboronic acid (296 mg, 2.174 mmol), 2 M K<sub>3</sub>PO<sub>4</sub> solution (200 μL), and <b>55</b> (400 mg, 0.725 mmol) in DMF (1.5 mL) was heated in a microwave reactor at 130 °C for 30 min. The mixture was filtered and the filtrate purified by silica gel chromatography to afford (2<i>S</i>)-methyl 2-(<i>tert</i>-butoxy)-2-(7-(8-fluoro-5-methylchroman-6-yl)-5-methyl-2-(2′-methyl-[1,1′-biphenyl]-3-yl)pyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)acetate (225.6 mg, 51.2%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ (ppm): 7.86–7.76 (m, 2H), 7.42 (t, <i>J</i> = 7.8 Hz, 1H), 7.29–7.26 (m, 5H), 6.88–6.86 (m, 2H), 4.99 (s, 1H), 4.39–4.27 (m, 2H), 3.64 (s, 3H), 2.83–2.70 (m, 5H), 2.26 (s, 3H), 2.22–2.13 (m, 2H), 1.84 (s, 3H), 1.16 (s, 9H). MS (C<sub>37</sub>H<sub>38</sub>FN<sub>3</sub>O<sub>4</sub>): <i>m</i>/<i>z</i> 608 (M + H)<sup>+</sup>. 1 N NaOH aqueous solution (9 mL, 9 mmol) was added to a solution of (2<i>S</i>)-methyl 2-(<i>tert</i>-butoxy)-2-(7-(8-fluoro-5-methylchroman-6-yl)-5-methyl-2-(2′-methyl-[1,1′-biphenyl]-3-yl)pyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)acetate (1.28 g, 2.1 mmol) in dioxane (12 mL) and the mixture stirred at 50 °C for 2 h. The mixture was diluted with H<sub>2</sub>O (50 mL), neutralized with AcOH, and extracted with EtOAc (3 × 100 mL). The organic phase was combined, dried over Na<sub>2</sub>SO<sub>4</sub>, concentrated and the crude product purified by preparative HPLC to afford (<i>S</i>,<i>S</i>)-<b>27</b> (840 mg, 66%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 7.86–7.75 (m, 2H), 7.50 (t, <i>J</i> = 7.7 Hz, 1H), 7.40–7.22 (m, 5H), 7.18 (s, 1H), 7.09 (d, <i>J</i> = 1.0 Hz, 1H), 4.83 (s, 1H), 4.34–4.22 (m, 2H), 2.82–2.66 (m, 5H), 2.24 (s, 3H), 2.13–2.02 (m, 2H), 1.83 (s, 3H), 1.09 (s, 9H). MS (C<sub>36</sub>H<sub>36</sub>FN<sub>3</sub>O<sub>4</sub>): <i>m</i>/<i>z</i> 594 (M + H)<sup>+</sup>. Anal. (C<sub>36</sub>H<sub>36</sub>FN<sub>3</sub>O<sub>4</sub> with 1.26% H<sub>2</sub>O) Calcd: C, 71.91; H, 6.18; N, 6.99; F, 3.16. Found: C, 71.67; H, 6.25; N, 7.07; F, 2.79.</div></div><div id="sec5_1_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> (2<i>S</i>)-2-(<i>tert</i>-Butoxy)-2-(7-(8-fluoro-5-methylchroman-6-yl)-2-(2′-methoxy-[1,1′-biphenyl]-3-yl)-5-methylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)acetic Acid ((<i>S</i>,<i>S</i>)-<b>28</b>)</h3><div class="NLM_p last">The title compound was prepared from (2<i>S</i>)-methyl 2-(<i>tert</i>-butoxy)-2-(2-(3-chlorophenyl)-7-(8-fluoro-5-methylchroman-6-yl)-5-methylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)acetate in a manner similar to that described for (<i>S</i>,<i>S</i>)-<b>27</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ (ppm): 8.00–7.95 (m, 1H), 7.79 (d, <i>J</i> = 7.6 Hz, 1H), 7.51–7.47 (m, 1H), 7.45–7.39 (m, 1H), 7.37–7.31 (m, 2H), 7.08–6.97 (m, 2H), 6.93 (d, <i>J</i> = 10.7 Hz, 1H), 6.90 (s, 1H), 5.08 (s, 1H), 4.39–4.24 (m, 2H), 3.79 (s, 3H), 2.82–2.64 (m, 5H), 2.15 (d, <i>J</i> = 3.7 Hz, 2H), 1.92 (s, 3H), 1.21 (s, 9H). MS (C<sub>36</sub>H<sub>36</sub>FN<sub>3</sub>O<sub>5</sub>): <i>m</i>/<i>z</i> 610 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> (2<i>S</i>)-2-(<i>tert</i>-Butoxy)-2-(7-(8-fluoro-5-methylchroman-6-yl)-2-(2′-fluoro-[1,1′-biphenyl]-3-yl)-5-methylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)acetic Acid ((<i>S</i>,<i>S</i>)-<b>29</b>)</h3><div class="NLM_p last">The title compound was prepared from (2<i>S</i>)-methyl 2-(<i>tert</i>-butoxy)-2-(2-(3-chlorophenyl)-7-(8-fluoro-5-methylchroman-6-yl)-5-methylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)acetate in a manner similar to that described for (<i>S</i>,<i>S</i>)-<b>27</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ (ppm): 7.95 (d, <i>J</i> = 1.2 Hz, 1H), 7.88–7.75 (m, 1H), 7.57–7.40 (m, 3H), 7.37–7.29 (m, 1H), 7.24–7.12 (m, 2H), 7.01–6.82 (m, 2H), 5.06 (s, 1H), 4.36–4.24 (m, 2H), 2.80–2.63 (m, 5H), 2.13 (dd, <i>J</i> = 6.1, 3.1 Hz, 2H), 1.89 (s, 3H), 1.17 (s, 9H). MS (C<sub>35</sub>H<sub>33</sub>F<sub>2</sub>N<sub>3</sub>O<sub>4</sub>): <i>m</i>/<i>z</i> 598 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> (2<i>S</i>)-2-(<i>tert</i>-Butoxy)-2-(7-(8-fluoro-5-methylchroman-6-yl)-5-methyl-2-(3-(pyridin-4-yl)phenyl)pyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)acetic Acid, TFA Salt ((<i>S</i>,<i>S</i>)-<b>30</b>)</h3><div class="NLM_p last">The title compound was prepared from (2<i>S</i>)-methyl 2-(<i>tert</i>-butoxy)-2-(2-(3-chlorophenyl)-7-(8-fluoro-5-methylchroman-6-yl)-5-methylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)acetate in a manner similar to that described for (<i>S</i>,<i>S</i>)-<b>27</b>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ (ppm): 8.91 (d, <i>J</i> = 6.41 Hz, 2H), 8.13–8.05 (m, 4H), 7.75–7.60 (m, 2H), 7.00 (s, 1H), 6.92 (d, <i>J</i> = 10.38 Hz, 1H), 5.09 (s, 1H), 4.33 (t, <i>J</i> = 5.04 Hz, 2H), 2.79–2.69 (m, 5H), 2.22–2.11 (m, 2H), 1.95 (s, 3H), 1.21 (s, 9H). MS (C<sub>34</sub>H<sub>33</sub>FN<sub>4</sub>O<sub>4</sub>): <i>m</i>/<i>z</i> 581 (M + H)<sup>+</sup>. HRMS calcd for C<sub>34</sub>H<sub>33</sub>FN<sub>4</sub>O<sub>4</sub> (MH<sup>+</sup>) 581.2559, found 581.2574.</div></div><div id="sec5_1_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> (2<i>S</i>)-2-(<i>tert</i>-Butoxy)-2-(7-(8-fluoro-5-methylchroman-6-yl)-2-(3-(6-methoxypyridin-3-yl)phenyl)-5-methylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)acetic Acid ((<i>S</i>,<i>S</i>)-<b>31</b>)</h3><div class="NLM_p last">The title compound was prepared from (2<i>S</i>)-methyl 2-(<i>tert</i>-butoxy)-2-(2-(3-chlorophenyl)-7-(8-fluoro-5-methylchroman-6-yl)-5-methylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)acetate in a manner similar to that described for (<i>S</i>,<i>S</i>)-<b>27</b>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 8.55 (d, <i>J</i> = 2.4 Hz, 1H), 8.13–8.05 (m, 2H), 7.79 (d, <i>J</i> = 7.9 Hz, 1H), 7.66 (d, <i>J</i> = 7.9 Hz, 1H), 7.51 (t, <i>J</i> = 7.6 Hz, 1H), 7.26 (s, 1H), 7.09 (d, <i>J</i> = 11.3 Hz, 1H), 6.95 (d, <i>J</i> = 8.5 Hz, 1H), 4.78 (s, 1H), 4.34–4.21 (m, 2H), 3.92 (s, 3H), 2.75–2.73 (m, 2H), 2.71 (s, 3H), 2.08 (t, <i>J</i> = 5.6 Hz, 2H), 1.83 (s, 3H), 1.09 (s, 9H). MS (C<sub>35</sub>H<sub>35</sub>FN<sub>4</sub>O<sub>5</sub>): <i>m</i>/<i>z</i> 611 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> Methyl 5-Methyl-2-phenyl-7-<i>p</i>-tolylpyrazolo[1,5-<i>a</i>]pyrimidine-6-carboxylate (<b>34</b>)</h3><div class="NLM_p last">To a stirred solution of 4-methylbenzaldehyde <b>32</b> (1.2 g, 9.99 mmol), 3-phenyl-1<i>H</i>-pyrazol-5-amine <b>33</b> (1.6 g, 9.99 mmol), and methyl 3-oxobutanoate (1.3 g, 10.99 mmol) in THF (80 mL) and heptane (20 mL) was added piperidine (30 μL, 0.303 mmol). The reaction mixture was heated at reflux for 20 h, the solvent was evaporated, and the crude material was dissolved in CH<sub>2</sub>Cl<sub>2</sub>. DDQ (2.041 g, 8.99 mmol) was added, and the mixture was stirred at room temperature for 1 h. The solvent was evaporated and the residue purified by silica gel chromatography to provide <b>34</b> (2.3 g, 64%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ (ppm): 7.99–7.86 (m, 2H), 7.63 (d, <i>J</i> = 7.9 Hz, 2H), 7.47–7.31 (m, 5H), 6.93 (s, 1 H), 3.64 (s, 3 H), 2.65 (s, 3 H), 2.47 (s, 3 H). MS (C<sub>22</sub>H<sub>19</sub>N<sub>3</sub>O<sub>2</sub>): <i>m</i>/<i>z</i> 358 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 5-Methyl-2-phenyl-7-<i>p</i>-tolylpyrazolo[1,5-<i>a</i>]pyrimidine-6-carbaldehyde (<b>35</b>)</h3><div class="NLM_p">DIBAL-H (1 M in THF, 6.72 mL, 6.72 mmol) was added dropwise to a stirred solution of <b>34</b> (800 mg, 2.238 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (50 mL). The reaction mixture was stirred at room temperature for 1 h before being quenched with saturated NH<sub>4</sub>Cl solution. The aqueous layer was extracted with CH<sub>2</sub>Cl<sub>2</sub>, and the combined organic layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The residue was purified by silica gel chromatography to give (5-methyl-2-phenyl-7-<i>p</i>-tolylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)methanol (344 mg, 46.7%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ (ppm): 1.61 (1 H, t, <i>J</i> = 5.0 Hz), 2.49 (3 H, s), 2.78 (3 H, s), 4.59 (2 H, d, <i>J</i> = 5.0 Hz), 6.88 (1 H, s), 7.29–7.42 (5 H, m), 7.56 (2 H, d, <i>J</i> = 8.2 Hz), 7.81–7.96 (2 H, m). MS (C<sub>21</sub>H<sub>19</sub>N<sub>3</sub>O): <i>m</i>/<i>z</i> 330 (M + H)<sup>+</sup>.</div><div class="NLM_p last">To a stirred solution of (5-methyl-2-phenyl-7-<i>p</i>-tolylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)methanol (100 mg, 0.304 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (8 mL) was added PCC (98 mg, 0.455 mmol). The reaction mixture was stirred at room temperature for 16 h. The solvent was evaporated and the residue was purified by silica gel chromatography to give the title compound <b>35</b> (82 mg, 83%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ (ppm): 9.80 (s, 1 H), 7.91 (dd, <i>J</i> = 8.1, 1.4 Hz, 2H), 7.60 (d, <i>J</i> = 7.9 Hz, 2H), 7.50–7.33 (m, 5 H), 6.98 (s, 1 H), 2.89 (s, 3 H), 2.52 (s, 3 H). MS (C<sub>21</sub>H<sub>17</sub>N<sub>3</sub>O): <i>m</i>/<i>z</i> 328 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> 2-Hydroxy-2-(5-methyl-2-phenyl-7-<i>p</i>-tolylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)acetonitrile (<b>36</b>)</h3><div class="NLM_p last">To a solution of <b>35</b> (30 mg, 0.092 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (2 mL) at 0 °C was added ZnI<sub>2</sub> (14.63 mg, 0.046 mmol) followed by TMS-CN (0.049 mL, 0.367 mmol). The reaction mixture was stirred at room temperature for 4 h and diluted with CH<sub>2</sub>Cl<sub>2</sub> (100 mL), washed with H<sub>2</sub>O, and dried over Na<sub>2</sub>SO<sub>4</sub>. The solvent was evaporated and the residue was purified by preparative HPLC to give the title compound <b>36</b> (15 mg, 46.2%) as a TFA salt. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ (ppm): 7.76–7.63 (m, 2 H), 7.44–7.30 (m, 4 H), 7.25–7.16 (m, 3 H), 6.85 (s, 1 H), 5.39 (s, 1 H), 2.89 (s, 3 H), 2.46 (s, 3 H). MS (C<sub>22</sub>H<sub>18</sub>N<sub>4</sub>O): <i>m</i>/<i>z</i> 355 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> Methyl 2-(5-Methyl-7-oxo-2-phenyl-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)acetate (<b>38</b>)</h3><div class="NLM_p last"><i>p</i>-TsOH.H<sub>2</sub>O (50 mg, 0.263 mmol) was added to a solution of 3-phenyl-1<i>H</i>-pyrazol-5-amine <b>33</b> (4 g, 25.1 mmol) and dimethyl 2-acetylsuccinate <b>37</b> (12 mL, 74.0 mmol) in xylene (120 mL) and the mixture heated at reflux under a Dean–Stark trap for 20 h. The solid was filtered and washed with hexanes to afford <b>38</b> (6.4 g, 86%). <sup>1</sup>H NMR (400 MHz, MeOD) δ (ppm): 8.06–7.87 (m, 2 H), 7.53–7.34 (m, 3 H), 6.46 (s, 1 H), 3.72 (s, 3 H), 3.66 (s, 2 H), 2.37 (s, 3 H). MS (C<sub>16</sub>H<sub>15</sub>N<sub>3</sub>O<sub>3</sub>): <i>m</i>/<i>z</i> 298 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> Methyl 2-(7-Chloro-5-methyl-2-phenylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)acetate (<b>39</b>)</h3><div class="NLM_p last">POCl<sub>3</sub> (25 mL, 268 mmol) was added to <b>38</b> (3 g, 10.09 mmol) and the mixture heated at reflux for 1 h. After cooling, the reaction mixture was added dropwise to ice–water to afford a brown precipitate. The solid was filtered off, washed with H<sub>2</sub>O, and dissolved in EtOAc. The organic solution was washed with saturated NaHCO<sub>3</sub> and dried over Na<sub>2</sub>SO<sub>4</sub>. The solvent was evaporated to give <b>39</b> (2.77 g, 84%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 8.07 (d, <i>J</i> = 7.0 Hz, 2H), 7.58–7.43 (m, 3 H), 7.29 (s, 1 H), 4.04 (s, 2 H), 3.71 (s, 3 H), 2.58 (s, 3 H). MS (C<sub>16</sub>H<sub>14</sub>ClN<sub>3</sub>O<sub>2</sub>): <i>m</i>/<i>z</i> 316 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> Methyl 2-(7-Chloro-5-methyl-2-phenylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)-2-hydroxyacetate (<b>40</b>)</h3><div class="NLM_p last">A solution of <b>39</b> (1 g, 3.17 mmol) in THF (24 mL) was added dropwise over 40 min to a stirred solution of KHMDS (0.5 M in toluene, 9.50 mL, 4.75 mmol) in THF (24 mL) maintained at −78 °C. The mixture was stirred at −78 °C for 30 min before adding a solution of 3-phenyl-2-(phenylsulfonyl)-1,2-oxaziridine (1.241 g, 4.75 mmol) in THF (24 mL) over 20 min. The reaction mixture was stirred for additional 30 min at −78 °C before being quenched by the addition of saturated aqueous NH<sub>4</sub>Cl solution (4 mL). The reaction mixture was allowed to warm to room temperature, diluted with EtOAc (100 mL) and the organic phase washed with H<sub>2</sub>O and brine and dried over Na<sub>2</sub>SO<sub>4</sub>. The solvent was evaporated and the residue purified by silica gel chromatography to provide <b>40</b> (535 mg, 50.9%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ ppm: 8.02–8.00 (m, 2 H), 7.50–7.38 (m, 3 H), 6.94 (s, 1 H), 5.76 (s, 1 H), 5.29 (s, 1 H), 3.83 (s, 3 H), 2.62 (s, 3 H). MS (C<sub>16</sub>H<sub>14</sub>ClN<sub>3</sub>O<sub>3</sub>): <i>m</i>/<i>z</i> 332 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> Methyl 2-<i>tert</i>-Butoxy-2-(7-chloro-5-methyl-2-phenylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)acetate (<b>41</b>)</h3><div class="NLM_p last">CH<sub>2</sub>Cl<sub>2</sub> (2 mL) and HClO<sub>4</sub> (0.027 mL, 0.452 mmol) were added sequentially to a suspension of methyl 2-(7-chloro-5-methyl-2-phenylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)-2-hydroxyacetate <b>40</b> (100 mg, 0.301 mmol) in <i>tert</i>-butyl acetate (2 mL), and the mixture was stirred for 2 h at room temperature. The reaction mixture was quenched with H<sub>2</sub>O, diluted with EtOAc and the organic phase washed with saturated NaHCO<sub>3</sub> and dried over Na<sub>2</sub>SO<sub>4</sub>. The solvent was evaporated and the residue purified by silica gel chromatography to provide <b>41</b> (71 mg, 60.7%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ (ppm): 8.01 (d, <i>J</i> = 7.3 Hz, 2H), 7.52–7.34 (m, 3 H), 6.93 (s, 1 H), 5.66 (s, 1 H), 3.73 (s, 3 H), 1.27 (s, 9 H). MS (C<sub>20</sub>H<sub>22</sub>ClN<sub>3</sub>O<sub>3</sub>): <i>m</i>/<i>z</i> 388 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> Methyl 2-(2-Bromo-7-hydroxy-5-methylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)acetate (<b>43</b>)</h3><div class="NLM_p last"><i>p</i>-TsOH·H<sub>2</sub>O (2 mg, 10.51 μmol) was added to a solution of <b>42</b> (0.2 g, 1.235 mmol) and <b>37</b> (0.697 g, 3.70 mmol) in xylene (10 mL) and the mixture heated at reflux under a Dean–Stark trap for 8 h. The solid was filtered and washed with hexanes to afford <b>43</b> (0.201 g, 54.2%). <sup>1</sup>H NMR (400 MHz, MeOD) δ (ppm): 6.20 (s, 1 H), 3.71 (s, 3 H), 3.65 (s, 2 H), 2.37 (s, 3 H). MS (C<sub>10</sub>H<sub>10</sub>BrN<sub>3</sub>O<sub>3</sub>): <i>m</i>/<i>z</i> 300 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> Methyl 2-(2-Bromo-7-chloro-5-methylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)acetate (<b>44</b>)</h3><div class="NLM_p last">POCl<sub>3</sub> (1 mL, 10.73 mmol) was added to <b>43</b> (180 mg, 0.600 mmol) and the mixture heated at reflux for 1 h. After cooling, the reaction mixture was added dropwise to ice–water to afford a brown solid precipitate. The solid was filtered off and washed with H<sub>2</sub>O to give <b>44</b> (158 mg, 83%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ (ppm): 6.99 (s, 1 H), 4.01 (s, 2 H), 3.69 (s, 3 H), 2.56 (s, 3 H). MS (C<sub>10</sub>H<sub>9</sub>BrClN<sub>3</sub>O<sub>2</sub>): <i>m</i>/<i>z</i> 318 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> Methyl 2-(2-Bromo-7-chloro-5-methylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)-2-hydroxyacetate (<b>45</b>)</h3><div class="NLM_p last">A solution of <b>44</b> (300 mg, 0.942 mmol) in THF (6 mL) was added dropwise over 20 min to a stirred solution of KHMDS (0.5 M in toluene, 2.83 mL, 1.413 mmol) in THF (6 mL) maintained at −78 °C. The mixture was stirred at −78 °C for 30 min before adding a solution of 3-phenyl-2-(phenylsulfonyl)-1,2-oxaziridine (369 mg, 1.413 mmol) in THF (6 mL) over 15 min. The mixture was stirred for an additional 60 min at −78 °C before being quenched with saturated NH<sub>4</sub>Cl aqueous solution (4 mL). The mixture was allowed to warm to room temperature, diluted with EtOAc (100 mL) and the organic phase washed with H<sub>2</sub>O and brine before being dried over Na<sub>2</sub>SO<sub>4</sub>. The solvent was evaporated and the residue purified by silica gel chromatography to provide <b>45</b> (85 mg, 27%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ (ppm): 6.71 (s, 1 H), 5.74 (s, 1 H), 3.84 (s, 3 H), 2.63 (s, 3 H). MS (C<sub>10</sub>H<sub>9</sub>BrClN<sub>3</sub>O<sub>3</sub>): <i>m</i>/<i>z</i> 334.</div></div><div id="sec5_1_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> Methyl 2-(2-Bromo-7-chloro-5-methylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)-2-<i>tert</i>-butoxyacetate (<b>46</b>)</h3><div class="NLM_p last">CH<sub>2</sub>Cl<sub>2</sub> (2 mL) and HClO<sub>4</sub> (0.022 mL, 0.359 mmol) were added to a suspension of <b>45</b> (80 mg, 0.239 mmol) in <i>tert</i>-butyl acetate (2 mL) and the mixture stirred for 4 h at room temperature. The reaction mixture was quenched with H<sub>2</sub>O, diluted with EtOAc and the organic phase washed with saturated NaHCO<sub>3</sub> and dried over Na<sub>2</sub>SO<sub>4</sub>. The solvent was evaporated and the residue purified by silica gel chromatography to provide <b>46</b> (56 mg, 59.9%). <sup>1</sup>H NMR (500 MHz, MeOD) δ (ppm): 6.75 (s, 1 H), 5.75 (s, 1 H), 3.74 (s, 3 H), 2.62 (s, 3 H), 1.27 (s, 9 H). MS (C<sub>14</sub>H<sub>17</sub>BrClN<sub>3</sub>O<sub>3</sub>): <i>m</i>/<i>z</i> 390.</div></div><div id="sec5_1_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> Methyl 2-<i>tert</i>-Butoxy-2-(7-chloro-5-methyl-2-<i>p</i>-tolylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)acetate, TFA Salt (<b>47</b>)</h3><div class="NLM_p last">A mixture of <b>46</b> (28 mg, 0.072 mmol), Pd(PPh<sub>3</sub>)<sub>4</sub> (12.42 mg, 10.75 μmol), <i>p</i>-tolylboronic acid (10.72 mg, 0.079 mmol), 2 M K<sub>2</sub>CO<sub>3</sub> solution (100 μL), and DMF (3 mL), was heated in a microwave reactor at 70 °C for 60 min. The mixture was filtered and the filtrate purified by preparative HPLC to afford <b>47</b> (16 mg, 43.3%) as the TFA salt. <sup>1</sup>H NMR (500 MHz, MeOD) δ (ppm): 7.92 (d, <i>J</i> = 7.9 Hz, 2H), 7.30 (d, <i>J</i> = 7.9 Hz, 2H), 6.98 (s, 1 H), 5.79 (s, 1 H), 3.75 (s, 3 H), 2.62 (s, 3 H), 2.40 (s, 3 H), 1.29 (s, 9 H). MS (C<sub>21</sub>H<sub>24</sub>ClN<sub>3</sub>O<sub>3</sub>): <i>m</i>/<i>z</i> 402 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> Methyl 2-(2-(3-Chlorophenyl)-7-hydroxy-5-methylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)acetate (<b>49</b>)</h3><div class="NLM_p last"><i>p</i>-TsOH·H<sub>2</sub>O (100 mg, 0.526 mmol) was added to a solution of <b>48</b> (23 g, 119 mmol) and dimethyl 2-acetylsuccinate <b>37</b> (22.35 g, 119 mmol) in <i>o</i>-xylene (200 mL) and the mixture heated at reflux under a Dean–Stark trap for 2 h. The solid was filtered and washed with hexanes to afford <b>49</b> (39 g, 99%). <sup>1</sup>H NMR (500 MHz, MeOD) δ (ppm): 8.14–7.95 (m, 1H), 7.93–7.79 (m, 1H), 7.51–7.27 (m, 2H), 6.62–6.35 (m, 1H), 3.72 (s, 3H), 3.67 (s, 2H), 2.39 (s, 3H). MS (C<sub>16</sub>H<sub>14</sub>ClN<sub>3</sub>O<sub>3</sub>): <i>m</i>/<i>z</i> 332 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> Methyl 2-(7-Chloro-2-(3-chlorophenyl)-5-methylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)acetate (<b>50</b>)</h3><div class="NLM_p last">A mixture of <b>49</b> (12 g, 36.2 mmol) and POCl<sub>3</sub> (50 mL) was heated at reflux for 2.5 h. After cooling, the reaction mixture was added dropwise to ice–water to precipitate a brown solid which was filtered and washed with H<sub>2</sub>O before dissolving in EtOAc. The organic layer was washed with saturated NaHCO<sub>3</sub>, dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated to give <b>50</b> (11.9 g, 94%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ (ppm): 8.03 (t, <i>J</i> = 1.8 Hz, 1H), 7.94–7.82 (m, 1H), 7.48–7.34 (m, 2H), 6.94 (s, 1H), 3.93 (s, 2H), 3.78 (s, 3H), 2.63 (s, 3H). MS (C<sub>16</sub>H<sub>13</sub>Cl<sub>2</sub>N<sub>3</sub>O<sub>2</sub>): <i>m</i>/<i>z</i> 350 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> Methyl 2-(7-Chloro-2-(3-chlorophenyl)-5-methylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)-2-hydroxyacetate (<b>51</b>)</h3><div class="NLM_p last">KHMDS (44.5 mL, 22.27 mmol) was added dropwise over 30 min to a stirred solution of <b>50</b> (7.8 g, 22.27 mmol) in THF (40 mL) maintained at −78 °C. The mixture was stirred at −78 °C for 30 min before adding a solution of 3-phenyl-2-(phenylsulfonyl)-1,2-oxaziridine (8.73 g, 33.4 mmol) in THF (50 mL) over 30 min. After stirring for an additional 2 h at −78 °C, the mixture was quenched with saturated NH<sub>4</sub>Cl aqueous solution (40 mL) and allowed to warm to room temperature before being diluted with EtOAc (200 mL). The organic phase was washed with H<sub>2</sub>O and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated to leave a residue that was purified by silica gel chromatography to provide <b>51</b> (4.2 g, 51.5%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ (ppm): 8.05–7.97 (m, 1H), 7.88 (dt, <i>J</i> = 6.7, 1.8 Hz, 1H), 7.44–7.38 (m, 2H), 6.93 (s, 1H), 5.76 (s, 1H), 3.84 (s, 3H), 2.62 (s, 3H). MS (C<sub>16</sub>H<sub>13</sub>Cl<sub>2</sub>N<sub>3</sub>O<sub>3</sub>): <i>m</i>/<i>z</i> 366 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> Methyl 2-(7-Chloro-2-(3-chlorophenyl)-5-methylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)-2-oxoacetate (<b>52</b>)</h3><div class="NLM_p last">Dess–Martin periodinane (6.37 g, 15.02 mmol) was added to a mixture of <b>51</b> (5.0 g, 13.65 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (20 mL), and the mixture was stirred at room temp for 1 h. The mixture was diluted with EtOAc (100 mL), the organic layer was washed with saturated NaHCO<sub>3</sub> solution (100 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated. The residue was purified by silica gel chromatography to afford <b>52</b> (3.8 g, 76%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ (ppm): 8.10–7.98 (m, 1H), 7.89 (td, <i>J</i> = 4.4, 1.5 Hz, 1H), 7.51–7.36 (m, 2H), 7.00 (s, 1H), 4.00 (s, 3H), 2.62 (s, 3H). MS (C<sub>16</sub>H<sub>11</sub>Cl<sub>2</sub>N<sub>3</sub>O<sub>3</sub>): <i>m</i>/<i>z</i> 364 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> (<i>S</i>)-Methyl 2-(7-Chloro-2-(3-chlorophenyl)-5-methylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)-2-hydroxyacetate (<b>53</b>)</h3><div class="NLM_p last">(<i>R</i>)-1-Methyl-3,3-diphenylhexahydropyrrolo[1,2-<i>c</i>][1,3,2]oxazaborole/toluene (1.797 mL of a 1.1 M solution, 1.977 mmol) was added to a stirred solution of <b>52</b> (1.8 g, 4.94 mmol) in anhydrous toluene (30 mL) and the mixture cooled to −40 °C (acetonitrile/dry ice bath). A solution of catecholborane (50% by weight) in toluene (1.695 mL, 6.92 mmol) was added over 30 min and the mixture stirred at −45 to −35 °C for 2 h and at −25 °C to −15 °C for an additional 1 h. Saturated Na<sub>2</sub>CO<sub>3</sub> solution (20 mL) was added to quench the reaction, and the mixture was stirred vigorously for 30 min and extracted with EtOAc. The organic layer was washed with saturated Na<sub>2</sub>CO<sub>3</sub> solution, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated to leave a residue that was purified by silica gel chromatography (15–50% EtOAc/hexane) to afford <b>53</b> (1.5 g, 83%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ (ppm): 8.05–7.97 (m, 1H), 7.88 (dt, <i>J</i> = 6.7, 1.8 Hz, 1H), 7.44–7.38 (m, 2H), 6.93 (s, 1H), 5.76 (s, 1H), 3.84 (s, 3H), 2.62 (s, 3H). MS (C<sub>16</sub>H<sub>13</sub>Cl<sub>2</sub>N<sub>3</sub>O<sub>3</sub>): <i>m</i>/<i>z</i> 366 (M + H)<sup>+</sup>.</div></div><div id="sec5_1_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> (<i>S</i>)-Methyl 2-(<i>tert</i>-Butoxy)-2-(7-chloro-2-(3-chlorophenyl)-5-methylpyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)acetate (<b>54</b>)</h3><div class="NLM_p last"><i>tert</i>-Butyl acetate (20 mL) and HClO<sub>4</sub> (0.282 mL, 3.28 mmol) were added to a solution of <b>53</b> (1.0 g, 2.73 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (100 mL), and the mixture was stirred for 16 h at room temperature. The mixture was quenched with H<sub>2</sub>O, diluted with EtOAc and the organic phase washed with saturated NaHCO<sub>3</sub> and dried over Na<sub>2</sub>SO<sub>4</sub>. The solvent was evaporated and the residue purified by silica gel chromatography to provide <b>54</b> (520 mg, 50%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ (ppm): 8.07–8.00 (m, 1H), 7.89 (dt, <i>J</i> = 6.7, 1.9 Hz, 1H), 7.48–7.37 (m, 2H), 6.93 (s, 1H), 5.68 (s, 1H), 3.75 (s, 3H), 2.69 (s, 3H), 1.29 (s, 9H). MS (C<sub>20</sub>H<sub>21</sub>Cl<sub>2</sub>N<sub>3</sub>O<sub>3</sub>): <i>m</i>/<i>z</i> 422 (M + H)<sup>+</sup>.</div></div><div id="sec999" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> (2<i>S</i>)-Methyl 2-(tert-Butoxy)-2-(2-(3-chlorophenyl)-7-(8-fluoro-5-methylchroman-6-yl)-5-methylpyrazolo[1,5-a]pyrimidin-6-yl)acetate ((S,S)-<b>5</b><b>5</b>)</h3><div class="NLM_p last">A mixture of <b>54</b> (420 mg, 0.995 mmol), Pd(PPh<sub>3</sub>)<sub>4</sub> (115 mg, 0.099 mmol), 2-(8-fluoro-5-methylchroman-6-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (320 mg, 1.094 mmol), 2M K<sub>2</sub>CO<sub>3</sub> solution (400 μL) in DMF (4 mL) was heated in a microwave reactor at 125 °C for 45 min. The mixture was filtered and the filtrate purified by silica gel chromatography to afford <b>55</b> (204 mg, 37.2%). The enantiomeric excess was determined by a chiral SFC method: Chiralpak AD-H analytical column, 4.6 × 250 mm, 5 m; Mobile Phase: 15% MeOH in CO<sub>2</sub>. Temp: 35 °C. Flow rate: 2.0 mL/min. for 10 min. UV monitored @ 266nm. Injection: 5 L of ∼2.0 mg/mL solution in 50:50 MeOH:CHCl<sub>3</sub>.  The enantiomeric excess was 93.0%. <sup>1</sup>H-NMR (500 MHz, CDCl3) δ (ppm): 7.83−7.78 (m, 1H), 7.69 (dt, <i>J</i> = 6.7, 1.8 Hz, 1H), 7.35−7.28 (m, 2H), 6.87 (d, <i>J</i> = 10.7 Hz, 1H), 6.84 (s, 1H), 5.00 (s, 1H), 4.48−4.26 (m, 2H), 3.64 (s, 3H), 2.85−2.67 (m, 5H), 2.30−2.13 (m, 2H), 1.84 (s, 3H), 1.16 (s, 9H). MS (C<sub>30</sub>H<sub>31</sub>ClFN<sub>3</sub>O<sub>4</sub>): <i>m</i>/<i>z</i> 552 (M + H)<sup>+</sup>.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> Crystallization, Data Collection, and Structure Refinement for the HIV-1 Integrase CCD:(<i>S</i>,<i>S</i>)-<b>14</b> Complex</h3><div class="NLM_p last">Crystals of HIV(50-212)-C56S-W131E-F185K were prepared by the sitting drop vapor diffusion method. The protein stock solution consisted of 12.5 mg/mL (0.691 mM based on the calculated MW of 18 098 Da) in 25 mM Hepes, pH 7.5, 500 mM NaCl, 1 mM EDTA, and 5 mM DTT. The addition of 50 mM MgCl<sub>2</sub> to the buffer prior to complexing improved crystal screening hits; however, later magnesium was added directly to the crystallization screen. The protein was complexed with 1.74 mM compound <b>14</b> from a 100 mM stock solution dissolved in 100% DMSO. The protein/ligand complex was incubated for 4 h at 4 °C and clarified by centrifugation. Crystallization screens were prepared using a SCREENMAKER 96+8 (Innovadyne, Santa Rosa, CA, USA) on MRC 2 well sitting drop trays. Crystals grew from reservoir solution conditions of 2.0 M (NH<sub>4</sub>)<sub>2</sub>SO<sub>4</sub> and 100 mM citric acid, pH 3.5. Drops were formed from 0.8 μL of the protein solution and 0.8 μL of the reservoir solution (total initial volume of 1.6 μL), mixed, and placed at 20 °C to equilibrate. Crystals appeared within 3 days and grew for an additional 7 days. Single crystals were removed and transferred to a cryo-solution consisting of 1.75 M (NH<sub>4</sub>)<sub>2</sub>SO<sub>4</sub>, 75 mM citric acid, pH 3.5, 10% (v/v) glycerol, and 10% (v/v) PEG 400. Crystals were flash frozen in liquid N<sub>2</sub> and stored prior to data collection. Data for the HIV-1 integrase/(<i>S</i>,<i>S</i>)-<b>14</b> complex were collected at beamline 17ID at IMCA-CAT of the Advanced Photon Source at Argonne National Laboratory. The wavelength used was 1.0 Å, and the detector was a DECTRIS PILATUS 6M. The diffraction images were indexed, integrated, and scaled with XDS using autoPROC (Global Phasing Ltd., Cambridge, England). The structure was determined by molecular replacement using the program PHASER<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> with a previously reported structure of HIV integrase (PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6NCJ">6NCJ</a>) used as the starting model in the refinement. The structure was refined with the program autoBUSTER (Global Phasing Ltd., Cambridge, England) and was examined and manually refitted with the program COOT.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Grade (Global Phasing Ltd., Cambridge, England) was used to generate a CIF restraint dictionary for (<i>S</i>,<i>S</i>)-<b>14</b>, and rhofit (Global Phasing Ltd., Cambridge, England) was used to place the ligand. Refinement was completed using Coot and autoBUSTER, and the statistics are included in <a href="/doi/suppl/10.1021/acs.jmedchem.9b01681/suppl_file/jm9b01681_si_001.pdf" class="ext-link">Supporting Information</a>. Display graphics were produced with PyMOL version 1.4 (Schrödinger). The coordinates of the HIV-1 integrase CCD:(<i>S</i>,<i>S</i>)-<b>14</b> complex have been deposited in the PDB under PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6UM8">6UM8</a>.</div></div><div id="sec5_3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> Virology Materials and Methods. Competitive Binding Assay Method</h3><div class="NLM_p last">Compounds were evaluated for their ability to displace a tritiated LEDGF inhibitor ([<sup>3</sup>H]-<b>1</b>) from binding to HIV-1 integrase via a LEDGF inhibitor displacement assay (LIDIA). Relative inhibitor avidity for HIV-1 integrase is expressed as a <i>K</i><sub>i</sub> value. The final concentrations of reagents in the 50 μL LIDIA assay are 26 mM MOPS buffer, pH 7.0, 11 mM DTT, 100 mM NaCl, 20 mM MgCl<sub>2</sub>, 0.05% NP-40, 5% PEG-8000, 27 μM [<sup>3</sup>H]-<b>1</b>, 13 μM purified HIV-1 integrase, and 2 mg/mL PVT SPA beads (polyvinyltoluene scintillation proximity assay beads. PerkinElmer, Waltham, MA). Compounds are titrated in 10 μL volumes in 25% DMSO over a final concentration range of 100 μM to 0.0512 nM (ten 5-fold dilutions). Initially, HIV-1 integrase was incubated with PVT SPA beads in 1.25× cocktail (minus [<sup>3</sup>H]-<b>1</b>) for 1 h with rocking in a tube. [<sup>3</sup>H]-<b>1</b> was added, vortexed, and then 40 μL was immediately added to 10 μL of test compound in a white opaque 96-well plate (Corning 3600, Corning, NY). The plate was rocked for 1 h at room temperature in the dark. After sitting in the dark overnight, the plate was read on a Microbeta plate reader (PerkinElmer, Waltham MA). Data were imported into ToolSet (BMS, Wallingford, CT) and analyzed in CurveMaster (BMS, Wallingford, CT) to calculate <i>K</i><sub>i</sub> values.</div></div><div id="sec5_3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> Cell Lines and Viruses</h3><div class="NLM_p">MT-2 and HEK 293T cells were obtained from the NIH AIDS Research and Reference Reagent Program. Cells were propagated in RPMI 1640 media supplemented with 10% heat inactivated fetal bovine serum, 10 mM HEPES buffer, pH 7.55, 2 mM <span class="smallcaps smallerCapital">l</span>-glutamine, 100 units/mL penicillin G, 100 μg/mL streptomycin. The proviral DNA clone of NL<sub>4–3</sub> was obtained through the NIH AIDS Research and Reference Reagent Program.</div><div class="NLM_p last">For analysis of the potency of ALLINI compounds, an NL<sub>4–3</sub>-derived replication competent virus, NLRepRluc/SacII (the unique SacII site was engineered at the end of the integrase gene), was generated from a proviral clone. In this clone, a section of the nef gene from NL<sub>4–3</sub> was replaced with the <i>Renilla</i> luciferase gene. This virus is infectious and can undergo multiple cycles of replication in cell culture, while the luciferase reporter provides a simple and easy method for quantitating the extent of virus growth and consequently the antiviral activity of test compounds. The NLRepRLuc/SacII virus was prepared by transfection of HEK 293T cells using the LipofectAMINE PLUS kit from Invitrogen (Carlsbad, CA) according to the manufacturer, and the virus generated was titered in MT-2 cells, using luciferase enzyme activity as an end point.</div></div><div id="sec5_3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> Drug Susceptibility and Cytotoxicity Assays</h3><div class="NLM_p last">Titrated virus was used to infect MT-2 cells in the presence of serial dilutions of ALLINI compounds. A 10 mM stock compound in 100% DMSO was used to make the serial dilutions. Final DMSO concentration in each well was 1%. After 3–4 days of incubation, cells were processed and quantitated for virus growth by the amount of expressed luciferase. Assay medium was RPMI 1640 supplemented with 10% heat inactivated fetal bovine serum (FBS), 100 units/mL penicillin G/100 μg/mL streptomycin, 10 mM HEPES buffer, pH 7.55, and 2 mM <span class="smallcaps smallerCapital">l</span>-glutamine. Luciferase was quantitated using Enduren from Promega (Madison, WI). The 50% effective concentration (EC<sub>50</sub>) was calculated by using the exponential form of the median effect equation where (Fa) = 1/[1+ (ED<sub>50</sub>/drug conc)<i>m</i>].<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Cytotoxicity in MT-2 cells was determined after 4 days incubation using XTT (2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-2<i>H</i>-tetrazolium-5-carboxanilide) to measure cell viability using an established protocol.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a></div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> Evaluation of in Vitro Metabolism Rates in Liver Microsomes<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></h3><div class="NLM_p last">The metabolic stability (Metstab) assay evaluates cytochrome P450 (CYP)-mediated metabolism of test compounds in vitro using human and rat microsomes after a 10 min incubation. The incubation was automated on a Biomek FX automation workstation (Beckman Coulter, Fullerton, CA, USA). Each compound was incubated in duplicate in the respective species at a concentration of 0.5 μM. Compounds were received as 3.5 mM solutions in DMSO and were diluted with CH<sub>3</sub>CN to 50 μM before being added to the prewarmed (37 °C) microsomal suspension (1 mg/mL) prepared in 100 mM sodium phosphate, pH 7.4, and 6.6 mM MgCl<sub>2</sub>. The reaction was initiated by adding 17 μL of prewarmed 5 mM NADPH in 100 mM sodium phosphate, pH 7.4, into 153 μL of reaction mix. The concentration of DMSO in the incubation mixture was 0.014%. Reaction components were mixed well, and 75 μL was transferred into 150 μL of quench solution at 0 min time point (t0) and again at the 10 min incubation time point (t10). Quenched mixtures were centrifuged at 1500 rpm in an Allegra X-12 centrifuge (Beckman Coulter) for 15 min, and 90 μL of the supernatant was then transferred to a separate 96-well plate for analysis. Metabolism rate was determined based on the parent compound disappearance over time, as measured by LC–MS/MS.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> PAMPA Evaluation</h3><div class="NLM_p last">PAMPA assay was conducted in a sandwich setup, consisting of the donor and acceptor chambers separated by an artificial lipid membrane. Test compound (100 μM) was diluted with donor buffer at pH 7.4 and placed in the donor side and allowed to permeate to the acceptor side through the artificial membrane over a 4 h incubation. After incubation the “sandwich” plate was separated. The donor and acceptor solutions, along with the t0 solution, were then measured with a UV plate reader, and the permeability value was calculated by pION software.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> In Vivo Rat PK Studies</h3><div class="NLM_p last">All animal studies were performed under the approval of the Bristol-Myers Squibb Animal Care and Use Committee and in accordance with the Association for Assessment and Accreditation of Laboratory Animal Care. The pharmacokinetic profiles of <b>27</b>, <b>28</b>, and <b>29</b> were determined in male Sprague-Dawley rats. Animals were dosed iv by cannula implanted in an acceptable vein with an infusion period of 10 min for rats. Animals were dosed orally by gavage following an overnight fast. The vehicle for both iv and po studies was 10% dimethylacetamide (DMAC)/90% PEG400. Blood was collected via a venous port and centrifuged to obtain plasma. Samples were treated with CH<sub>3</sub>CN containing an internal standard, centrifuged, and analyzed by LC–MS/MS. Pharmacokinetic parameters were obtained by noncompartmental analysis of plasma concentration versus time data (KINETICA software).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i75"><a href="/doi/suppl/10.1021/acs.jmedchem.9b01681" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12654" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12654" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.9b01681?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01681</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Crystallography data for compounds (<i>S</i>,<i>S</i> and <i>R</i>,<i>R</i>)-<b>14</b> and (<i>S</i>,<i>R</i> and <i>R</i>,<i>S</i>)-<b>15</b>; crystallization, data collection, and structure refinement results for the HIV-1 integrase CCD:(<i>S</i>,<i>S</i>)-<b>14</b> complex (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01681/suppl_file/jm9b01681_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01681/suppl_file/jm9b01681_si_002.xlsx" class="ext-link">XLSX</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01681/suppl_file/jm9b01681_si_001.pdf">jm9b01681_si_001.pdf (358.37 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01681/suppl_file/jm9b01681_si_002.xlsx">jm9b01681_si_002.xlsx (11.21 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The coordinates of the HIV-1 integrase CCD:(<i>S</i>,<i>S</i>)-<b>14</b> complex have been deposited in the PDB under PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6UM8">6UM8</a>. Single crystal structures for (<i>S</i>,<i>S</i> and <i>R</i>,<i>R</i>)-<b>14</b> and (<i>S</i>,<i>R</i> and <i>R</i>,<i>S</i>)-<b>15</b> have been deposited in the CCDC database under CCDC deposition numbers 1862636 and 1862637, respectively.</p><div class="testing" data-doi="10.1021/acs.jmedchem.9b01681" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40502" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40502" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Guo Li</span> - <span class="hlFld-Affiliation affiliation">Department
of Early Discovery Chemistry, Bristol-Myers
Squibb Research and Development, Wallingford, Connecticut 06492, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#f6918399d89a9fb6949b85d895999b"><span class="__cf_email__" data-cfemail="9dfae8f2b3f1f4ddfff0eeb3fef2f0">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Annapurna Pendri</span> - <span class="hlFld-Affiliation affiliation">Department
of Early Discovery Chemistry, Bristol-Myers
Squibb Research and Development, Wallingford, Connecticut 06492, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6070-5171" title="Orcid link">http://orcid.org/0000-0002-6070-5171</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#b4d5dadad5c4c1c6dad59ac4d1dad0c6ddf4d6d9c79ad7dbd9"><span class="__cf_email__" data-cfemail="7a1b14141b0a0f08141b540a1f141e08133a18170954191517">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nicholas A. Meanwell</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Bristol-Myers Squibb Research
and Development, Wallingford, Connecticut 06492, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-8857-1515" title="Orcid link">http://orcid.org/0000-0002-8857-1515</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mark R. Krystal</span> - <span class="hlFld-Affiliation affiliation">Department
of Virology Discovery Biology, Bristol-Myers
Squibb Research and Development, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David R. Langley</span> - <span class="hlFld-Affiliation affiliation">Department
of Computer-Aided Drug Design & Molecular Analytics, Bristol-Myers Squibb Research and Development, Princeton, New Jersey 08543-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">B. Narasimhulu Naidu</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Bristol-Myers Squibb Research
and Development, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Prasanna Sivaprakasam</span> - <span class="hlFld-Affiliation affiliation">Department
of Computer-Aided Drug Design & Molecular Analytics, Bristol-Myers Squibb Research and Development, Princeton, New Jersey 08543-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hal Lewis</span> - <span class="hlFld-Affiliation affiliation">Department
of Molecular Structure and Design, Bristol-Myers
Squibb Research and Development, Princeton, New Jersey 08543-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kevin Kish</span> - <span class="hlFld-Affiliation affiliation">Department
of Molecular Structure and Design, Bristol-Myers
Squibb Research and Development, Princeton, New Jersey 08543-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Javed A. Khan</span> - <span class="hlFld-Affiliation affiliation">Department
of Molecular Structure and Design, Bristol-Myers
Squibb Research and Development, Princeton, New Jersey 08543-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alicia Ng</span> - <span class="hlFld-Affiliation affiliation">Department
of Materials Science, Bristol-Myers Squibb
Research and Development, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">George L. Trainor</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Bristol-Myers Squibb Research
and Development, P.O.
Box 4000, Princeton, New
Jersey 08543-4000, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher Cianci</span> - <span class="hlFld-Affiliation affiliation">Department
of Virology Discovery Biology, Bristol-Myers
Squibb Research and Development, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ira B. Dicker</span> - <span class="hlFld-Affiliation affiliation">Department
of Virology Discovery Biology, Bristol-Myers
Squibb Research and Development, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael A. Walker</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Bristol-Myers Squibb Research
and Development, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zeyu Lin</span> - <span class="hlFld-Affiliation affiliation">Department
of Virology Discovery Biology, Bristol-Myers
Squibb Research and Development, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tricia Protack</span> - <span class="hlFld-Affiliation affiliation">Department
of Virology Discovery Biology, Bristol-Myers
Squibb Research and Development, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Linda Discotto</span> - <span class="hlFld-Affiliation affiliation">Department
of Virology Discovery Biology, Bristol-Myers
Squibb Research and Development, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Susan Jenkins</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Research and Development, Wallingford, Connecticut 06492, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Samuel W. Gerritz</span> - <span class="hlFld-Affiliation affiliation">Department
of Early Discovery Chemistry, Bristol-Myers
Squibb Research and Development, Wallingford, Connecticut 06492, United States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br><p class="inlineNote">The authors are or were at the time these studies employees and shareholders of Bristol-Myers Squibb.</p></div></li></ul></div><div class="ack" id="ACK-d7e7269-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i88">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11834" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11834" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Robert Gentles and Stella Huang are acknowledged for helpful discussions and NMR interpretation. The Bristol-Myers Squibb Department of Discovery Synthesis and BBRC Bangalore, India, are acknowledged for synthetic support. We thank Wilson Shou, Amy Sarjeant, Xianmei Cai, Bhupinder Sandhu, and Kathy Mosure for help and support.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">AIDS</td><td class="NLM_def"><p class="first last">acquired immunodeficiency syndrome</p></td></tr><tr><td class="NLM_term">ALLINI</td><td class="NLM_def"><p class="first last">allosteric integrase inhibitor</p></td></tr><tr><td class="NLM_term">AUC</td><td class="NLM_def"><p class="first last">area under the curve</p></td></tr><tr><td class="NLM_term">CADD</td><td class="NLM_def"><p class="first last">computer-aided drug design</p></td></tr><tr><td class="NLM_term">CCD</td><td class="NLM_def"><p class="first last">catalytic core domain</p></td></tr><tr><td class="NLM_term">CD4</td><td class="NLM_def"><p class="first last">cluster of differentiation 4</p></td></tr><tr><td class="NLM_term">CCR5</td><td class="NLM_def"><p class="first last">C–C chemokine receptor 5</p></td></tr><tr><td class="NLM_term">CTD</td><td class="NLM_def"><p class="first last">carboxyl terminal domain</p></td></tr><tr><td class="NLM_term">DDQ</td><td class="NLM_def"><p class="first last">2,3-dichloro-5,6-dicyanobenzoquinone</p></td></tr><tr><td class="NLM_term">DIBAL</td><td class="NLM_def"><p class="first last">diisobutylaluminum hydride</p></td></tr><tr><td class="NLM_term">DTT</td><td class="NLM_def"><p class="first last">dithiothreitol</p></td></tr><tr><td class="NLM_term">EDTA</td><td class="NLM_def"><p class="first last">ethylenediaminetetraacetic acid</p></td></tr><tr><td class="NLM_term">FDA</td><td class="NLM_def"><p class="first last">U.S. Food and Drug Administration</p></td></tr><tr><td class="NLM_term">gp41</td><td class="NLM_def"><p class="first last">glycoprotein 41</p></td></tr><tr><td class="NLM_term">HAART</td><td class="NLM_def"><p class="first last">highly active antiretroviral therapy</p></td></tr><tr><td class="NLM_term">HIV-1</td><td class="NLM_def"><p class="first last">human immunodeficiency virus type 1</p></td></tr><tr><td class="NLM_term">HLM</td><td class="NLM_def"><p class="first last">human liver microsome</p></td></tr><tr><td class="NLM_term">HSA</td><td class="NLM_def"><p class="first last">human serum albumin</p></td></tr><tr><td class="NLM_term">IBD</td><td class="NLM_def"><p class="first last">integrase binding domain</p></td></tr><tr><td class="NLM_term">IN</td><td class="NLM_def"><p class="first last">integrase</p></td></tr><tr><td class="NLM_term">INSTI</td><td class="NLM_def"><p class="first last">integrase strand transfer inhibitor</p></td></tr><tr><td class="NLM_term">iv</td><td class="NLM_def"><p class="first last">intravenous</p></td></tr><tr><td class="NLM_term">LEDGF</td><td class="NLM_def"><p class="first last">lens epithelium-derived growth factor</p></td></tr><tr><td class="NLM_term">PAMPA</td><td class="NLM_def"><p class="first last">parallel artificial membrane permeability assay</p></td></tr><tr><td class="NLM_term">PCC</td><td class="NLM_def"><p class="first last">pyridinium chlorochromate</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetic</p></td></tr><tr><td class="NLM_term">po</td><td class="NLM_def"><p class="first last">per os</p></td></tr><tr><td class="NLM_term">RLM</td><td class="NLM_def"><p class="first last">rat liver microsome</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">TI</td><td class="NLM_def"><p class="first last">therapeutic index</p></td></tr><tr><td class="NLM_term">WT</td><td class="NLM_def"><p class="first last">wild-type</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i90">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21835" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21835" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 30 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gubernick, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felix, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamad, B.</span></span> <span> </span><span class="NLM_article-title">The HIV therapy market</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">451</span>, <span class="refDoi"> DOI: 10.1038/nrd.2016.69</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=10.1038%2Fnrd.2016.69" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=27312723" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVSjt7fL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=451&author=S.+I.+Gubernickauthor=N.+Felixauthor=D.+Leeauthor=J.+J.+Xuauthor=B.+Hamad&title=The+HIV+therapy+market&doi=10.1038%2Fnrd.2016.69"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The HIV therapy market</span></div><div class="casAuthors">Gubernick, Steven I.; Felix, Nuno; Lee, Dolim; Xu, Jing J.; Hamad, Bashar</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">451-452</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Key emerging therapies for HIV include novel combination regimens as well as extended-duration antiretroviral drugs.  This article provides an overview of novel drugs and combinations in the pipeline, as well as an anal. of the current HIV drug market.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTdefjBZ7897Vg90H21EOLACvtfcHk0lgcuqDGqnilvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVSjt7fL&md5=83e62421bc579eea958b3246d9784398</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2016.69&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2016.69%26sid%3Dliteratum%253Aachs%26aulast%3DGubernick%26aufirst%3DS.%2BI.%26aulast%3DFelix%26aufirst%3DN.%26aulast%3DLee%26aufirst%3DD.%26aulast%3DXu%26aufirst%3DJ.%2BJ.%26aulast%3DHamad%26aufirst%3DB.%26atitle%3DThe%2520HIV%2520therapy%2520market%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2016%26volume%3D15%26spage%3D451%26doi%3D10.1038%2Fnrd.2016.69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Demeulemeester, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Maeyer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debyser, Z.</span></span> <span> </span><span class="NLM_article-title">HIV-1 integrase drug discovery comes of age</span>. <i>Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">52</span>, <span class="refDoi"> DOI: 10.1007/7355_2013_33</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=10.1007%2F7355_2013_33" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2013&pages=1-52&author=J.+Demeulemeesterauthor=M.+De+Maeyerauthor=Z.+Debyser&title=HIV-1+integrase+drug+discovery+comes+of+age&doi=10.1007%2F7355_2013_33"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1007%2F7355_2013_33&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F7355_2013_33%26sid%3Dliteratum%253Aachs%26aulast%3DDemeulemeester%26aufirst%3DJ.%26aulast%3DDe%2BMaeyer%26aufirst%3DM.%26aulast%3DDebyser%26aufirst%3DZ.%26atitle%3DHIV-1%2520integrase%2520drug%2520discovery%2520comes%2520of%2520age%26jtitle%3DTop.%2520Med.%2520Chem.%26date%3D2013%26volume%3D15%26spage%3D1%26epage%3D52%26doi%3D10.1007%2F7355_2013_33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Christ, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debyser, Z.</span></span> <span> </span><span class="NLM_article-title">The LEDGF/p75 integrase interaction, a novel target for anti-HIV therapy</span>. <i>Virology</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>435</i></span>,  <span class="NLM_fpage">102</span>– <span class="NLM_lpage">109</span>, <span class="refDoi"> DOI: 10.1016/j.virol.2012.09.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=10.1016%2Fj.virol.2012.09.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=23217620" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVaju7nN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=435&publication_year=2013&pages=102-109&author=F.+Christauthor=Z.+Debyser&title=The+LEDGF%2Fp75+integrase+interaction%2C+a+novel+target+for+anti-HIV+therapy&doi=10.1016%2Fj.virol.2012.09.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The LEDGF/p75 integrase interaction, a novel target for anti-HIV therapy</span></div><div class="casAuthors">Christ, Frauke; Debyser, Zeger</div><div class="citationInfo"><span class="NLM_cas:title">Virology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">435</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">102-109</span>CODEN:
                <span class="NLM_cas:coden">VIRLAX</span>;
        ISSN:<span class="NLM_cas:issn">0042-6822</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  To accomplish their viral life cycle, lentiviruses such as HIV highjack host proteins, the so-called cellular co-factors of replication.  Lens Epithelium-derived Growth factor (LEDGF/p75), a transcriptional co-activator, is a co-factor of HIV-integrase (IN) and is required for the tethering and correct integration of the viral genome into the host chromatin.  Due to its important role in HIV-replication the LEDGF/p75-IN interaction is an attractive antiviral novel target for the treatment of HIV/AIDS.  Intensive drug discovery efforts over the past years have validated the LEDGF/p75-IN interaction as a drugable target for antiviral therapy and have resulted in the design and synthesis of LEDGINs, small mol. inhibitors binding to the dimer interface of HIV-integrase and inhibiting viral replication with a dual mechanism of action: potent inhibition of the LEDGF/p75-IN protein-protein interaction and allosteric inhibition of the catalytic function.  Furthermore they inhibit both early and late steps of the replication cycle which increases their potential for further clin. development.  In this review the authors will highlight the research validating the LEDGF/p75-IN interaction as a target for anti-HIV drug discovery and the recent advances in the design and development of LEDGINs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_mTW5TAo2y7Vg90H21EOLACvtfcHk0ljdKspVTEjfXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVaju7nN&md5=2249c51a1792bc8edc5ce449500e6627</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.virol.2012.09.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.virol.2012.09.033%26sid%3Dliteratum%253Aachs%26aulast%3DChrist%26aufirst%3DF.%26aulast%3DDebyser%26aufirst%3DZ.%26atitle%3DThe%2520LEDGF%252Fp75%2520integrase%2520interaction%252C%2520a%2520novel%2520target%2520for%2520anti-HIV%2520therapy%26jtitle%3DVirology%26date%3D2013%26volume%3D435%26spage%3D102%26epage%3D109%26doi%3D10.1016%2Fj.virol.2012.09.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Engelman, A. E.</span></span> <span> </span><span class="NLM_article-title">Multifaceted HIV integrase functionalities and therapeutic strategies for their inhibition</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>294</i></span>,  <span class="NLM_fpage">15137</span>– <span class="NLM_lpage">15157</span>, <span class="refDoi"> DOI: 10.1074/jbc.REV119.006901</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=10.1074%2Fjbc.REV119.006901" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=31467082" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=1%3ACAS%3A528%3ADC%252BC1MXit1yltLzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=294&publication_year=2019&pages=15137-15157&author=A.+E.+Engelman&title=Multifaceted+HIV+integrase+functionalities+and+therapeutic+strategies+for+their+inhibition&doi=10.1074%2Fjbc.REV119.006901"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Multifaceted HIV integrase functionalities and therapeutic strategies for their inhibition</span></div><div class="casAuthors">Engelman, Alan N.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">294</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">15137-15157</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">A review.  Antiretroviral inhibitors that are used to manage HIV infection/AIDS predominantly target three enzymes required for virus replication: reverse transcriptase, protease, and integrase.  Although integrase inhibitors were the last among this group to be approved for treating people living with HIV, they have since risen to the forefront of treatment options.  Integrase strand transfer inhibitors (INSTIs) are now recommended components of frontline and drug-switch antiretroviral therapy formulations.  Integrase catalyzes two successive magnesium-dependent polynucleotidyl transferase reactions, 3' processing and strand transfer, and INSTIs tightly bind the divalent metal ions and viral DNA end after 3' processing, displacing from the integrase active site the DNA 3'-hydroxyl group that is required for strand transfer activity.  Although second-generation INSTIs present higher barriers to the development of viral drug resistance than first-generation compds., the mechanisms underlying these superior barrier profiles are incompletely understood.  A sep. class of HIV-1 integrase inhibitors, the allosteric integrase inhibitors (ALLINIs), engage integrase distal from the enzyme active site, namely at the binding site for the cellular cofactor lens epithelium-derived growth factor (LEDGF)/p75 that helps to guide integration into host genes.  ALLINIs inhibit HIV-1 replication by inducing integrase hypermultimerization, which precludes integrase binding to genomic RNA and perturbs the morphogenesis of new viral particles.  Although not yet approved for human use, ALLINIs provide important probes that can be used to investigate the link between HIV-1 integrase and viral particle morphogenesis.  Herein, I review the mechanisms of retroviral integration as well as the promises and challenges of using integrase inhibitors for HIV/AIDS management.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0Q3IXGz5Hc7Vg90H21EOLACvtfcHk0ljdKspVTEjfXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXit1yltLzE&md5=90801bc3dfde7cfc8936113649d83910</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1074%2Fjbc.REV119.006901&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.REV119.006901%26sid%3Dliteratum%253Aachs%26aulast%3DEngelman%26aufirst%3DA.%2BE.%26atitle%3DMultifaceted%2520HIV%2520integrase%2520functionalities%2520and%2520therapeutic%2520strategies%2520for%2520their%2520inhibition%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2019%26volume%3D294%26spage%3D15137%26epage%3D15157%26doi%3D10.1074%2Fjbc.REV119.006901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Poeschla, E. M.</span></span> <span> </span><span class="NLM_article-title">Integrase, LEDGF/p75 and HIV replication</span>. <i>Cell. Mol. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">1403</span>– <span class="NLM_lpage">1424</span>, <span class="refDoi"> DOI: 10.1007/s00018-008-7540-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=10.1007%2Fs00018-008-7540-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=18264802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=1%3ACAS%3A528%3ADC%252BD1cXltFyhu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2008&pages=1403-1424&author=E.+M.+Poeschla&title=Integrase%2C+LEDGF%2Fp75+and+HIV+replication&doi=10.1007%2Fs00018-008-7540-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Integrase, LEDGF/p75 and HIV replication</span></div><div class="casAuthors">Poeschla, E. M.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1403-1424</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Verlag</span>)
        </div><div class="casAbstract">A review.  HIV integrates a DNA copy of its genome into a host cell chromosome in each replication cycle.  The essential DNA cleaving and joining chem. of integration is known, but there is less understanding of the process as it occurs in a cell, where two complex and dynamic macromol. entities are joined: the viral pre-integration complex and chromatin.  Among implicated cellular factors, much recent attention has coalesced around LEDGF/p75, a nuclear protein that may act as a chromatin docking factor or receptor for lentiviral pre-integration complexes.  LEDGF/p75 tethers HIV integrase to chromatin, protects it from degrdn., and strongly influences the genome-wide pattern of HIV integration.  Depleting the protein from cells and/or over-expressing its integrase-binding domain blocks viral replication.  Current goals are to establish the underlying mechanisms and to det. whether this knowledge can be exploited for antiviral therapy or for targeting lentiviral vector integration in human gene therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhiwI_GBCtWrVg90H21EOLACvtfcHk0lhTQYVFSChxZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXltFyhu7s%253D&md5=87fda953018faed92a13cdc2d1322ce9</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1007%2Fs00018-008-7540-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-008-7540-5%26sid%3Dliteratum%253Aachs%26aulast%3DPoeschla%26aufirst%3DE.%2BM.%26atitle%3DIntegrase%252C%2520LEDGF%252Fp75%2520and%2520HIV%2520replication%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2008%26volume%3D65%26spage%3D1403%26epage%3D1424%26doi%3D10.1007%2Fs00018-008-7540-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emiliani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mousnier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Busschots, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maroun, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Maele, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tempe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandekerckhove, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moisant, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ben-Slama, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witvrouw, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christ, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rain, J.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dargemont, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debyser, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benarous, R.</span></span> <span> </span><span class="NLM_article-title">Integrase mutants defective for interaction with LEDGF/p75 are impaired in chromosome tethering and HIV-1 replication</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">25517</span>– <span class="NLM_lpage">25523</span>, <span class="refDoi"> DOI: 10.1074/jbc.M501378200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=10.1074%2Fjbc.M501378200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=15855167" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlslylurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=25517-25523&author=S.+Emilianiauthor=A.+Mousnierauthor=K.+Busschotsauthor=M.+Marounauthor=B.+Van+Maeleauthor=D.+Tempeauthor=L.+Vandekerckhoveauthor=F.+Moisantauthor=L.+Ben-Slamaauthor=M.+Witvrouwauthor=F.+Christauthor=J.-C.+Rainauthor=C.+Dargemontauthor=Z.+Debyserauthor=R.+Benarous&title=Integrase+mutants+defective+for+interaction+with+LEDGF%2Fp75+are+impaired+in+chromosome+tethering+and+HIV-1+replication&doi=10.1074%2Fjbc.M501378200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Integrase Mutants Defective for Interaction with LEDGF/p75 Are Impaired in Chromosome Tethering and HIV-1 Replication</span></div><div class="casAuthors">Emiliani, Stephane; Mousnier, Aurelie; Busschots, Katrien; Maroun, Marlene; Van Maele, Benedicte; Tempe, Denis; Vandekerckhove, Linos; Moisant, Fanny; Ben-Slama, Lilia; Witvrouw, Myriam; Christ, Frauke; Rain, Jean-Christophe; Dargemont, Catherine; Debyser, Zeger; Benarous, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">25517-25523</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The insertion of a DNA copy of its RNA genome into a chromosome of the host cell is mediated by the viral integrase with the help of mostly uncharacterized cellular cofactors.  The authors have recently described that the transcriptional co-activator LEDGF/p75 strongly interacts with HIV-1 integrase.  Here the authors show that interaction of HIV-1 integrase with LEDGF/p75 is important for viral replication.  Using multiple approaches including two-hybrid interaction studies, random and directed mutagenesis, the authors could demonstrate that HIV-1 virus harboring a single mutation that disrupts integrase-LEDGF/p75 interaction, resulted in defective HIV-1 replication.  Furthermore, the authors found that LEDGF/p75 tethers HIV-1 integrase to chromosomes and that this interaction may be important for the integration process and the replication of HIV-1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzM3afp0-QirVg90H21EOLACvtfcHk0lhTQYVFSChxZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlslylurs%253D&md5=bfb817b7b839abb70183377eb843ebe2</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M501378200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M501378200%26sid%3Dliteratum%253Aachs%26aulast%3DEmiliani%26aufirst%3DS.%26aulast%3DMousnier%26aufirst%3DA.%26aulast%3DBusschots%26aufirst%3DK.%26aulast%3DMaroun%26aufirst%3DM.%26aulast%3DVan%2BMaele%26aufirst%3DB.%26aulast%3DTempe%26aufirst%3DD.%26aulast%3DVandekerckhove%26aufirst%3DL.%26aulast%3DMoisant%26aufirst%3DF.%26aulast%3DBen-Slama%26aufirst%3DL.%26aulast%3DWitvrouw%26aufirst%3DM.%26aulast%3DChrist%26aufirst%3DF.%26aulast%3DRain%26aufirst%3DJ.-C.%26aulast%3DDargemont%26aufirst%3DC.%26aulast%3DDebyser%26aufirst%3DZ.%26aulast%3DBenarous%26aufirst%3DR.%26atitle%3DIntegrase%2520mutants%2520defective%2520for%2520interaction%2520with%2520LEDGF%252Fp75%2520are%2520impaired%2520in%2520chromosome%2520tethering%2520and%2520HIV-1%2520replication%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D25517%26epage%3D25523%26doi%3D10.1074%2Fjbc.M501378200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Busschots, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voet, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Maeyer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rain, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emiliani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benarous, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desender, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debyser, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christ, F.</span></span> <span> </span><span class="NLM_article-title">Identification of the LEDGF/p75 binding site in HIV-1 integrase</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>365</i></span>,  <span class="NLM_fpage">1480</span>– <span class="NLM_lpage">1492</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2006.10.094</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=10.1016%2Fj.jmb.2006.10.094" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=17137594" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=1%3ACAS%3A528%3ADC%252BD2sXls12nsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=365&publication_year=2007&pages=1480-1492&author=K.+Busschotsauthor=A.+Voetauthor=M.+De+Maeyerauthor=J.+C.+Rainauthor=S.+Emilianiauthor=R.+Benarousauthor=L.+Desenderauthor=Z.+Debyserauthor=F.+Christ&title=Identification+of+the+LEDGF%2Fp75+binding+site+in+HIV-1+integrase&doi=10.1016%2Fj.jmb.2006.10.094"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of the LEDGF/p75 Binding Site in HIV-1 Integrase</span></div><div class="casAuthors">Busschots, Katrien; Voet, Arnout; De Maeyer, Marc; Rain, Jean-Christophe; Emiliani, Stephane; Benarous, Richard; Desender, Linda; Debyser, Zeger; Christ, Frauke</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">365</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1480-1492</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Lens epithelium-derived growth factor (LEDGF)/p75 is an important cellular co-factor for human immunodeficiency virus (HIV) replication.  We originally identified LEDGF/p75 as a binding partner of integrase (IN) in human cells.  The interaction has been mapped to the integrase-binding domain (IBD) of LEDGF/p75 located in the C-terminal part.  We have subsequently shown that IN carrying the Q168A mutation remains enzymically active but is impaired for interaction with LEDGF/p75.  To map the integrase/LEDGF interface in more detail, we have now identified and characterized two regions within the enzyme involved in the interaction with LEDGF/p75.  The first region centers around residues W131 and W132 while the second extends from I161 up to E170.  For the different IN mutants the interaction with LEDGF/p75 and the enzymic activities were detd.  IN(W131A), IN(I161A), IN(R166A), IN(Q168A) and IN(E170A) are impaired for interaction with LEDGF/p75, but retain 3' processing and strand transfer activities.  Due to impaired integration, an HIV-1 strain contg. the W131A mutation in IN displays reduced replication capacity, whereas virus carrying IN(Q168A) is replication defective.  Comparison of the wild-type IN-LEDGF/p75 co-crystal structure with that of the modelled structure of the IN(Q168A) and IN(W131A) mutant integrases corroborated our exptl. data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDwOlPntfkJbVg90H21EOLACvtfcHk0lhTQYVFSChxZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXls12nsA%253D%253D&md5=6e41029f4dd3d56546d484c33d4549a7</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2006.10.094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2006.10.094%26sid%3Dliteratum%253Aachs%26aulast%3DBusschots%26aufirst%3DK.%26aulast%3DVoet%26aufirst%3DA.%26aulast%3DDe%2BMaeyer%26aufirst%3DM.%26aulast%3DRain%26aufirst%3DJ.%2BC.%26aulast%3DEmiliani%26aufirst%3DS.%26aulast%3DBenarous%26aufirst%3DR.%26aulast%3DDesender%26aufirst%3DL.%26aulast%3DDebyser%26aufirst%3DZ.%26aulast%3DChrist%26aufirst%3DF.%26atitle%3DIdentification%2520of%2520the%2520LEDGF%252Fp75%2520binding%2520site%2520in%2520HIV-1%2520integrase%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2007%26volume%3D365%26spage%3D1480%26epage%3D1492%26doi%3D10.1016%2Fj.jmb.2006.10.094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Rijck, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandekerckhove, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsbers, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hombrouck, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendrix, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vercammen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engelborghs, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christ, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debyser, Z.</span></span> <span> </span><span class="NLM_article-title">Overexpression of the lens epithelium-derived growth factor/p75 integrase binding domain inhibits human immunodeficiency virus replication</span>. <i>J. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">11498</span>– <span class="NLM_lpage">11509</span>, <span class="refDoi"> DOI: 10.1128/JVI.00801-06</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=10.1128%2FJVI.00801-06" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=16987986" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht12hu7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2006&pages=11498-11509&author=J.+De%0ARijckauthor=L.+Vandekerckhoveauthor=R.+Gijsbersauthor=A.+Hombrouckauthor=J.+Hendrixauthor=J.+Vercammenauthor=Y.+Engelborghsauthor=F.+Christauthor=Z.+Debyser&title=Overexpression+of+the+lens+epithelium-derived+growth+factor%2Fp75+integrase+binding+domain+inhibits+human+immunodeficiency+virus+replication&doi=10.1128%2FJVI.00801-06"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpression of the lens epithelium-derived growth factor/p75 integrase binding domain inhibits human immunodeficiency virus replication</span></div><div class="casAuthors">De Rijck, Jan; Vandekerckhove, Linos; Gijsbers, Rik; Hombrouck, Anneleen; Hendrix, Jelle; Vercammen, Jo; Engelborghs, Yves; Christ, Frauke; Debyser, Zeger</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">11498-11509</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">We initially identified lens epithelium-derived growth factor/p75 (LEDGF/p75) as a binding partner of human immunodeficiency virus type 1 (HIV-1) integrase.  To investigate the role of LEDGF/p75 in HIV replication and its potential as a new antiviral target, we stably overexpressed two different fragments contg. the integrase binding domain (IBD) of LEDGF/p75 fused to enhanced green fluorescent protein (eGFP).  HIV-1 replication was severely inhibited by overexpression of the eGFP-IBD fusion proteins, while no inhibition was obsd. in cell lines overexpressing the interaction-deficient D366A mutant.  Quant. PCR pinpointed the block to the integration step, whereas nuclear import was not affected.  Competition of the IBD fusion proteins with endogenous LEDGF/p75 for binding to integrase led to a potent defect in HIV-1 replication in both HeLaP4- and MT-4-derived cell lines.  A previously described diketo acid-resistant HIV-1 strain remained fully susceptible to inhibition, suggesting that this strategy will also work in patients who harbor strains resistant to the current exptl. integrase inhibitors.  These data support LEDGF/p75 as an important cofactor for HIV replication and provide proof of concept for the LEDGF/p75-integrase interaction as a novel target for treating HIV-1 infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzpWZpQsxg27Vg90H21EOLACvtfcHk0lhzXrefbqRq3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht12hu7vJ&md5=1ee6c9f0fa7765de3b41a615e54673f3</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1128%2FJVI.00801-06&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.00801-06%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BRijck%26aufirst%3DJ.%26aulast%3DVandekerckhove%26aufirst%3DL.%26aulast%3DGijsbers%26aufirst%3DR.%26aulast%3DHombrouck%26aufirst%3DA.%26aulast%3DHendrix%26aufirst%3DJ.%26aulast%3DVercammen%26aufirst%3DJ.%26aulast%3DEngelborghs%26aufirst%3DY.%26aulast%3DChrist%26aufirst%3DF.%26aulast%3DDebyser%26aufirst%3DZ.%26atitle%3DOverexpression%2520of%2520the%2520lens%2520epithelium-derived%2520growth%2520factor%252Fp75%2520integrase%2520binding%2520domain%2520inhibits%2520human%2520immunodeficiency%2520virus%2520replication%26jtitle%3DJ.%2520Virol.%26date%3D2006%26volume%3D80%26spage%3D11498%26epage%3D11509%26doi%3D10.1128%2FJVI.00801-06" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Llano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saenz, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meehan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wongthida, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peretz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poeschla, E. M.</span></span> <span> </span><span class="NLM_article-title">An essential role for LEDGF/p75 in HIV integration</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>314</i></span>,  <span class="NLM_fpage">461</span>– <span class="NLM_lpage">464</span>, <span class="refDoi"> DOI: 10.1126/science.1132319</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=10.1126%2Fscience.1132319" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=16959972" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVyqtr3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=314&publication_year=2006&pages=461-464&author=M.+Llanoauthor=D.+T.+Saenzauthor=A.+Meehanauthor=P.+Wongthidaauthor=M.+Peretzauthor=W.+H.+Walkerauthor=W.+Teoauthor=E.+M.+Poeschla&title=An+essential+role+for+LEDGF%2Fp75+in+HIV+integration&doi=10.1126%2Fscience.1132319"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">An Essential Role for LEDGF/p75 in HIV Integration</span></div><div class="casAuthors">Llano, Manuel; Saenz, Dyana T.; Meehan, Anne; Wongthida, Phonphimon; Peretz, Mary; Walker, William H.; Teo, Wulin; Poeschla, Eric M.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">314</span>
        (<span class="NLM_cas:issue">5798</span>),
    <span class="NLM_cas:pages">461-464</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Chromosomal integration enables human immunodeficiency virus (HIV) to establish a permanent reservoir that can be therapeutically suppressed but not eradicated.  Participation of cellular proteins in this obligate replication step is poorly understood.  We used intensified RNA interference and dominant-neg. protein approaches to show that the cellular transcriptional coactivator lens epithelium-derived growth factor (LEDGF)/p75 (p75) is an essential HIV integration cofactor.  The mechanism requires both linkages of a mol. tether that p75 forms between integrase and chromatin.  Fractionally minute levels of endogenous p75 are sufficient to enable integration, showing that cellular factors that engage HIV after entry may elude identification in less intensive knockdowns.  Perturbing the p75-integrase interaction may have therapeutic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRKqlWtCPsYbVg90H21EOLACvtfcHk0lhzXrefbqRq3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVyqtr3O&md5=fe62c3d583b14c92eca29654895c9691</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1126%2Fscience.1132319&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1132319%26sid%3Dliteratum%253Aachs%26aulast%3DLlano%26aufirst%3DM.%26aulast%3DSaenz%26aufirst%3DD.%2BT.%26aulast%3DMeehan%26aufirst%3DA.%26aulast%3DWongthida%26aufirst%3DP.%26aulast%3DPeretz%26aufirst%3DM.%26aulast%3DWalker%26aufirst%3DW.%2BH.%26aulast%3DTeo%26aufirst%3DW.%26aulast%3DPoeschla%26aufirst%3DE.%2BM.%26atitle%3DAn%2520essential%2520role%2520for%2520LEDGF%252Fp75%2520in%2520HIV%2520integration%26jtitle%3DScience%26date%3D2006%26volume%3D314%26spage%3D461%26epage%3D464%26doi%3D10.1126%2Fscience.1132319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jurado, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slaughter, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kessl, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koh, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballandras-Colas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuchs, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kvaratskhelia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engelman, A.</span></span> <span> </span><span class="NLM_article-title">Allosteric integrase inhibitor potency is determined through the inhibition of HIV-1 particle maturation</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">8690</span>– <span class="NLM_lpage">8695</span>, <span class="refDoi"> DOI: 10.1073/pnas.1300703110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=10.1073%2Fpnas.1300703110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=23610442" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFSjt7nO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=8690-8695&author=K.+A.+Juradoauthor=H.+Wangauthor=A.+Slaughterauthor=L.+Fengauthor=J.+J.+Kesslauthor=Y.+Kohauthor=W.+Wangauthor=A.+Ballandras-Colasauthor=P.+A.+Patelauthor=J.+R.+Fuchsauthor=M.+Kvaratskheliaauthor=A.+Engelman&title=Allosteric+integrase+inhibitor+potency+is+determined+through+the+inhibition+of+HIV-1+particle+maturation&doi=10.1073%2Fpnas.1300703110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric integrase inhibitor potency is determined through the inhibition of HIV-1 particle maturation</span></div><div class="casAuthors">Jurado, Kellie A.; Wang, Hao; Slaughter, Alison; Feng, Lei; Kessl, Jacques J.; Koh, Yasuhiro; Wang, Weifeng; Ballandras-Colas, Allison; Patel, Pratiq A.; Fuchs, James R.; Kvaratskhelia, Mamuka; Engelman, Alan</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8690-8695, S8690/1-S8690/7</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Integration is essential for HIV-1 replication, and the viral integrase (IN) protein is an important therapeutic target.  Allosteric IN inhibitors (ALUNIs) that engage the IN dimer interface at the binding site for the host protein lens epithelium-derived growth factor (LEDGF)/ transcriptional coactivator p75 are an emerging class of small mol. antagonists.  Consistent with the inhibition of a multivalent drug target, ALLINIs display steep antiviral dose-response curves ex vivo.  ALUNIs multimerize IN protein and concordantly block its assembly with viral DNA in vitro, indicating that the disruption of two integration-assocd. functions, IN catalysis and the IN-LEDGF/p75 interaction, dets. the multimode mechanism of ALUNI action.  We now demonstrate that ALLINI potency is unexpectedly accounted for during the late phase of HIV-1 replication.  The compds. promote virion IN multimerization and, reminiscent of class II IN mutations, block the formation of the electron-dense viral core and inhibit reverse transcription and integration in subsequently infected target cells.  Mature virions are recalcitrant to ALLINI treatment and compd. potency during virus prodn. is independent of the level of LEDGF/p75 expression.  We conclude that cooperative multimerization of IN by ALLINIs together with the inability for LEDGF/p75 to effectively engage the virus during its egress from cells underscores the multimodal mechanism of ALLINI action.  Our results highlight the versatile nature of allosteric inhibitors to primarily inhibit viral replication at a step that is distinct from the catalytic requirement for the target enzyme.  The vulnerability of IN to small mols. during the late phase of HIV-1 replication unveils a pharmacol. Achilles' heel for exploitation in clin. ALLINI development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiAzDFbZo0ALVg90H21EOLACvtfcHk0lhzXrefbqRq3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFSjt7nO&md5=ec563f39468aabeae04685971722b070</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1300703110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1300703110%26sid%3Dliteratum%253Aachs%26aulast%3DJurado%26aufirst%3DK.%2BA.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DSlaughter%26aufirst%3DA.%26aulast%3DFeng%26aufirst%3DL.%26aulast%3DKessl%26aufirst%3DJ.%2BJ.%26aulast%3DKoh%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DBallandras-Colas%26aufirst%3DA.%26aulast%3DPatel%26aufirst%3DP.%2BA.%26aulast%3DFuchs%26aufirst%3DJ.%2BR.%26aulast%3DKvaratskhelia%26aufirst%3DM.%26aulast%3DEngelman%26aufirst%3DA.%26atitle%3DAllosteric%2520integrase%2520inhibitor%2520potency%2520is%2520determined%2520through%2520the%2520inhibition%2520of%2520HIV-1%2520particle%2520maturation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3D8690%26epage%3D8695%26doi%3D10.1073%2Fpnas.1300703110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slaughter, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jena, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koh, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shkriabai, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larue, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitsuya, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kessl, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engelman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuchs, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kvaratskhelia, M.</span></span> <span> </span><span class="NLM_article-title">The A128T resistance mutation reveals aberrant protein multimerization as the primary mechanism of action of allosteric HIV-1integrase inhibitors</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>288</i></span>,  <span class="NLM_fpage">15813</span>– <span class="NLM_lpage">15820</span>, <span class="refDoi"> DOI: 10.1074/jbc.M112.443390</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=10.1074%2Fjbc.M112.443390" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=23615903" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=1%3ACAS%3A528%3ADC%252BC3sXosFyktL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2013&pages=15813-15820&author=L.+Fengauthor=A.+Sharmaauthor=A.+Slaughterauthor=N.+Jenaauthor=Y.+Kohauthor=N.+Shkriabaiauthor=R.+C.+Larueauthor=P.+A.+Patelauthor=H.+Mitsuyaauthor=J.+J.+Kesslauthor=A.+Engelmanauthor=J.+R.+Fuchsauthor=M.+Kvaratskhelia&title=The+A128T+resistance+mutation+reveals+aberrant+protein+multimerization+as+the+primary+mechanism+of+action+of+allosteric+HIV-1integrase+inhibitors&doi=10.1074%2Fjbc.M112.443390"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The A128T Resistance Mutation Reveals Aberrant Protein Multimerization as the Primary Mechanism of Action of Allosteric HIV-1 Integrase Inhibitors</span></div><div class="casAuthors">Feng, Lei; Sharma, Amit; Slaughter, Alison; Jena, Nivedita; Koh, Yasuhiro; Shkriabai, Nikolozi; Larue, Ross C.; Patel, Pratiq A.; Mitsuya, Hiroaki; Kessl, Jacques J.; Engelman, Alan; Fuchs, James R.; Kvaratskhelia, Mamuka</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">288</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">15813-15820</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Allosteric HIV-1 integrase (IN) inhibitors (ALLINIs) are a very promising new class of anti-HIV-1 agents that exhibit a multimodal mechanism of action by allosterically modulating IN multimerization and interfering with IN-lens epithelium-derived growth factor (LEDGF)/p75 binding.  Selection of viral strains under ALLINI pressure has revealed an A128T substitution in HIV-1 IN as a primary mechanism of resistance.  Here, the authors elucidated the structural and mechanistic basis for this resistance.  The A128T substitution did not affect the hydrogen bonding between ALLINI and IN that mimics the IN-LEDGF/p75 interaction but instead altered the positioning of the inhibitor at the IN dimer interface.  Consequently, the A128T substitution had only a minor effect on the ALLINI IC50 values for IN-LEDGF/p75 binding.  Instead, ALLINIs markedly altered the multimerization of IN by promoting aberrant higher order WT (but not A128T) IN oligomers.  Accordingly, WT IN catalytic activities and HIV-1 replication were potently inhibited by ALLINIs, whereas the A128T substitution in IN resulted in significant resistance to the inhibitors both in vitro and in cell culture assays.  The differential multimerization of WT and A128T INs induced by ALLINIs correlated with the differences in infectivity of HIV-1 progeny virions.  The authors conclude that ALLINIs primarily target IN multimerization rather than IN-LEDGF/p75 binding.  The authors' findings provide the structural foundations for developing improved ALLINIs with increased potency and decreased potential to select for drug resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE64Fk1-DKebVg90H21EOLACvtfcHk0lhhkCCsGdFMIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXosFyktL0%253D&md5=f33a3921b5aaa7b2f94a39ccaea84cc8</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M112.443390&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M112.443390%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DL.%26aulast%3DSharma%26aufirst%3DA.%26aulast%3DSlaughter%26aufirst%3DA.%26aulast%3DJena%26aufirst%3DN.%26aulast%3DKoh%26aufirst%3DY.%26aulast%3DShkriabai%26aufirst%3DN.%26aulast%3DLarue%26aufirst%3DR.%2BC.%26aulast%3DPatel%26aufirst%3DP.%2BA.%26aulast%3DMitsuya%26aufirst%3DH.%26aulast%3DKessl%26aufirst%3DJ.%2BJ.%26aulast%3DEngelman%26aufirst%3DA.%26aulast%3DFuchs%26aufirst%3DJ.%2BR.%26aulast%3DKvaratskhelia%26aufirst%3DM.%26atitle%3DThe%2520A128T%2520resistance%2520mutation%2520reveals%2520aberrant%2520protein%2520multimerization%2520as%2520the%2520primary%2520mechanism%2520of%2520action%2520of%2520allosteric%2520HIV-1integrase%2520inhibitors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2013%26volume%3D288%26spage%3D15813%26epage%3D15820%26doi%3D10.1074%2Fjbc.M112.443390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Desimmie, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schrijvers, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demeulemeester, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borrenberghs, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weydert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thys, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vets, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Remoortel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofkens, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Rijck, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendrix, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bannert, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsbers, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christ, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debyser, Z.</span></span> <span> </span><span class="NLM_article-title">LEDGINs inhibit late stage HIV-1 replication by modulating integrase multimerization in the virions</span>. <i>Retrovirology</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">57</span>, <span class="refDoi"> DOI: 10.1186/1742-4690-10-57</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=10.1186%2F1742-4690-10-57" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=23721378" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpvFGkur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2013&pages=57&author=B.+A.+Desimmieauthor=R.+Schrijversauthor=J.+Demeulemeesterauthor=D.+Borrenberghsauthor=C.+Weydertauthor=W.+Thysauthor=S.+Vetsauthor=B.+Van+Remoortelauthor=J.+Hofkensauthor=J.+De+Rijckauthor=J.+Hendrixauthor=N.+Bannertauthor=R.+Gijsbersauthor=F.+Christauthor=Z.+Debyser&title=LEDGINs+inhibit+late+stage+HIV-1+replication+by+modulating+integrase+multimerization+in+the+virions&doi=10.1186%2F1742-4690-10-57"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">LEDGINs inhibit late stage HIV-1 replication by modulating integrase multimerization in the virions</span></div><div class="casAuthors">Desimmie, Belete Ayele; Schrijvers, Rik; Demeulemeester, Jonas; Borrenberghs, Doortje; Weydert, Caroline; Thys, Wannes; Vets, Sofie; Van Remoortel, Barbara; Hofkens, Johan; De Rijck, Jan; Hendrix, Jelle; Bannert, Norbert; Gijsbers, Rik; Christ, Frauke; Debyser, Zeger</div><div class="citationInfo"><span class="NLM_cas:title">Retrovirology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">57</span>CODEN:
                <span class="NLM_cas:coden">RETRBO</span>;
        ISSN:<span class="NLM_cas:issn">1742-4690</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">LEDGINs are novel allosteric HIV integrase (IN) inhibitors that target the lens epithelium-derived growth factor (LEDGF)/p75 binding pocket of IN.  They block HIV-1 integration by abrogating the interaction between LEDGF/p75 and IN as well as by allosterically inhibiting the catalytic activity of IN.  Here we demonstrate that LEDGINs reduce the replication capacity of HIV particles produced in their presence.  We systematically studied the mol. basis of this late effect of LEDGINs and demonstrate that HIV virions produced in their presence display a severe replication defect.  Both the late effect and the previously described, early effect on integration contribute to LEDGIN antiviral activity as shown by time-of-addn., qPCR and infectivity assays.  The late effect phenotype requires binding of LEDGINs to integrase without influencing proteolytic cleavage or prodn. of viral particles.  LEDGINs augment IN multimerization during virion assembly or in the released viral particles and severely hamper the infectivity of progeny virions.  About 70% of the particles produced in LEDGIN-treated cells do not form a core or display aberrant empty cores with a mislocalized electron-dense ribonucleoprotein.  The LEDGIN-treated virus displays defective reverse transcription and nuclear import steps in the target cells.  The LEDGIN effect is possibly exerted at the level of the Pol precursor polyprotein.  Our results suggest that LEDGINs modulate IN multimerization in progeny virions and impair the formation of regular cores during the maturation step, resulting in a decreased infectivity of the viral particles in the target cells.  LEDGINs thus profile as unique antivirals with combined early (integration) and late (IN assembly) effects on the HIV replication cycle.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxfs8rqLNsR7Vg90H21EOLACvtfcHk0lhhkCCsGdFMIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpvFGkur0%253D&md5=a89a453220c3f8cd51338018b430b9fd</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1186%2F1742-4690-10-57&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1742-4690-10-57%26sid%3Dliteratum%253Aachs%26aulast%3DDesimmie%26aufirst%3DB.%2BA.%26aulast%3DSchrijvers%26aufirst%3DR.%26aulast%3DDemeulemeester%26aufirst%3DJ.%26aulast%3DBorrenberghs%26aufirst%3DD.%26aulast%3DWeydert%26aufirst%3DC.%26aulast%3DThys%26aufirst%3DW.%26aulast%3DVets%26aufirst%3DS.%26aulast%3DVan%2BRemoortel%26aufirst%3DB.%26aulast%3DHofkens%26aufirst%3DJ.%26aulast%3DDe%2BRijck%26aufirst%3DJ.%26aulast%3DHendrix%26aufirst%3DJ.%26aulast%3DBannert%26aufirst%3DN.%26aulast%3DGijsbers%26aufirst%3DR.%26aulast%3DChrist%26aufirst%3DF.%26aulast%3DDebyser%26aufirst%3DZ.%26atitle%3DLEDGINs%2520inhibit%2520late%2520stage%2520HIV-1%2520replication%2520by%2520modulating%2520integrase%2520multimerization%2520in%2520the%2520virions%26jtitle%3DRetrovirology%26date%3D2013%26volume%3D10%26spage%3D57%26doi%3D10.1186%2F1742-4690-10-57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Le
Rouzic, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnard, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chasset, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruneau, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chevreuil, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Strat, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beauvoir, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amadori, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brias, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vomscheid, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eiler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lévy, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delelis, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deprez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saïb, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamborlini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emiliani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruff, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ledoussal, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreau, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benarous, R.</span></span> <span> </span><span class="NLM_article-title">Dual inhibition of HIV-1 replication by integrase-LEDGF allosteric inhibitors is predominant at the post-integration stage</span>. <i>Retrovirology</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">144</span>, <span class="refDoi"> DOI: 10.1186/1742-4690-10-144</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=10.1186%2F1742-4690-10-144" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=24261564" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmvFagtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2013&pages=144&author=E.+Le%0ARouzicauthor=D.+Bonnardauthor=S.+Chassetauthor=J.+M.+Bruneauauthor=F.+Chevreuilauthor=F.+Le+Stratauthor=J.+Nguyenauthor=R.+Beauvoirauthor=C.+Amadoriauthor=J.+Briasauthor=S.+Vomscheidauthor=S.+Eilerauthor=N.+L%C3%A9vyauthor=O.+Delelisauthor=E.+Deprezauthor=A.+Sa%C3%AFbauthor=A.+Zamborliniauthor=S.+Emilianiauthor=M.+Ruffauthor=B.+Ledoussalauthor=F.+Moreauauthor=R.+Benarous&title=Dual+inhibition+of+HIV-1+replication+by+integrase-LEDGF+allosteric+inhibitors+is+predominant+at+the+post-integration+stage&doi=10.1186%2F1742-4690-10-144"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Dual inhibition of HIV-1 replication by integrase-LEDGF allosteric inhibitors is predominant at the post-integration stage</span></div><div class="casAuthors">Le Rouzic, Erwann; Bonnard, Damien; Chasset, Sophie; Bruneau, Jean-Michel; Chevreuil, Francis; Le Strat, Frederic; Nguyen, Juliette; Beauvoir, Roxane; Amadori, Celine; Brias, Julie; Vomscheid, Sophie; Eiler, Sylvia; Levy, Nicolas; Delelis, Olivier; Deprez, Eric; Saib, Ali; Zamborlini, Alessia; Emiliani, Stephane; Ruff, Marc; Ledoussal, Benoit; Moreau, Francois; Benarous, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Retrovirology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">144/1-144/21, 21 pp.</span>CODEN:
                <span class="NLM_cas:coden">RETRBO</span>;
        ISSN:<span class="NLM_cas:issn">1742-4690</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: LEDGF/p75 (LEDGF) is the main cellular cofactor of HIV-1 integrase (IN).  It acts as a tethering factor for IN, and targets the integration of HIV in actively transcribed gene regions of chromatin.  A recently developed class of IN allosteric inhibitors can inhibit the LEDGF-IN interaction.  Results: We describe a new series of IN-LEDGF allosteric inhibitors, the most active of which is Mut101.  We detd. the crystal structure of Mut101 in complex with IN and showed that the compd. binds to the LEDGF-binding pocket, promoting conformational changes of IN which explain at the at. level the allosteric effect of the IN/LEDGF interaction inhibitor on IN functions.  In vitro, Mut101 inhibited both IN-LEDGF interaction and IN strand transfer activity while enhancing IN-IN interaction.  Time of addn. expts. indicated that Mut101 behaved as an integration inhibitor.  Mut101 was fully active on HIV-1 mutants resistant to INSTIs and other classes of anti-HIV drugs, indicative that this compd. has a new mode of action.  However, we found that Mut101 also displayed a more potent antiretroviral activity at a post-integration step.  Infectivity of viral particles produced in presence of Mut101 was severely decreased.  This latter effect also required the binding of the compd. to the LEDGF-binding pocket.  Conclusion: Mut101 has dual anti-HIV-1 activity, at integration and post-integration steps of the viral replication cycle, by binding to a unique target on IN (the LEDGF-binding pocket).  The post-integration block of HIV-1 replication in virus-producer cells is the mechanism by which Mut101 is most active as an antiretroviral.  To explain this difference between Mut101 antiretroviral activity at integration and post-integration stages, we propose the following model: LEDGF is a nuclear, chromatin-bound protein that is absent in the cytoplasm.  Therefore, LEDGF can outcompete compd. binding to IN in the nucleus of target cells lowering its antiretroviral activity at integration, but not in the cytoplasm where post-integration prodn. of infectious viral particles takes place.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryOJ47iOvkx7Vg90H21EOLACvtfcHk0lhhkCCsGdFMIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmvFagtLg%253D&md5=44448a2b2a9af9c65759a02295137303</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1186%2F1742-4690-10-144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1742-4690-10-144%26sid%3Dliteratum%253Aachs%26aulast%3DLe%2BRouzic%26aufirst%3DE.%26aulast%3DBonnard%26aufirst%3DD.%26aulast%3DChasset%26aufirst%3DS.%26aulast%3DBruneau%26aufirst%3DJ.%2BM.%26aulast%3DChevreuil%26aufirst%3DF.%26aulast%3DLe%2BStrat%26aufirst%3DF.%26aulast%3DNguyen%26aufirst%3DJ.%26aulast%3DBeauvoir%26aufirst%3DR.%26aulast%3DAmadori%26aufirst%3DC.%26aulast%3DBrias%26aufirst%3DJ.%26aulast%3DVomscheid%26aufirst%3DS.%26aulast%3DEiler%26aufirst%3DS.%26aulast%3DL%25C3%25A9vy%26aufirst%3DN.%26aulast%3DDelelis%26aufirst%3DO.%26aulast%3DDeprez%26aufirst%3DE.%26aulast%3DSa%25C3%25AFb%26aufirst%3DA.%26aulast%3DZamborlini%26aufirst%3DA.%26aulast%3DEmiliani%26aufirst%3DS.%26aulast%3DRuff%26aufirst%3DM.%26aulast%3DLedoussal%26aufirst%3DB.%26aulast%3DMoreau%26aufirst%3DF.%26aulast%3DBenarous%26aufirst%3DR.%26atitle%3DDual%2520inhibition%2520of%2520HIV-1%2520replication%2520by%2520integrase-LEDGF%2520allosteric%2520inhibitors%2520is%2520predominant%2520at%2520the%2520post-integration%2520stage%26jtitle%3DRetrovirology%26date%3D2013%26volume%3D10%26spage%3D144%26doi%3D10.1186%2F1742-4690-10-144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fader, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malenfant, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parisien, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bilodeau, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landry, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pesant, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brochu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chabot, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halmos, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bousquet, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailey, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawai, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coulombe, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaPlante, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakalian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhardwaj, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wernic, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schroeder, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garneau, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cordingley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bethell, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonneau, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poupart, M.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faucher, A.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simoneau, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenwick, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoakim, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsantrizos, Y.</span></span> <span> </span><span class="NLM_article-title">Discovery of BI 224436, a noncatalytic site integrase inhibitor (NCINI) of HIV-1</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">422</span>– <span class="NLM_lpage">427</span>, <span class="refDoi"> DOI: 10.1021/ml500002n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500002n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1eitb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=422-427&author=L.+D.+Faderauthor=E.+Malenfantauthor=M.+Parisienauthor=R.+Carsonauthor=F.+Bilodeauauthor=S.+Landryauthor=M.+Pesantauthor=C.+Brochuauthor=S.+Morinauthor=C.+Chabotauthor=T.+Halmosauthor=Y.+Bousquetauthor=M.+D.+Baileyauthor=S.+H.+Kawaiauthor=R.+Coulombeauthor=S.+LaPlanteauthor=A.+Jakalianauthor=P.+K.+Bhardwajauthor=D.+Wernicauthor=P.+Schroederauthor=M.+Amadauthor=P.+Edwardsauthor=M.+Garneauauthor=J.+Duanauthor=M.+Cordingleyauthor=R.+Bethellauthor=S.+W.+Masonauthor=M.+Bosauthor=P.+Bonneauauthor=M.-A.+Poupartauthor=A.-M.+Faucherauthor=B.+Simoneauauthor=C.+Fenwickauthor=C.+Yoakimauthor=Y.+Tsantrizos&title=Discovery+of+BI+224436%2C+a+noncatalytic+site+integrase+inhibitor+%28NCINI%29+of+HIV-1&doi=10.1021%2Fml500002n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of BI 224436, a Noncatalytic Site Integrase Inhibitor (NCINI) of HIV-1</span></div><div class="casAuthors">Fader, Lee D.; Malenfant, Eric; Parisien, Mathieu; Carson, Rebekah; Bilodeau, Francois; Landry, Serge; Pesant, Marc; Brochu, Christian; Morin, Sebastien; Chabot, Catherine; Halmos, Ted; Bousquet, Yves; Bailey, Murray D.; Kawai, Stephen H.; Coulombe, Rene; LaPlante, Steven; Jakalian, Araz; Bhardwaj, Punit K.; Wernic, Dominik; Schroeder, Patricia; Amad, Ma'an; Edwards, Paul; Garneau, Michel; Duan, Jianmin; Cordingley, Michael; Bethell, Richard; Mason, Stephen W.; Bos, Michael; Bonneau, Pierre; Poupart, Marc-Andre; Faucher, Anne-Marie; Simoneau, Bruno; Fenwick, Craig; Yoakim, Christiane; Tsantrizos, Youla</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">422-427</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An assay recapitulating the 3' processing activity of HIV-1 integrase (IN) was used to screen the Boehringer Ingelheim compd. collection.  Hit-to-lead and lead optimization beginning with compd. I established the importance of the C3 and C4 substituent to antiviral potency against viruses with different aa124/aa125 variants of IN.  The importance of the C7 position on the serum shifted potency was established.  Introduction of a quinoline substituent at the C4 position provided a balance of potency and metabolic stability.  Combination of these findings ultimately led to the discovery of compd. II (BI 224436), the first NCINI to advance into a phase Ia clin. trial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrE57FQpskKLVg90H21EOLACvtfcHk0linPkLdl9YcMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1eitb8%253D&md5=6df7ddab6dadf569d00d4314a773532c</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fml500002n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500002n%26sid%3Dliteratum%253Aachs%26aulast%3DFader%26aufirst%3DL.%2BD.%26aulast%3DMalenfant%26aufirst%3DE.%26aulast%3DParisien%26aufirst%3DM.%26aulast%3DCarson%26aufirst%3DR.%26aulast%3DBilodeau%26aufirst%3DF.%26aulast%3DLandry%26aufirst%3DS.%26aulast%3DPesant%26aufirst%3DM.%26aulast%3DBrochu%26aufirst%3DC.%26aulast%3DMorin%26aufirst%3DS.%26aulast%3DChabot%26aufirst%3DC.%26aulast%3DHalmos%26aufirst%3DT.%26aulast%3DBousquet%26aufirst%3DY.%26aulast%3DBailey%26aufirst%3DM.%2BD.%26aulast%3DKawai%26aufirst%3DS.%2BH.%26aulast%3DCoulombe%26aufirst%3DR.%26aulast%3DLaPlante%26aufirst%3DS.%26aulast%3DJakalian%26aufirst%3DA.%26aulast%3DBhardwaj%26aufirst%3DP.%2BK.%26aulast%3DWernic%26aufirst%3DD.%26aulast%3DSchroeder%26aufirst%3DP.%26aulast%3DAmad%26aufirst%3DM.%26aulast%3DEdwards%26aufirst%3DP.%26aulast%3DGarneau%26aufirst%3DM.%26aulast%3DDuan%26aufirst%3DJ.%26aulast%3DCordingley%26aufirst%3DM.%26aulast%3DBethell%26aufirst%3DR.%26aulast%3DMason%26aufirst%3DS.%2BW.%26aulast%3DBos%26aufirst%3DM.%26aulast%3DBonneau%26aufirst%3DP.%26aulast%3DPoupart%26aufirst%3DM.-A.%26aulast%3DFaucher%26aufirst%3DA.-M.%26aulast%3DSimoneau%26aufirst%3DB.%26aulast%3DFenwick%26aufirst%3DC.%26aulast%3DYoakim%26aufirst%3DC.%26aulast%3DTsantrizos%26aufirst%3DY.%26atitle%3DDiscovery%2520of%2520BI%2520224436%252C%2520a%2520noncatalytic%2520site%2520integrase%2520inhibitor%2520%2528NCINI%2529%2520of%2520HIV-1%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D422%26epage%3D427%26doi%3D10.1021%2Fml500002n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsantrizos, Y. S.</span>; <span class="NLM_string-name">Bailey, M. D.</span>; <span class="NLM_string-name">Bilodeau, F.</span>; <span class="NLM_string-name">Carson, R. J.</span>; <span class="NLM_string-name">Coulombe, R.</span>; <span class="NLM_string-name">Fader, L.</span>; <span class="NLM_string-name">Halmos, T.</span>; <span class="NLM_string-name">Kawai, S.</span>; <span class="NLM_string-name">Landry, S.</span>; <span class="NLM_string-name">Laplante, S.</span>; <span class="NLM_string-name">Morin, S.</span>; <span class="NLM_string-name">Parisien, M.</span>; <span class="NLM_string-name">Poupart, M.-A.</span>; <span class="NLM_string-name">Simoneau, B.</span></span> <span> </span><span class="NLM_article-title">Preparation of 2-(<i>tert</i>-Butyloxy)-2-(2-methylquinolin-3-yl)acetic Acid Derivatives as Inhibitors of Human Immunodeficiency Virus Replication</span>. World Patent <span class="NLM_patent">WO2009/062285A1</span>, <span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=Y.+S.+Tsantrizos&author=M.+D.+Bailey&author=F.+Bilodeau&author=R.+J.+Carson&author=R.+Coulombe&author=L.+Fader&author=T.+Halmos&author=S.+Kawai&author=S.+Landry&author=S.+Laplante&author=S.+Morin&author=M.+Parisien&author=M.-A.+Poupart&author=B.+Simoneau&title=Preparation+of+2-%28tert-Butyloxy%29-2-%282-methylquinolin-3-yl%29acetic+Acid+Derivatives+as+Inhibitors+of+Human+Immunodeficiency+Virus+Replication"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DTsantrizos%26aufirst%3DY.%2BS.%26atitle%3DPreparation%2520of%25202-%2528tert-Butyloxy%2529-2-%25282-methylquinolin-3-yl%2529acetic%2520Acid%2520Derivatives%2520as%2520Inhibitors%2520of%2520Human%2520Immunodeficiency%2520Virus%2520Replication%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fader, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bilodeau, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chabot, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halmos, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailey, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawai, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coulombe, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laplante, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mekhssian, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakalian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garneau, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simoneau, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenwick, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsantrizos, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoakim, C.</span></span> <span> </span><span class="NLM_article-title">Minimizing the contribution of enterohepatic recirculation to clearance in rat for the NCINI class of inhibitors of HIV</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">711</span>– <span class="NLM_lpage">716</span>, <span class="refDoi"> DOI: 10.1021/ml500110j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500110j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmt1Shu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=711-716&author=L.+D.+Faderauthor=R.+Carsonauthor=S.+Morinauthor=F.+Bilodeauauthor=C.+Chabotauthor=T.+Halmosauthor=M.+D.+Baileyauthor=S.+H.+Kawaiauthor=R.+Coulombeauthor=S.+Laplanteauthor=K.+Mekhssianauthor=A.+Jakalianauthor=M.+Garneauauthor=J.+Duanauthor=S.+W.+Masonauthor=B.+Simoneauauthor=C.+Fenwickauthor=Y.+Tsantrizosauthor=C.+Yoakim&title=Minimizing+the+contribution+of+enterohepatic+recirculation+to+clearance+in+rat+for+the+NCINI+class+of+inhibitors+of+HIV&doi=10.1021%2Fml500110j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Minimizing the Contribution of Enterohepatic Recirculation to Clearance in Rat for the NCINI Class of Inhibitors of HIV</span></div><div class="casAuthors">Fader, Lee D.; Carson, Rebekah; Morin, Sebastien; Bilodeau, Francois; Chabot, Catherine; Halmos, Ted; Bailey, Murray D.; Kawai, Stephen H.; Coulombe, Rene; Laplante, Steven; Mekhssian, Kevork; Jakalian, Araz; Garneau, Michel; Duan, Jianmin; Mason, Stephen W.; Simoneau, Bruno; Fenwick, Craig; Tsantrizos, Youla; Yoakim, Christiane</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">711-716</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A scaffold replacement approach was used to identifying the pyridine series of noncatalytic site integrase inhibitors (NCINIs).  These mols. bind with higher affinity to a tetrameric form compared to a dimeric form of integrase.  Optimization of the C6 and C4 positions revealed that viruses harboring T124 or A124 amino acid substitutions are highly susceptible to these inhibitors, but viruses having the N124 amino acid substitution are about 100-fold less susceptible.  Compd. 20 (I) had EC50 values <10 nM against viruses having T124 or A124 substitutions in IN and >800 nM in viruses having N124 substitutions.  Compd. 20 had an excellent in vitro ADME profile and demonstrated reduced contribution of biliary excretion to in vivo clearance compared to BI 224436, the lead compd. from the quinoline series of NCINIs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDe8rX5yeRo7Vg90H21EOLACvtfcHk0ljCKyUvU8qKAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmt1Shu7g%253D&md5=076346757ea2aa73e103f580952a51c9</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fml500110j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500110j%26sid%3Dliteratum%253Aachs%26aulast%3DFader%26aufirst%3DL.%2BD.%26aulast%3DCarson%26aufirst%3DR.%26aulast%3DMorin%26aufirst%3DS.%26aulast%3DBilodeau%26aufirst%3DF.%26aulast%3DChabot%26aufirst%3DC.%26aulast%3DHalmos%26aufirst%3DT.%26aulast%3DBailey%26aufirst%3DM.%2BD.%26aulast%3DKawai%26aufirst%3DS.%2BH.%26aulast%3DCoulombe%26aufirst%3DR.%26aulast%3DLaplante%26aufirst%3DS.%26aulast%3DMekhssian%26aufirst%3DK.%26aulast%3DJakalian%26aufirst%3DA.%26aulast%3DGarneau%26aufirst%3DM.%26aulast%3DDuan%26aufirst%3DJ.%26aulast%3DMason%26aufirst%3DS.%2BW.%26aulast%3DSimoneau%26aufirst%3DB.%26aulast%3DFenwick%26aufirst%3DC.%26aulast%3DTsantrizos%26aufirst%3DY.%26aulast%3DYoakim%26aufirst%3DC.%26atitle%3DMinimizing%2520the%2520contribution%2520of%2520enterohepatic%2520recirculation%2520to%2520clearance%2520in%2520rat%2520for%2520the%2520NCINI%2520class%2520of%2520inhibitors%2520of%2520HIV%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D711%26epage%3D716%26doi%3D10.1021%2Fml500110j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fader, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailey, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaulieu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bilodeau, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonneau, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bousquet, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carson, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chabot, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coulombe, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenwick, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garneau, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halmos, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakalian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawai, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landry, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laplante, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rioux, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simoneau, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surprenant, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thavonekham, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thibeault, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trinh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsantrizos, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsoung, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoakim, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wernic, D.</span></span> <span> </span><span class="NLM_article-title">Aligning potency and pharmacokinetic properties for pyridine-based NCINIs</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">797</span>– <span class="NLM_lpage">801</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00194</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00194" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=1%3ACAS%3A528%3ADC%252BC28XpsFaqsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=797-801&author=L.+D.+Faderauthor=M.+D.+Baileyauthor=E.+Beaulieuauthor=F.+Bilodeauauthor=P.+Bonneauauthor=Y.+Bousquetauthor=R.+J.+Carsonauthor=C.+Chabotauthor=R.+Coulombeauthor=J.+Duanauthor=C.+Fenwickauthor=M.+Garneauauthor=T.+Halmosauthor=A.+Jakalianauthor=C.+Jamesauthor=S.+H.+Kawaiauthor=S.+Landryauthor=S.+R.+Laplanteauthor=S.+W.+Masonauthor=S.+Morinauthor=N.+Riouxauthor=B.+Simoneauauthor=S.+Surprenantauthor=B.+Thavonekhamauthor=C.+Thibeaultauthor=T.+Trinhauthor=Y.+Tsantrizosauthor=J.+Tsoungauthor=C.+Yoakimauthor=D.+Wernic&title=Aligning+potency+and+pharmacokinetic+properties+for+pyridine-based+NCINIs&doi=10.1021%2Facsmedchemlett.6b00194"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Aligning Potency and Pharmacokinetic Properties for Pyridine-Based NCINIs</span></div><div class="casAuthors">Fader, Lee D.; Bailey, Murray; Beaulieu, Eric; Bilodeau, Francois; Bonneau, Pierre; Bousquet, Yves; Carson, Rebekah J.; Chabot, Catherine; Coulombe, Rene; Duan, Jianmin; Fenwick, Craig; Garneau, Michel; Halmos, Ted; Jakalian, Araz; James, Clint; Kawai, Stephen H.; Landry, Serge; LaPlante, Steven R.; Mason, Stephen W.; Morin, Sebastien; Rioux, Nathalie; Simoneau, Bruno; Surprenant, Simon; Thavonekham, Bounkham; Thibeault, Carl; Trinh, Thao; Tsantrizos, Youla; Tsoung, Jennifer; Yoakim, Christiane; Wernic, Dominik</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">797-801</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Optimization of pyridine-based noncatalytic site integrase inhibitors (NCINIs) based on compd. (I) has led to the discovery of mols. capable of inhibiting virus harboring N124 variants of HIV integrase (IN) while maintaining minimal contribution of enterohepatic recirculation to clearance in rat.  Structure-activity relationships at the C6 position established chem. space where the extent of enterohepatic recirculation in the rat is minimized.  Desymmetrization of the C4 substituent allowed for potency optimization against virus having the N124 variant of integrase.  Combination of these lessons led to the discovery of compd. (II), having balanced serum-shifted antiviral potency and minimized excretion in to the biliary tract in rat, potentially representing a clin. viable starting point for a new treatment option for individuals infected with HIV.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQtz6e-ThyHLVg90H21EOLACvtfcHk0lj7mi4OOYTXCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpsFaqsrw%253D&md5=26945fd82b47268403d348233247db01</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00194&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00194%26sid%3Dliteratum%253Aachs%26aulast%3DFader%26aufirst%3DL.%2BD.%26aulast%3DBailey%26aufirst%3DM.%2BD.%26aulast%3DBeaulieu%26aufirst%3DE.%26aulast%3DBilodeau%26aufirst%3DF.%26aulast%3DBonneau%26aufirst%3DP.%26aulast%3DBousquet%26aufirst%3DY.%26aulast%3DCarson%26aufirst%3DR.%2BJ.%26aulast%3DChabot%26aufirst%3DC.%26aulast%3DCoulombe%26aufirst%3DR.%26aulast%3DDuan%26aufirst%3DJ.%26aulast%3DFenwick%26aufirst%3DC.%26aulast%3DGarneau%26aufirst%3DM.%26aulast%3DHalmos%26aufirst%3DT.%26aulast%3DJakalian%26aufirst%3DA.%26aulast%3DJames%26aufirst%3DC.%26aulast%3DKawai%26aufirst%3DS.%2BH.%26aulast%3DLandry%26aufirst%3DS.%26aulast%3DLaplante%26aufirst%3DS.%2BR.%26aulast%3DMason%26aufirst%3DS.%2BW.%26aulast%3DMorin%26aufirst%3DS.%26aulast%3DRioux%26aufirst%3DN.%26aulast%3DSimoneau%26aufirst%3DB.%26aulast%3DSurprenant%26aufirst%3DS.%26aulast%3DThavonekham%26aufirst%3DB.%26aulast%3DThibeault%26aufirst%3DC.%26aulast%3DTrinh%26aufirst%3DT.%26aulast%3DTsantrizos%26aufirst%3DY.%26aulast%3DTsoung%26aufirst%3DJ.%26aulast%3DYoakim%26aufirst%3DC.%26aulast%3DWernic%26aufirst%3DD.%26atitle%3DAligning%2520potency%2520and%2520pharmacokinetic%2520properties%2520for%2520pyridine-based%2520NCINIs%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D797%26epage%3D801%26doi%3D10.1021%2Facsmedchemlett.6b00194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsiang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niedziela-Majka, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lansdon, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samuel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novikov, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babaoglu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geleziunas, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakowicz, R.</span></span> <span> </span><span class="NLM_article-title">New class of HIV-1 integrase (IN) inhibitors with a dual mode of action</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>287</i></span>,  <span class="NLM_fpage">21189</span>– <span class="NLM_lpage">21203</span>, <span class="refDoi"> DOI: 10.1074/jbc.M112.347534</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=10.1074%2Fjbc.M112.347534" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=22535962" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=1%3ACAS%3A528%3ADC%252BC38Xos1Cksbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=21189-21203&author=M.+Tsiangauthor=G.+S.+Jonesauthor=A.+Niedziela-Majkaauthor=E.+Kanauthor=E.+B.+Lansdonauthor=W.+Huangauthor=M.+Hungauthor=D.+Samuelauthor=N.+Novikovauthor=Y.+Xuauthor=M.+Mitchellauthor=H.+Guoauthor=K.+Babaogluauthor=X.+Liuauthor=R.+Geleziunasauthor=R.+Sakowicz&title=New+class+of+HIV-1+integrase+%28IN%29+inhibitors+with+a+dual+mode+of+action&doi=10.1074%2Fjbc.M112.347534"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">New Class of HIV-1 Integrase (IN) Inhibitors with a Dual Mode of Action</span></div><div class="casAuthors">Tsiang, Manuel; Jones, Gregg S.; Niedziela-Majka, Anita; Kan, Elaine; Lansdon, Eric B.; Huang, Wayne; Hung, Magdeleine; Samuel, Dharmaraj; Novikov, Nikolai; Xu, Yili; Mitchell, Michael; Guo, Hongyan; Babaoglu, Kerim; Liu, Xiaohong; Geleziunas, Romas; Sakowicz, Roman</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">287</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">21189-21203</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Tert-Butoxy-(4-phenyl-quinolin-3-yl)-acetic acids (tBPQA) are a new class of HIV-1 integrase (IN) inhibitors that are structurally distinct from IN strand transfer inhibitors but analogous to LEDGINs.  LEDGINs are a class of potent antiviral compds. that interacts with the lens epithelium-derived growth factor (LEDGF) binding pocket on IN and were identified through competition binding against LEDGF.  LEDGF tethers IN to the host chromatin and enables targeted integration of viral DNA.  The prevailing understanding of the antiviral mechanism of LEDGINs is that they inhibit LEDGF binding to IN, which prevents targeted integration of HIV-1.  We showed that in addn. to the properties already known for LEDGINs, the binding of tBPQAs to the IN dimer interface inhibits IN enzymic activity in a LEDGF-independent manner.  Using the anal. of two long terminal repeat junctions in HIV-infected cells, we showed that the inhibition by tBPQAs occurs at or prior to the viral DNA 3'-processing step.  Biochem. studies revealed that this inhibition operates by compd.-induced conformational changes in the IN dimer that prevent proper assembly of IN onto viral DNA.  For the first time, tBPQAs were demonstrated to be allosteric inhibitors of HIV-1 IN displaying a dual mode of action: inhibition of IN-viral DNA assembly and inhibition of IN-LEDGF interaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9a7vKSwQy6rVg90H21EOLACvtfcHk0lj7mi4OOYTXCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xos1Cksbc%253D&md5=15268f38a9c9aaf318f94d49ad53054f</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M112.347534&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M112.347534%26sid%3Dliteratum%253Aachs%26aulast%3DTsiang%26aufirst%3DM.%26aulast%3DJones%26aufirst%3DG.%2BS.%26aulast%3DNiedziela-Majka%26aufirst%3DA.%26aulast%3DKan%26aufirst%3DE.%26aulast%3DLansdon%26aufirst%3DE.%2BB.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DHung%26aufirst%3DM.%26aulast%3DSamuel%26aufirst%3DD.%26aulast%3DNovikov%26aufirst%3DN.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DMitchell%26aufirst%3DM.%26aulast%3DGuo%26aufirst%3DH.%26aulast%3DBabaoglu%26aufirst%3DK.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DGeleziunas%26aufirst%3DR.%26aulast%3DSakowicz%26aufirst%3DR.%26atitle%3DNew%2520class%2520of%2520HIV-1%2520integrase%2520%2528IN%2529%2520inhibitors%2520with%2520a%2520dual%2520mode%2520of%2520action%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D21189%26epage%3D21203%26doi%3D10.1074%2Fjbc.M112.347534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brady, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyer, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malani, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Male, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolte, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velthuisen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeffrey, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Duyne, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bushman, F. D.</span></span> <span> </span><span class="NLM_article-title">Allosteric inhibition of human immunodeficiency virus integrase</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>289</i></span>,  <span class="NLM_fpage">20477</span>– <span class="NLM_lpage">20488</span>, <span class="refDoi"> DOI: 10.1074/jbc.M114.551119</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=10.1074%2Fjbc.M114.551119" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=24904063" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1SksLfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=20477-20488&author=K.+Guptaauthor=T.+Bradyauthor=B.+M.+Dyerauthor=N.+Malaniauthor=Y.+Hwangauthor=F.+Maleauthor=R.+T.+Nolteauthor=L.+Wangauthor=E.+Velthuisenauthor=J.+Jeffreyauthor=G.+D.+Van+Duyneauthor=F.+D.+Bushman&title=Allosteric+inhibition+of+human+immunodeficiency+virus+integrase&doi=10.1074%2Fjbc.M114.551119"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric Inhibition of Human Immunodeficiency Virus Integrase</span></div><div class="casAuthors">Gupta, Kushol; Brady, Troy; Dyer, Benjamin M.; Malani, Nirav; Hwang, Young; Male, Frances; Nolte, Robert T.; Wang, Liping; Velthuisen, Emile; Jeffrey, Jerry; Van Duyne, Gregory D.; Bushman, Frederic D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">20477-20488</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">HIV-1 replication in the presence of antiviral agents results in evolution of drug-resistant variants, motivating the search for addnl. drug classes.  Here the authors report studies of GSK1264, which was identified as a compd. that disrupts the interaction between HIV-1 integrase (IN) and the cellular factor lens epithelium-derived growth factor (LEDGF)/p75.  GSK1264 displayed potent antiviral activity and was found to bind at the site occupied by LEDGF/p75 on IN by x-ray crystallog.  Assays of HIV replication in the presence of GSK1264 showed only modest inhibition of the early infection steps and little effect on integration targeting, which is guided by the LEDGF/p75·IN interaction.  In contrast, inhibition of late replication steps was more potent.  Particle prodn. was normal, but particles showed reduced infectivity.  GSK1264 promoted aggregation of IN and preformed LEDGF/p75·IN complexes, suggesting a mechanism of inhibition.  LEDGF/p75 was not displaced from IN during aggregation, indicating trapping of LEDGF/p75 in aggregates.  Aggregation assays with truncated IN variants revealed that a construct with catalytic and C-terminal domains of IN only formed an open polymer assocd. with efficient drug-induced aggregation.  These data suggest that the allosteric inhibitors of IN are promising antiviral agents and provide new information on their mechanism of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfGVxAhaPY-7Vg90H21EOLACvtfcHk0lj7mi4OOYTXCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1SksLfN&md5=a1cadf2734267122e9bc3a6b013f21dc</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M114.551119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M114.551119%26sid%3Dliteratum%253Aachs%26aulast%3DGupta%26aufirst%3DK.%26aulast%3DBrady%26aufirst%3DT.%26aulast%3DDyer%26aufirst%3DB.%2BM.%26aulast%3DMalani%26aufirst%3DN.%26aulast%3DHwang%26aufirst%3DY.%26aulast%3DMale%26aufirst%3DF.%26aulast%3DNolte%26aufirst%3DR.%2BT.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DVelthuisen%26aufirst%3DE.%26aulast%3DJeffrey%26aufirst%3DJ.%26aulast%3DVan%2BDuyne%26aufirst%3DG.%2BD.%26aulast%3DBushman%26aufirst%3DF.%2BD.%26atitle%3DAllosteric%2520inhibition%2520of%2520human%2520immunodeficiency%2520virus%2520integrase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26spage%3D20477%26epage%3D20488%26doi%3D10.1074%2Fjbc.M114.551119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turkki, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherrill-Mix, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eilers, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDanal, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Temelkoff, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolte, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velthuisen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeffrey, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Duyne, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bushman, F. D.</span></span> <span> </span><span class="NLM_article-title">Structural basis for inhibitor-induced aggregation of HIV integrase</span>. <i>PLoS Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">e1002584</span>, <span class="refDoi"> DOI: 10.1371/journal.pbio.1002584</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=10.1371%2Fjournal.pbio.1002584" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=27935939" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=1%3ACAS%3A528%3ADC%252BC2sXosVelu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2016&pages=e1002584&author=K.+Guptaauthor=V.+Turkkiauthor=S.+Sherrill-Mixauthor=Y.+Hwangauthor=G.+Eilersauthor=L.+Taylorauthor=C.+McDanalauthor=P.+Wangauthor=D.+Temelkoffauthor=R.+T.+Nolteauthor=E.+Velthuisenauthor=J.+Jeffreyauthor=G.+D.+Van+Duyneauthor=F.+D.+Bushman&title=Structural+basis+for+inhibitor-induced+aggregation+of+HIV+integrase&doi=10.1371%2Fjournal.pbio.1002584"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for inhibitor-induced aggregation of HIV integrase</span></div><div class="casAuthors">Gupta, Kushol; Turkki, Vesa; Sherrill-Mix, Scott; Hwang, Young; Eilers, Grant; Taylor, Louis; McDanal, Charlene; Wang, Ping; Temelkoff, David; Nolte, Robert T.; Velthuisen, Emile; Jeffrey, Jerry; Van Duyne, Gregory D.; Bushman, Frederic D.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">e1002584/1-e1002584/24</span>CODEN:
                <span class="NLM_cas:coden">PBLIBG</span>;
        ISSN:<span class="NLM_cas:issn">1545-7885</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">The allosteric inhibitors of integrase (termed ALLINIs) interfere with HIV replication by binding to the viral-encoded integrase (IN) protein.  Surprisingly, ALLINIs interfere not with DNA integration but with viral particle assembly late during HIV replication.  To investigate the ALLINI inhibitory mechanism, we crystd. full-length HIV-1 IN bound to the ALLINI GSK1264 and detd. the structure of the complex at 4.4 Å resoln.  The structure shows GSK1264 buried between the IN C-terminal domain (CTD) and the catalytic core domain.  In the crystal lattice, the interacting domains are contributed by two different dimers so that IN forms an open polymer mediated by inhibitor-bridged contacts; the N-terminal domains do not participate and are structurally disordered.  Engineered amino acid substitutions at the inhibitor interface blocked ALLINI-induced multimerization.  HIV escape mutants with reduced sensitivity to ALLINIs commonly altered amino acids at or near the inhibitorbound interface, and these substitutions also diminished IN multimerization.  We propose that ALLINIs inhibit particle assembly by stimulating inappropriate polymn. of IN via interactions between the catalytic core domain and the CTD and that understanding the interface involved offers new routes to inhibitor optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3wrTwfpC_UbVg90H21EOLACvtfcHk0liN6lxFofiDrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXosVelu7c%253D&md5=a41f3eb25160c7c02b66ed84307f0e54</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pbio.1002584&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pbio.1002584%26sid%3Dliteratum%253Aachs%26aulast%3DGupta%26aufirst%3DK.%26aulast%3DTurkki%26aufirst%3DV.%26aulast%3DSherrill-Mix%26aufirst%3DS.%26aulast%3DHwang%26aufirst%3DY.%26aulast%3DEilers%26aufirst%3DG.%26aulast%3DTaylor%26aufirst%3DL.%26aulast%3DMcDanal%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DTemelkoff%26aufirst%3DD.%26aulast%3DNolte%26aufirst%3DR.%2BT.%26aulast%3DVelthuisen%26aufirst%3DE.%26aulast%3DJeffrey%26aufirst%3DJ.%26aulast%3DVan%2BDuyne%26aufirst%3DG.%2BD.%26aulast%3DBushman%26aufirst%3DF.%2BD.%26atitle%3DStructural%2520basis%2520for%2520inhibitor-induced%2520aggregation%2520of%2520HIV%2520integrase%26jtitle%3DPLoS%2520Biol.%26date%3D2016%26volume%3D14%26spage%3De1002584%26doi%3D10.1371%2Fjournal.pbio.1002584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cherepanov, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambrosio, A. L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellenberger, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engelman, A.</span></span> <span> </span><span class="NLM_article-title">Structural basis for the recognition between HIV-1 integrase and transcriptional coactivator p75</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">17308</span>– <span class="NLM_lpage">17313</span>, <span class="refDoi"> DOI: 10.1073/pnas.0506924102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=10.1073%2Fpnas.0506924102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=16260736" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlSqtLfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=17308-17313&author=P.+Cherepanovauthor=A.+L.+B.+Ambrosioauthor=S.+Rahmanauthor=T.+Ellenbergerauthor=A.+Engelman&title=Structural+basis+for+the+recognition+between+HIV-1+integrase+and+transcriptional+coactivator+p75&doi=10.1073%2Fpnas.0506924102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for the recognition between HIV-1 integrase and transcriptional coactivator p75</span></div><div class="casAuthors">Cherepanov, Peter; Ambrosio, Andre L. B.; Rahman, Shaila; Ellenberger, Tom; Engelman, Alan</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">17308-17313</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Integrase (IN) is an essential retroviral enzyme, and human transcriptional coactivator p75, which is also referred to as lens epithelium-derived growth factor (LEDGF), is the dominant cellular binding partner of HIV-1 IN.  Here, we report the crystal structure of the dimeric catalytic core domain of HIV-1 IN complexed to the IN-binding domain of LEDGF.  Previously identified LEDGF hotspot residues anchor the protein to both monomers at the IN dimer interface.  The principal structural features of IN that are recognized by the host factor are the backbone conformation of residues 168-171 from one monomer and a hydrophobic patch that is primarily comprised of α-helixes 1 and 3 of the second IN monomer.  Inspection of diverse retroviral primary and secondary sequence elements helps to explain the apparent lentiviral tropism of the LEDGF-IN interaction.  Because the lethal phenotypes of HIV-1 mutant viruses unable to interact with LEDGF indicate that IN function is highly sensitive to perturbations of the structure around the LEDGF-binding site, we propose that small mol. inhibitors of the protein-protein interaction might similarly disrupt HIV-1 replication.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOcJ_wK2p6urVg90H21EOLACvtfcHk0liN6lxFofiDrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlSqtLfE&md5=92b763420ded097aad69decb895f49ab</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0506924102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0506924102%26sid%3Dliteratum%253Aachs%26aulast%3DCherepanov%26aufirst%3DP.%26aulast%3DAmbrosio%26aufirst%3DA.%2BL.%2BB.%26aulast%3DRahman%26aufirst%3DS.%26aulast%3DEllenberger%26aufirst%3DT.%26aulast%3DEngelman%26aufirst%3DA.%26atitle%3DStructural%2520basis%2520for%2520the%2520recognition%2520between%2520HIV-1%2520integrase%2520and%2520transcriptional%2520coactivator%2520p75%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2005%26volume%3D102%26spage%3D17308%26epage%3D17313%26doi%3D10.1073%2Fpnas.0506924102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davis, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vishwakarma, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billmers, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finn, J.</span></span> <span> </span><span class="NLM_article-title">Synthesis of α-hydroxycarbonyl compounds (acyloins): direct oxidation of enolates using 2-sulfonyloxaziridine</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">3241</span>– <span class="NLM_lpage">3243</span>, <span class="refDoi"> DOI: 10.1021/jo00191a048</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00191a048" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=1%3ACAS%3A528%3ADyaL2cXkvV2ru7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1984&pages=3241-3243&author=F.+A.+Davisauthor=L.+C.+Vishwakarmaauthor=J.+G.+Billmersauthor=J.+Finn&title=Synthesis+of+%CE%B1-hydroxycarbonyl+compounds+%28acyloins%29%3A+direct+oxidation+of+enolates+using+2-sulfonyloxaziridine&doi=10.1021%2Fjo00191a048"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of α-hydroxycarbonyl compounds (acyloins):  direct oxidation of enolates using 2-sulfonyloxaziridines</span></div><div class="casAuthors">Davis, Franklin A.; Vishwakarma, Lal C.; Billmers, Joanne G.; Finn, John</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">3241-3</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">Direct oxidn. of ketone and ester enolates with oxaziridine I affords α-hydroxycarbonyl compds. in higher yield, with fewer side reactions, and with superior stereoselectivity than similar oxidns. using Mo peroxide-pyridine-(Me2N)3PO or O2.  Competitive addn. of enolates to sulfonimide PhSO2:CHPh is unimportant.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIHYbwSFWMmrVg90H21EOLACvtfcHk0liN6lxFofiDrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXkvV2ru7Y%253D&md5=7a9c0eea5d2ca9135823cc4417705d07</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjo00191a048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00191a048%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DF.%2BA.%26aulast%3DVishwakarma%26aufirst%3DL.%2BC.%26aulast%3DBillmers%26aufirst%3DJ.%2BG.%26aulast%3DFinn%26aufirst%3DJ.%26atitle%3DSynthesis%2520of%2520%25CE%25B1-hydroxycarbonyl%2520compounds%2520%2528acyloins%2529%253A%2520direct%2520oxidation%2520of%2520enolates%2520using%25202-sulfonyloxaziridine%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1984%26volume%3D49%26spage%3D3241%26epage%3D3243%26doi%3D10.1021%2Fjo00191a048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Corey, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Link, J. O.</span></span> <span> </span><span class="NLM_article-title">A general, catalytic, and enantioselective synthesis of α-amino acids</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">1906</span>– <span class="NLM_lpage">1908</span>, <span class="refDoi"> DOI: 10.1021/ja00031a069</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00031a069" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=1%3ACAS%3A528%3ADyaK38Xht12msbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=1992&pages=1906-1908&author=E.+J.+Coreyauthor=J.+O.+Link&title=A+general%2C+catalytic%2C+and+enantioselective+synthesis+of+%CE%B1-amino+acids&doi=10.1021%2Fja00031a069"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">A general, catalytic, and enantioselective synthesis of α-amino acids</span></div><div class="casAuthors">Corey, E. J.; Link, John O.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1906-8</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">A useful and general new synthesis of chiral α-amino acids is reported which produces these valuable substances from inexpensive achiral precursors by an enantioselective catalytic process.  The synthesis of enantiomerically pure (S)-α-amino acids, n-amylglycine, homophenylalanine, p-phenylphenylalanine, β-naphthylalanine, cyclohexylglycine, and tert-butylglycine, from trichloromethyl ketones in good yield using three simple steps is reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovJJRXiDv2WrVg90H21EOLACvtfcHk0lhbMTBgYOJyKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xht12msbk%253D&md5=363811ba776e2ac646a1cbedfd7bd97b</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fja00031a069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00031a069%26sid%3Dliteratum%253Aachs%26aulast%3DCorey%26aufirst%3DE.%2BJ.%26aulast%3DLink%26aufirst%3DJ.%2BO.%26atitle%3DA%2520general%252C%2520catalytic%252C%2520and%2520enantioselective%2520synthesis%2520of%2520%25CE%25B1-amino%2520acids%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1992%26volume%3D114%26spage%3D1906%26epage%3D1908%26doi%3D10.1021%2Fja00031a069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carlens, G.</span>; <span class="NLM_string-name">Chaltin, P.</span>; <span class="NLM_string-name">Christ, F.</span>; <span class="NLM_string-name">Debyser, Z.</span>; <span class="NLM_string-name">Marchand, A.</span>; <span class="NLM_string-name">Marchand, D.</span>; <span class="NLM_string-name">Voet, A.</span>; <span class="NLM_string-name">De
Maeyer, M.</span></span> <span> </span><span class="NLM_article-title">Novel Antiviral Compounds</span>. World Patent <span class="NLM_patent">WO2011/076765A1</span>, <span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=G.+Carlens&author=P.+Chaltin&author=F.+Christ&author=Z.+Debyser&author=A.+Marchand&author=D.+Marchand&author=A.+Voet&author=M.+De%0AMaeyer&title=Novel+Antiviral+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCarlens%26aufirst%3DG.%26atitle%3DNovel%2520Antiviral%2520Compounds%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peese, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allard, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connolly, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorensen, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McAuliffe, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minassian, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krystal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kish, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolte, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simmermacher, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenkins, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cianci, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naidu, B. N.</span></span> <span> </span><span class="NLM_article-title">5,6,7,8-Tetrahydro-1,6-naphthyridine derivatives as potent HIV-1-integrase-allosteric-site inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">1348</span>– <span class="NLM_lpage">1361</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01473</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01473" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=1%3ACAS%3A528%3ADC%252BC1MXkslOktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=1348-1361&author=K.+M.+Peeseauthor=C.+W.+Allardauthor=T.+Connollyauthor=B.+L.+Johnsonauthor=C.+Liauthor=M.+Patelauthor=M.+E.+Sorensenauthor=M.+A.+Walkerauthor=N.+A.+Meanwellauthor=B.+McAuliffeauthor=B.+Minassianauthor=M.+Krystalauthor=D.+D.+Parkerauthor=H.+A.+Lewisauthor=K.+Kishauthor=P.+Zhangauthor=R.+T.+Nolteauthor=J.+Simmermacherauthor=S.+Jenkinsauthor=C.+Cianciauthor=B.+N.+Naidu&title=5%2C6%2C7%2C8-Tetrahydro-1%2C6-naphthyridine+derivatives+as+potent+HIV-1-integrase-allosteric-site+inhibitors&doi=10.1021%2Facs.jmedchem.8b01473"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">5,6,7,8-Tetrahydro-1,6-naphthyridine Derivatives as Potent HIV-1-Integrase-Allosteric-Site Inhibitors</span></div><div class="casAuthors">Peese, Kevin M.; Allard, Christopher W.; Connolly, Timothy; Johnson, Barry L.; Li, Chen; Patel, Manoj; Sorensen, Margaret E.; Walker, Michael A.; Meanwell, Nicholas A.; McAuliffe, Brian; Minassian, Beatrice; Krystal, Mark; Parker, Dawn D.; Lewis, Hal A.; Kish, Kevin; Zhang, Ping; Nolte, Robert T.; Simmermacher, Jean; Jenkins, Susan; Cianci, Christopher; Naidu, B. Narasimhulu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1348-1361</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of 5,6,7,8-tetrahydro-1,6-naphthyridine derivs. targeting the allosteric lens-epithelium-derived-growth-factor-p75 (LEDGF/p75)-binding site on HIV-1 integrase, an attractive target for antiviral chemotherapy, was prepd. and screened for activity against HIV-1 infection in cell culture.  Small mols. that bind within the LEDGF/p75-binding site promote aberrant multimerization of the integrase enzyme and are of significant interest as HIV-1-replication inhibitors.  Structure-activity-relationship studies and rat pharmacokinetic studies of lead compds. are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxfRugKDl9IbVg90H21EOLACvtfcHk0lhbMTBgYOJyKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXkslOktw%253D%253D&md5=23f771095384ab88b0edce6f12704fc0</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01473&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01473%26sid%3Dliteratum%253Aachs%26aulast%3DPeese%26aufirst%3DK.%2BM.%26aulast%3DAllard%26aufirst%3DC.%2BW.%26aulast%3DConnolly%26aufirst%3DT.%26aulast%3DJohnson%26aufirst%3DB.%2BL.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DPatel%26aufirst%3DM.%26aulast%3DSorensen%26aufirst%3DM.%2BE.%26aulast%3DWalker%26aufirst%3DM.%2BA.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DMcAuliffe%26aufirst%3DB.%26aulast%3DMinassian%26aufirst%3DB.%26aulast%3DKrystal%26aufirst%3DM.%26aulast%3DParker%26aufirst%3DD.%2BD.%26aulast%3DLewis%26aufirst%3DH.%2BA.%26aulast%3DKish%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DNolte%26aufirst%3DR.%2BT.%26aulast%3DSimmermacher%26aufirst%3DJ.%26aulast%3DJenkins%26aufirst%3DS.%26aulast%3DCianci%26aufirst%3DC.%26aulast%3DNaidu%26aufirst%3DB.%2BN.%26atitle%3D5%252C6%252C7%252C8-Tetrahydro-1%252C6-naphthyridine%2520derivatives%2520as%2520potent%2520HIV-1-integrase-allosteric-site%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D1348%26epage%3D1361%26doi%3D10.1021%2Facs.jmedchem.8b01473" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse-Kunstleve, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winn, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storoni, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span> <span> </span><span class="NLM_article-title">Phaser crystallographic software</span>. <i>J. Appl. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">658</span>– <span class="NLM_lpage">674</span>, <span class="refDoi"> DOI: 10.1107/S0021889807021206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=10.1107%2FS0021889807021206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=19461840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2007&pages=658-674&author=A.+J.+McCoyauthor=R.+W.+Grosse-Kunstleveauthor=P.+D.+Adamsauthor=M.+D.+Winnauthor=L.+C.+Storoniauthor=R.+J.+Read&title=Phaser+crystallographic+software&doi=10.1107%2FS0021889807021206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Phaser crystallographic software</span></div><div class="casAuthors">McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.; Winn, Martyn D.; Storoni, Laurent C.; Read, Randy J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">658-674</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Phaser is a program for phasing macromol. crystal structures by both mol. replacement and exptl. phasing methods.  The novel phasing algorithms implemented in Phaser have been developed using max. likelihood and multivariate statistics.  For mol. replacement, the new algorithms have proved to be significantly better than traditional methods in discriminating correct solns. from noise, and for single-wavelength anomalous dispersion exptl. phasing, the new algorithms, which account for correlations between F+ and F-, give better phases (lower mean phase error with respect to the phases given by the refined structure) than those that use mean F and anomalous differences ΔF.  One of the design concepts of Phaser was that it be capable of a high degree of automation.  To this end, Phaser (written in C++) can be called directly from Python, although it can also be called using traditional CCP4 keyword-style input.  Phaser is a platform for future development of improved phasing methods and their release, including source code, to the crystallog. community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPeVyjN_FMGbVg90H21EOLACvtfcHk0lhbMTBgYOJyKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D&md5=c63b722ae97e0a74e6a5a079d388f09f</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1107%2FS0021889807021206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889807021206%26sid%3Dliteratum%253Aachs%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DStoroni%26aufirst%3DL.%2BC.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26atitle%3DPhaser%2520crystallographic%2520software%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2007%26volume%3D40%26spage%3D658%26epage%3D674%26doi%3D10.1107%2FS0021889807021206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emsley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohkamp, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowtan, K.</span></span> <span> </span><span class="NLM_article-title">Features and development of Coot</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">486</span>– <span class="NLM_lpage">501</span>, <span class="refDoi"> DOI: 10.1107/S0907444910007493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=10.1107%2FS0907444910007493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=20383002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=486-501&author=P.+Emsleyauthor=B.+Lohkampauthor=W.+G.+Scottauthor=K.+Cowtan&title=Features+and+development+of+Coot&doi=10.1107%2FS0907444910007493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Features and development of Coot</span></div><div class="casAuthors">Emsley, P.; Lohkamp, B.; Scott, W. G.; Cowtan, K.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">486-501</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Coot is a mol.-graphics application for model building and validation of biol. macromols.  The program displays electron-d. maps and at. models and allows model manipulations such as idealization, real-space refinement, manual rotation/translation, rigid-body fitting, ligand search, solvation, mutations, rotamers and Ramachandran idealization.  Furthermore, tools are provided for model validation as well as interfaces to external programs for refinement, validation and graphics.  The software is designed to be easy to learn for novice users, which is achieved by ensuring that tools for common tasks are 'discoverable' through familiar user-interface elements (menus and toolbars) or by intuitive behavior (mouse controls).  Recent developments have focused on providing tools for expert users, with customisable key bindings, extensions and an extensive scripting interface.  The software is under rapid development, but has already achieved very widespread use within the crystallog. community.  The current state of the software is presented, with a description of the facilities available and of some of the underlying methods employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAKBKszbqb_7Vg90H21EOLACvtfcHk0lgp_AQmtgM4Ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D&md5=67262cbfc60004de5ef962d5c043c910</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1107%2FS0907444910007493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910007493%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DLohkamp%26aufirst%3DB.%26aulast%3DScott%26aufirst%3DW.%2BG.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DFeatures%2520and%2520development%2520of%2520Coot%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D486%26epage%3D501%26doi%3D10.1107%2FS0907444910007493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, V. A.</span>; <span class="NLM_string-name">Byington, R. T.</span></span> <span> </span><span class="NLM_article-title">Infectivity Assay</span>. In  <i>Techniques in HIV Research</i>; <span class="NLM_publisher-name">Stockton Press</span>: <span class="NLM_publisher-loc">New York, NY</span>, <span class="NLM_year">1990</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=10.1007%2F978-1-349-11888-5_4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1990&author=V.+A.+Johnson&author=R.+T.+Byington&title=Techniques+in+HIV+Research"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1007%2F978-1-349-11888-5_4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-1-349-11888-5_4%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DV.%2BA.%26atitle%3DInfectivity%2520Assay%26btitle%3DTechniques%2520in%2520HIV%2520Research%26pub%3DStockton%2520Press%26date%3D1990" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weislow, O. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiser, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fine, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bader, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoemaker, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyd, M. R.</span></span> <span> </span><span class="NLM_article-title">New soluble-formazan assay for HIV-1 cytopathic effects: application to high-flux screening of synthetic and natural products for AIDS-antiviral activity</span>. <i>J. Natl. Cancer Inst.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">577</span>– <span class="NLM_lpage">586</span>, <span class="refDoi"> DOI: 10.1093/jnci/81.8.577</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=10.1093%2Fjnci%2F81.8.577" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=2495366" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=1%3ACAS%3A528%3ADyaL1MXkvV2lt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=1989&pages=577-586&author=O.+S.+Weislowauthor=R.+Kiserauthor=D.+L.+Fineauthor=J.+Baderauthor=R.+H.+Shoemakerauthor=M.+R.+Boyd&title=New+soluble-formazan+assay+for+HIV-1+cytopathic+effects%3A+application+to+high-flux+screening+of+synthetic+and+natural+products+for+AIDS-antiviral+activity&doi=10.1093%2Fjnci%2F81.8.577"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">New soluble-formazan assay for HIV-1 cytopathic effects:  application to high-flux screening of synthetic and natural products for AIDS-antiviral activity</span></div><div class="casAuthors">Weislow, Owen S.; Kiser, Rebecca; Fine, Donald L.; Bader, John; Shoemaker, Robert H.; Boyd, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">577-86</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    </div><div class="casAbstract">An effective and optimally safe microculture method was developed for the rapid and convenient assay of the in vitro cytopathic effects of human immunodeficiency virus (HIV-1) on human lymphoblastoid or other suitable host cells.  The assay procedure is applicable to the evaluation of drug effects on in vitro infections induced directly in cultured host cells by cell-free HIV-1 or by coculture with H9 cells chronically infected with HIV-1.  The assay uses a newly developed tetrazolium reagent that is metabolically reduced by viable cells to yield a sol., colored formazan product measureable by conventional colorimetric techniques.  This simple microassay minimizes the no. of plate manipulations typically required with other assay methods and, coupled with computerized data collection and anal., facilitates large-scale screening of agents for potential antiviral activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDJZMdwKZfgbVg90H21EOLACvtfcHk0lgp_AQmtgM4Ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXkvV2lt78%253D&md5=c39a027f4ddc6bb5d7b1108c1b128be6</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F81.8.577&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F81.8.577%26sid%3Dliteratum%253Aachs%26aulast%3DWeislow%26aufirst%3DO.%2BS.%26aulast%3DKiser%26aufirst%3DR.%26aulast%3DFine%26aufirst%3DD.%2BL.%26aulast%3DBader%26aufirst%3DJ.%26aulast%3DShoemaker%26aufirst%3DR.%2BH.%26aulast%3DBoyd%26aufirst%3DM.%2BR.%26atitle%3DNew%2520soluble-formazan%2520assay%2520for%2520HIV-1%2520cytopathic%2520effects%253A%2520application%2520to%2520high-flux%2520screening%2520of%2520synthetic%2520and%2520natural%2520products%2520for%2520AIDS-antiviral%2520activity%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D1989%26volume%3D81%26spage%3D577%26epage%3D586%26doi%3D10.1093%2Fjnci%2F81.8.577" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kieltyka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vath, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baglieri, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferraro, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zvyaga, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drexler, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weller, H. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shou, W. Z.</span></span> <span> </span><span class="NLM_article-title">A high-throughput bioanalytical platform using automated infusion for tandem mass spectrometric method optimization and its application in a metabolic stability screen</span>. <i>Rapid Commun. Mass Spectrom.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">1579</span>– <span class="NLM_lpage">1597</span>, <span class="refDoi"> DOI: 10.1002/rcm.4037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=10.1002%2Frcm.4037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=19399765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtVKmt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2009&pages=1579-1597&author=K.+Kieltykaauthor=J.+Zhangauthor=S.+Liauthor=M.+Vathauthor=C.+Baglieriauthor=C.+Ferraroauthor=T.+A.+Zvyagaauthor=D.+M.+Drexlerauthor=H.+N.+Wellerauthor=W.+Z.+Shou&title=A+high-throughput+bioanalytical+platform+using+automated+infusion+for+tandem+mass+spectrometric+method+optimization+and+its+application+in+a+metabolic+stability+screen&doi=10.1002%2Frcm.4037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">A high-throughput bioanalytical platform using automated infusion for tandem mass spectrometric method optimization and its application in a metabolic stability screen</span></div><div class="casAuthors">Kieltyka, Kasia; Zhang, Jun; Li, Shu; Vath, Marianne; Baglieri, Chris; Ferraro, Cheryl; Zvyaga, Tatyana A.; Drexler, Dieter M.; Weller, Harold N.; Shou, Wilson Z.</div><div class="citationInfo"><span class="NLM_cas:title">Rapid Communications in Mass Spectrometry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1579-1591</span>CODEN:
                <span class="NLM_cas:coden">RCMSEF</span>;
        ISSN:<span class="NLM_cas:issn">0951-4198</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Liq. chromatog./tandem mass spectrometry (LC/MS/MS) is the bioanal. method of choice to support plate-based, in vitro early ADME (Absorption, Distribution, Metab. and Excretion) screens such as metabolic stability (Metstab) assessment.  MS/MS method optimization has historically been the bottleneck in this environment, where samples from thousands of discrete compds. are analyzed on a monthly basis, mainly due to the lack of a high-quality com. available platform to handle the necessary MS/MS method optimization steps for sample anal. by selected reaction monitoring (SRM) on triple quadrupole mass spectrometers.  To address this challenge, we recently developed a highly automated bioanal. platform by successfully integrating QuickQuan 2.0, a unique high-throughput soln. featuring MS/MS method optimization by automated infusion, with a customized inhouse software tool in support of a Metstab screen.  In this platform, a dual-column setup running parallel chromatog. was also implemented to reduce the bioanal. cycle time for LC/MS/MS sample anal.  A set of 45 validation compds. was used to demonstrate the speed, quality and reproducibility of MS/MS method optimization, sample anal., and data processing using this automated platform.  Metstab results for the validation compds. in microsomes from multiple species (human, rat, mouse) showed good consistency within each batch, and also between batches conducted on different days.  We have achieved and maintained a monthly throughput of 1300 compd. assays representing 500 discrete compds. per instrument per mo on this platform, and it has been used to generate metabolic stability data for more than 25 000 compds. to date with an overall success rate of more than 95%.  Copyright © 2009 John Wiley & Sons, Ltd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8W1PNTqYnALVg90H21EOLACvtfcHk0lhXdTG6QY0KUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtVKmt70%253D&md5=57977322942dc41955c1d9cf015e5b05</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1002%2Frcm.4037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Frcm.4037%26sid%3Dliteratum%253Aachs%26aulast%3DKieltyka%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DVath%26aufirst%3DM.%26aulast%3DBaglieri%26aufirst%3DC.%26aulast%3DFerraro%26aufirst%3DC.%26aulast%3DZvyaga%26aufirst%3DT.%2BA.%26aulast%3DDrexler%26aufirst%3DD.%2BM.%26aulast%3DWeller%26aufirst%3DH.%2BN.%26aulast%3DShou%26aufirst%3DW.%2BZ.%26atitle%3DA%2520high-throughput%2520bioanalytical%2520platform%2520using%2520automated%2520infusion%2520for%2520tandem%2520mass%2520spectrometric%2520method%2520optimization%2520and%2520its%2520application%2520in%2520a%2520metabolic%2520stability%2520screen%26jtitle%3DRapid%2520Commun.%2520Mass%2520Spectrom.%26date%3D2009%26volume%3D23%26spage%3D1579%26epage%3D1597%26doi%3D10.1002%2Frcm.4037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 7 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Qinghe Gao, Zhenhua Sun, Qinfei Xia, Ruonan Li, Wenlong Wang, Siwei Ma, Yixin Chai, Manman Wu, Wei Hu, Péter Ábrányi-Balogh, György M. Keserű, <span class="NLM_string-name hlFld-ContribAuthor">Xinya Han</span>. </span><span class="cited-content_cbyCitation_article-title">Vinylation of α-Aminoazoles with Triethylamine: A General Strategy to Construct Azolo[1,5-a]pyrimidines with a Nonsubstituted Ethylidene Fragment. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2021,</strong> <em>23 </em>
                                    (7)
                                     , 2664-2669. <a href="https://doi.org/10.1021/acs.orglett.1c00571" title="DOI URL">https://doi.org/10.1021/acs.orglett.1c00571</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.1c00571&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.1c00571%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DVinylation%252Bof%252B%2525CE%2525B1-Aminoazoles%252Bwith%252BTriethylamine%25253A%252BA%252BGeneral%252BStrategy%252Bto%252BConstruct%252BAzolo%25255B1%25252C5-a%25255Dpyrimidines%252Bwith%252Ba%252BNonsubstituted%252BEthylidene%252BFragment%26aulast%3DGao%26aufirst%3DQinghe%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D17022021%26date%3D18032021%26volume%3D23%26issue%3D7%26spage%3D2664%26epage%3D2669" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andres  Arias-Gómez</span>, <span class="hlFld-ContribAuthor ">Andrés  Godoy</span>, <span class="hlFld-ContribAuthor ">Jaime  Portilla</span>. </span><span class="cited-content_cbyCitation_article-title">Functional Pyrazolo[1,5-a]pyrimidines: Current Approaches in Synthetic Transformations and Uses as an Antitumor Scaffold. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (9)
                                     , 2708. <a href="https://doi.org/10.3390/molecules26092708" title="DOI URL">https://doi.org/10.3390/molecules26092708</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26092708&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26092708%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DFunctional%252BPyrazolo%25255B1%25252C5-a%25255Dpyrimidines%25253A%252BCurrent%252BApproaches%252Bin%252BSynthetic%252BTransformations%252Band%252BUses%252Bas%252Ban%252BAntitumor%252BScaffold%26aulast%3DArias-G%25C3%25B3mez%26aufirst%3DAndres%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D9%26spage%3D2708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Junlin  Zhou</span>, <span class="hlFld-ContribAuthor ">Juan  Hao</span>, <span class="hlFld-ContribAuthor ">Lianxin  Peng</span>, <span class="hlFld-ContribAuthor ">Huaichuan  Duan</span>, <span class="hlFld-ContribAuthor ">Qing  Luo</span>, <span class="hlFld-ContribAuthor ">Hailian  Yan</span>, <span class="hlFld-ContribAuthor ">Hua  Wan</span>, <span class="hlFld-ContribAuthor ">Yichen  Hu</span>, <span class="hlFld-ContribAuthor ">Li  Liang</span>, <span class="hlFld-ContribAuthor ">Zhenjian  Xie</span>, <span class="hlFld-ContribAuthor ">Wei  Liu</span>, <span class="hlFld-ContribAuthor ">Gang  Zhao</span>, <span class="hlFld-ContribAuthor ">Jianping  Hu</span>, . </span><span class="cited-content_cbyCitation_article-title">Classification and Design of HIV-1 Integrase Inhibitors Based on Machine Learning. </span><span class="cited-content_cbyCitation_journal-name">Computational and Mathematical Methods in Medicine</span><span> <strong>2021,</strong> <em>2021 </em>, 1-11. <a href="https://doi.org/10.1155/2021/5559338" title="DOI URL">https://doi.org/10.1155/2021/5559338</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2021/5559338&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2021%2F5559338%26sid%3Dliteratum%253Aachs%26jtitle%3DComputational%2520and%2520Mathematical%2520Methods%2520in%2520Medicine%26atitle%3DClassification%252Band%252BDesign%252Bof%252BHIV-1%252BIntegrase%252BInhibitors%252BBased%252Bon%252BMachine%252BLearning%26aulast%3DZhou%26aufirst%3DJunlin%26date%3D2021%26volume%3D2021%26spage%3D1%26epage%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zeger  Debyser</span>, <span class="hlFld-ContribAuthor ">Anne  Bruggemans</span>, <span class="hlFld-ContribAuthor ">Siska  Van Belle</span>, <span class="hlFld-ContribAuthor ">Julie  Janssens</span>, <span class="hlFld-ContribAuthor ">Frauke  Christ</span>. </span><span class="cited-content_cbyCitation_article-title">LEDGINs, Inhibitors of the Interaction Between HIV-1 Integrase and LEDGF/p75, Are Potent Antivirals with a Potential to Cure HIV Infection. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 97-114. <a href="https://doi.org/10.1007/978-981-16-0267-2_4" title="DOI URL">https://doi.org/10.1007/978-981-16-0267-2_4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-981-16-0267-2_4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-981-16-0267-2_4%26sid%3Dliteratum%253Aachs%26atitle%3DLEDGINs%25252C%252BInhibitors%252Bof%252Bthe%252BInteraction%252BBetween%252BHIV-1%252BIntegrase%252Band%252BLEDGF%25252Fp75%25252C%252BAre%252BPotent%252BAntivirals%252Bwith%252Ba%252BPotential%252Bto%252BCure%252BHIV%252BInfection%26aulast%3DDebyser%26aufirst%3DZeger%26date%3D2021%26date%3D2021%26spage%3D97%26epage%3D114%26pub%3DSpringer%2520Singapore%26atitle%3DAntiviral%252BDrug%252BDiscovery%252Band%252BDevelopment%26aulast%3DLiu%26aufirst%3DXinyong%26date%3D2021%26volume%3D1322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Natalia A.  Elkina</span>, <span class="hlFld-ContribAuthor ">Yanina V.  Burgart</span>, <span class="hlFld-ContribAuthor ">Evgeny V.  Shchegolkov</span>, <span class="hlFld-ContribAuthor ">Olga P.  Krasnykh</span>, <span class="hlFld-ContribAuthor ">Vera V.  Maslova</span>, <span class="hlFld-ContribAuthor ">Galina A.  Triandafilova</span>, <span class="hlFld-ContribAuthor ">Sergey S.  Solodnikov</span>, <span class="hlFld-ContribAuthor ">Anna A.  Muryleva</span>, <span class="hlFld-ContribAuthor ">Maria A.  Misiurina</span>, <span class="hlFld-ContribAuthor ">Alexander V.  Slita</span>, <span class="hlFld-ContribAuthor ">Vladimir V.  Zarubaev</span>, <span class="hlFld-ContribAuthor ">Victor I.  Saloutin</span>. </span><span class="cited-content_cbyCitation_article-title">Competitive routes to cyclizations of polyfluoroalkyl-containing 2-tolylhydrazinylidene-1,3-diketones with 3-aminopyrazoles into bioactive pyrazoloazines. </span><span class="cited-content_cbyCitation_journal-name">Journal of Fluorine Chemistry</span><span> <strong>2020,</strong> <em>240 </em>, 109648. <a href="https://doi.org/10.1016/j.jfluchem.2020.109648" title="DOI URL">https://doi.org/10.1016/j.jfluchem.2020.109648</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jfluchem.2020.109648&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jfluchem.2020.109648%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Fluorine%2520Chemistry%26atitle%3DCompetitive%252Broutes%252Bto%252Bcyclizations%252Bof%252Bpolyfluoroalkyl-containing%252B2-tolylhydrazinylidene-1%25252C3-diketones%252Bwith%252B3-aminopyrazoles%252Binto%252Bbioactive%252Bpyrazoloazines%26aulast%3DElkina%26aufirst%3DNatalia%2BA.%26date%3D2020%26volume%3D240%26spage%3D109648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manoj  Patel</span>, <span class="hlFld-ContribAuthor ">Christopher  Cianci</span>, <span class="hlFld-ContribAuthor ">Christopher W.  Allard</span>, <span class="hlFld-ContribAuthor ">Dawn D.  Parker</span>, <span class="hlFld-ContribAuthor ">Jean  Simmermacher</span>, <span class="hlFld-ContribAuthor ">Susan  Jenkins</span>, <span class="hlFld-ContribAuthor ">Brian  Mcauliffe</span>, <span class="hlFld-ContribAuthor ">Beatrice  Minassian</span>, <span class="hlFld-ContribAuthor ">Linda  Discotto</span>, <span class="hlFld-ContribAuthor ">Mark  Krystal</span>, <span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>, <span class="hlFld-ContribAuthor ">B. Narasimhulu  Naidu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and SAR study of novel C2-pyrazolopyrimidine amides and amide isosteres as allosteric integrase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (21)
                                     , 127516. <a href="https://doi.org/10.1016/j.bmcl.2020.127516" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.127516</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.127516&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.127516%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252BSAR%252Bstudy%252Bof%252Bnovel%252BC2-pyrazolopyrimidine%252Bamides%252Band%252Bamide%252Bisosteres%252Bas%252Ballosteric%252Bintegrase%252Binhibitors%26aulast%3DPatel%26aufirst%3DManoj%26date%3D2020%26volume%3D30%26issue%3D21%26spage%3D127516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Prasanna  Sivaprakasam</span>, <span class="hlFld-ContribAuthor ">Zhongyu  Wang</span>, <span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>, <span class="hlFld-ContribAuthor ">Javed A.  Khan</span>, <span class="hlFld-ContribAuthor ">David R.  Langley</span>, <span class="hlFld-ContribAuthor ">Stephen R.  Johnson</span>, <span class="hlFld-ContribAuthor ">Guo  Li</span>, <span class="hlFld-ContribAuthor ">Annapurna  Pendri</span>, <span class="hlFld-ContribAuthor ">Timothy P.  Connolly</span>, <span class="hlFld-ContribAuthor ">Mian  Gao</span>, <span class="hlFld-ContribAuthor ">Daniel M.  Camac</span>, <span class="hlFld-ContribAuthor ">Cheryl  Klakouski</span>, <span class="hlFld-ContribAuthor ">Tatyana  Zvyaga</span>, <span class="hlFld-ContribAuthor ">Christopher  Cianci</span>, <span class="hlFld-ContribAuthor ">Brian  McAuliffe</span>, <span class="hlFld-ContribAuthor ">Bo  Ding</span>, <span class="hlFld-ContribAuthor ">Linda  Discotto</span>, <span class="hlFld-ContribAuthor ">Mark R.  Krystal</span>, <span class="hlFld-ContribAuthor ">Susan  Jenkins</span>, <span class="hlFld-ContribAuthor ">Kevin M.  Peese</span>, <span class="hlFld-ContribAuthor ">B.  Narasimhulu Naidu</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based amelioration of PXR transactivation in a novel series of macrocyclic allosteric inhibitors of HIV-1 integrase. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (22)
                                     , 127531. <a href="https://doi.org/10.1016/j.bmcl.2020.127531" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.127531</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.127531&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.127531%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructure-based%252Bamelioration%252Bof%252BPXR%252Btransactivation%252Bin%252Ba%252Bnovel%252Bseries%252Bof%252Bmacrocyclic%252Ballosteric%252Binhibitors%252Bof%252BHIV-1%252Bintegrase%26aulast%3DSivaprakasam%26aufirst%3DPrasanna%26date%3D2020%26volume%3D30%26issue%3D22%26spage%3D127531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01681/20200306/images/medium/jm9b01681_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01681/20200306/images/large/jm9b01681_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01681&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01681/20200306/images/medium/jm9b01681_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01681/20200306/images/large/jm9b01681_0001.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of Food and Drug Administration (FDA)-approved HIV-1 active site-targeted integrase strand transfer inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01681/20200306/images/large/jm9b01681_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01681&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01681/20200306/images/medium/jm9b01681_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01681/20200306/images/large/jm9b01681_0002.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Scaffold modification and preliminary SAR exploration associated with ALLINIs <b>2</b>–<b>6</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01681/20200306/images/large/jm9b01681_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01681&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01681/20200306/images/medium/jm9b01681_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01681/20200306/images/large/jm9b01681_0003.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Single crystal X-ray structure of (<i>S</i>,<i>S</i> and <i>R</i>,<i>R</i>)-<b>14</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01681/20200306/images/large/jm9b01681_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01681&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01681/20200306/images/medium/jm9b01681_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01681/20200306/images/large/jm9b01681_0004.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Single crystal X-ray structure of (<i>S</i>,<i>R</i> and <i>R</i>,<i>S</i>)-<b>15</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01681/20200306/images/large/jm9b01681_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01681&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01681/20200306/images/medium/jm9b01681_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01681/20200306/images/large/jm9b01681_0005.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (a) Snapshot of the cocrystal structure of (<i>S</i>,<i>S</i>)-<b>14</b> bound to the HIV-1 integrase CCD dimer. Subunits 1 and 2 of the dimer are colored cyan and green, respectively, and (<i>S</i>,<i>S</i>)-<b>14</b> is colored orange. The catalytic domain of HIV-1 integrase that contains the DDE triad is highlighted in purple patches for comparison to the LEDGF binding site where (<i>S</i>,<i>S</i>)-<b>14</b> binds crystallographically. (b) Close-up view of the binding interactions of (<i>S</i>,<i>S</i>)-<b>14</b> in one of the two LEDGF binding pockets at the dimer interface. Hydrogen atoms were added in silico followed by a restrained minimization of the X-ray structure. (c) <i>F</i><sub>o</sub> – <i>F</i><sub>c</sub> electron density map for (<i>S</i>,<i>S</i>)-<b>14</b> and surrounding water molecules contoured at 3σ.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01681/20200306/images/large/jm9b01681_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01681&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01681/20200306/images/medium/jm9b01681_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01681/20200306/images/large/jm9b01681_0006.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (a) Cocrystal structures of the dimeric HIV-1 integrase CCD bound to the LEDGF IBD. (b) Molecular modeling of substitution at the <i>meta</i>-position of the 2-phenyl group of (<i>S</i>,<i>S</i>)-<b>14</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01681/20200306/images/large/jm9b01681_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01681&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01681/20200306/images/medium/jm9b01681_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01681/20200306/images/large/jm9b01681_0007.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Pyrazolopyrimidine <b>4</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01681/20200306/images/large/jm9b01681_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01681&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (i) Methyl acetoacetate, THF, heptane, piperidine, reflux; (ii) DDQ, CH<sub>2</sub>Cl<sub>2</sub>; (b) (i) DIBAL, THF, CH<sub>2</sub>Cl<sub>2</sub>; (ii) PCC, CH<sub>2</sub>Cl<sub>2</sub>; (c) ZnI<sub>2</sub>, TMSCN, CH<sub>2</sub>Cl<sub>2</sub>; (d) HCl (conc), 90 °C; (e) (i) SOCl<sub>2</sub>, MeOH; (ii) HClO<sub>4</sub>, <i>tert</i>-butyl acetate, CH<sub>2</sub>Cl<sub>2</sub>; (iii) LiOH, 1,4-dioxane; (f) HClO<sub>4</sub>, <i>tert</i>-butyl acetate, CH<sub>2</sub>Cl<sub>2</sub>.</p></p></figure><figure data-id="sch2" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01681/20200306/images/medium/jm9b01681_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01681/20200306/images/large/jm9b01681_0008.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Pyrazolopyrimidine <b>14</b>, <b>15</b>, <b>16</b>, and <b>19</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01681/20200306/images/large/jm9b01681_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01681&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <i>p</i>-TsOH·H<sub>2</sub>O, xylene, reflux; (b) POCl<sub>3</sub>, reflux; (c) (i) KHMDS, THF, −78 °C; (ii) 2-(phenylsulfonyl)-3-phenyloxaziridine (Davis reagent); (d) HClO<sub>4</sub>, <i>tert</i>-butylacetate, CH<sub>2</sub>Cl<sub>2</sub>; (e) (i) 2-(8-fluoro-5-methylchroman-6-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, DMF, microwave, 130 °C; (ii) LiOH, 1,4-dioxane; (f) (i) Pd(PPh<sub>3</sub>)<sub>4</sub>, MeZnCl, THF; (ii) LiOH, 1,4-dioxane; (g) (i) 4,4-dimethylpiperidine, HCl salt, DIEA, NMP, 50 °C; (ii) LiOH.</p></p></figure><figure data-id="sch3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01681/20200306/images/medium/jm9b01681_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01681/20200306/images/large/jm9b01681_0009.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Pyrazolopyrimidine (<i>S</i>,<i>S</i>)- and (<i>R</i>,<i>R</i>)-<b>20</b> and -<b>25</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01681/20200306/images/large/jm9b01681_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01681&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <i>p</i>-TsOH·H<sub>2</sub>O, xylene, reflux; (b) POCl<sub>3</sub>, reflux; (c) (i) KHMDS, THF, −78 °C; (ii) 2-(phenylsulfonyl)-3-phenyloxaziridine (Davis reagent); (d) HClO<sub>4</sub>, <i>tert</i>-butyl acetate, DCM; (e) (i) <i>p</i>-tolylboronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub> (2M), DMF, microwave, 70 °C; (f) (i) 2-(8-fluoro-5-methylchroman-6-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>3</sub>PO<sub>4</sub> (2M), DMF, microwave, 130 °C; (ii) LiOH 1,4-dioxane; (g) (i) 2-([1,1′-biphenyl]-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub> (2 M), DMF, microwave, 70 °C; (ii) 4,4-dimethylpiperidine, HCl salt, DIEA, NMP, 50 °C; (iii) LiOH, 1,4-dioxane.</p></p></figure><figure data-id="sch4" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01681/20200306/images/medium/jm9b01681_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01681/20200306/images/large/jm9b01681_0010.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Chiral Synthesis of Pyrazolopyrimidine (<i>S</i>,<i>S</i>)-<b>27</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-5/acs.jmedchem.9b01681/20200306/images/large/jm9b01681_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01681&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <i>p</i>-TsOH·H<sub>2</sub>O, xylene, reflux; (b) POCl<sub>3</sub>, reflux; (c) (i) KHMDS, THF, −78 °C; (ii) 2-(phenylsulfonyl)-3-phenyloxaziridine (Davis reagent); (d) Dess–Martin periodinane, CH<sub>2</sub>Cl<sub>2</sub>; (e) (<i>R</i>)-1-methyl-3,3-diphenyltetrahydro-1<i>H</i>,3<i>H</i>-pyrrolo[1,2-<i>c</i>][1,3,2]oxazaborole, catecholborane, toluene; (f) HClO<sub>4</sub>, <i>tert</i>-butyl acetate, CH<sub>2</sub>Cl<sub>2</sub>; (g) 2-(8-fluoro-5-methylchroman-6-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>3</sub>PO<sub>4</sub> (2 M), DMF, microwave, 130 °C; (h) (i) <i>o</i>-tolylboronic acid, Pd(OAc)<sub>2</sub>, S-Phos, K<sub>3</sub>PO<sub>4</sub> (2M), DMF, microwave, 130 °C; (ii) LiOH, 1,4-dioxane.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i90">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57745" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57745" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 30 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gubernick, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felix, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamad, B.</span></span> <span> </span><span class="NLM_article-title">The HIV therapy market</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">451</span>, <span class="refDoi"> DOI: 10.1038/nrd.2016.69</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=10.1038%2Fnrd.2016.69" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=27312723" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVSjt7fL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=451&author=S.+I.+Gubernickauthor=N.+Felixauthor=D.+Leeauthor=J.+J.+Xuauthor=B.+Hamad&title=The+HIV+therapy+market&doi=10.1038%2Fnrd.2016.69"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The HIV therapy market</span></div><div class="casAuthors">Gubernick, Steven I.; Felix, Nuno; Lee, Dolim; Xu, Jing J.; Hamad, Bashar</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">451-452</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Key emerging therapies for HIV include novel combination regimens as well as extended-duration antiretroviral drugs.  This article provides an overview of novel drugs and combinations in the pipeline, as well as an anal. of the current HIV drug market.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTdefjBZ7897Vg90H21EOLACvtfcHk0ljGuf2H5h732w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVSjt7fL&md5=83e62421bc579eea958b3246d9784398</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2016.69&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2016.69%26sid%3Dliteratum%253Aachs%26aulast%3DGubernick%26aufirst%3DS.%2BI.%26aulast%3DFelix%26aufirst%3DN.%26aulast%3DLee%26aufirst%3DD.%26aulast%3DXu%26aufirst%3DJ.%2BJ.%26aulast%3DHamad%26aufirst%3DB.%26atitle%3DThe%2520HIV%2520therapy%2520market%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2016%26volume%3D15%26spage%3D451%26doi%3D10.1038%2Fnrd.2016.69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Demeulemeester, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Maeyer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debyser, Z.</span></span> <span> </span><span class="NLM_article-title">HIV-1 integrase drug discovery comes of age</span>. <i>Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">52</span>, <span class="refDoi"> DOI: 10.1007/7355_2013_33</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=10.1007%2F7355_2013_33" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2013&pages=1-52&author=J.+Demeulemeesterauthor=M.+De+Maeyerauthor=Z.+Debyser&title=HIV-1+integrase+drug+discovery+comes+of+age&doi=10.1007%2F7355_2013_33"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1007%2F7355_2013_33&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F7355_2013_33%26sid%3Dliteratum%253Aachs%26aulast%3DDemeulemeester%26aufirst%3DJ.%26aulast%3DDe%2BMaeyer%26aufirst%3DM.%26aulast%3DDebyser%26aufirst%3DZ.%26atitle%3DHIV-1%2520integrase%2520drug%2520discovery%2520comes%2520of%2520age%26jtitle%3DTop.%2520Med.%2520Chem.%26date%3D2013%26volume%3D15%26spage%3D1%26epage%3D52%26doi%3D10.1007%2F7355_2013_33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Christ, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debyser, Z.</span></span> <span> </span><span class="NLM_article-title">The LEDGF/p75 integrase interaction, a novel target for anti-HIV therapy</span>. <i>Virology</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>435</i></span>,  <span class="NLM_fpage">102</span>– <span class="NLM_lpage">109</span>, <span class="refDoi"> DOI: 10.1016/j.virol.2012.09.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=10.1016%2Fj.virol.2012.09.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=23217620" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVaju7nN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=435&publication_year=2013&pages=102-109&author=F.+Christauthor=Z.+Debyser&title=The+LEDGF%2Fp75+integrase+interaction%2C+a+novel+target+for+anti-HIV+therapy&doi=10.1016%2Fj.virol.2012.09.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The LEDGF/p75 integrase interaction, a novel target for anti-HIV therapy</span></div><div class="casAuthors">Christ, Frauke; Debyser, Zeger</div><div class="citationInfo"><span class="NLM_cas:title">Virology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">435</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">102-109</span>CODEN:
                <span class="NLM_cas:coden">VIRLAX</span>;
        ISSN:<span class="NLM_cas:issn">0042-6822</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  To accomplish their viral life cycle, lentiviruses such as HIV highjack host proteins, the so-called cellular co-factors of replication.  Lens Epithelium-derived Growth factor (LEDGF/p75), a transcriptional co-activator, is a co-factor of HIV-integrase (IN) and is required for the tethering and correct integration of the viral genome into the host chromatin.  Due to its important role in HIV-replication the LEDGF/p75-IN interaction is an attractive antiviral novel target for the treatment of HIV/AIDS.  Intensive drug discovery efforts over the past years have validated the LEDGF/p75-IN interaction as a drugable target for antiviral therapy and have resulted in the design and synthesis of LEDGINs, small mol. inhibitors binding to the dimer interface of HIV-integrase and inhibiting viral replication with a dual mechanism of action: potent inhibition of the LEDGF/p75-IN protein-protein interaction and allosteric inhibition of the catalytic function.  Furthermore they inhibit both early and late steps of the replication cycle which increases their potential for further clin. development.  In this review the authors will highlight the research validating the LEDGF/p75-IN interaction as a target for anti-HIV drug discovery and the recent advances in the design and development of LEDGINs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_mTW5TAo2y7Vg90H21EOLACvtfcHk0ljGuf2H5h732w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVaju7nN&md5=2249c51a1792bc8edc5ce449500e6627</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.virol.2012.09.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.virol.2012.09.033%26sid%3Dliteratum%253Aachs%26aulast%3DChrist%26aufirst%3DF.%26aulast%3DDebyser%26aufirst%3DZ.%26atitle%3DThe%2520LEDGF%252Fp75%2520integrase%2520interaction%252C%2520a%2520novel%2520target%2520for%2520anti-HIV%2520therapy%26jtitle%3DVirology%26date%3D2013%26volume%3D435%26spage%3D102%26epage%3D109%26doi%3D10.1016%2Fj.virol.2012.09.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Engelman, A. E.</span></span> <span> </span><span class="NLM_article-title">Multifaceted HIV integrase functionalities and therapeutic strategies for their inhibition</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>294</i></span>,  <span class="NLM_fpage">15137</span>– <span class="NLM_lpage">15157</span>, <span class="refDoi"> DOI: 10.1074/jbc.REV119.006901</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=10.1074%2Fjbc.REV119.006901" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=31467082" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=1%3ACAS%3A528%3ADC%252BC1MXit1yltLzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=294&publication_year=2019&pages=15137-15157&author=A.+E.+Engelman&title=Multifaceted+HIV+integrase+functionalities+and+therapeutic+strategies+for+their+inhibition&doi=10.1074%2Fjbc.REV119.006901"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Multifaceted HIV integrase functionalities and therapeutic strategies for their inhibition</span></div><div class="casAuthors">Engelman, Alan N.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">294</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">15137-15157</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">A review.  Antiretroviral inhibitors that are used to manage HIV infection/AIDS predominantly target three enzymes required for virus replication: reverse transcriptase, protease, and integrase.  Although integrase inhibitors were the last among this group to be approved for treating people living with HIV, they have since risen to the forefront of treatment options.  Integrase strand transfer inhibitors (INSTIs) are now recommended components of frontline and drug-switch antiretroviral therapy formulations.  Integrase catalyzes two successive magnesium-dependent polynucleotidyl transferase reactions, 3' processing and strand transfer, and INSTIs tightly bind the divalent metal ions and viral DNA end after 3' processing, displacing from the integrase active site the DNA 3'-hydroxyl group that is required for strand transfer activity.  Although second-generation INSTIs present higher barriers to the development of viral drug resistance than first-generation compds., the mechanisms underlying these superior barrier profiles are incompletely understood.  A sep. class of HIV-1 integrase inhibitors, the allosteric integrase inhibitors (ALLINIs), engage integrase distal from the enzyme active site, namely at the binding site for the cellular cofactor lens epithelium-derived growth factor (LEDGF)/p75 that helps to guide integration into host genes.  ALLINIs inhibit HIV-1 replication by inducing integrase hypermultimerization, which precludes integrase binding to genomic RNA and perturbs the morphogenesis of new viral particles.  Although not yet approved for human use, ALLINIs provide important probes that can be used to investigate the link between HIV-1 integrase and viral particle morphogenesis.  Herein, I review the mechanisms of retroviral integration as well as the promises and challenges of using integrase inhibitors for HIV/AIDS management.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0Q3IXGz5Hc7Vg90H21EOLACvtfcHk0lhHTzXAJ9Oo9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXit1yltLzE&md5=90801bc3dfde7cfc8936113649d83910</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1074%2Fjbc.REV119.006901&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.REV119.006901%26sid%3Dliteratum%253Aachs%26aulast%3DEngelman%26aufirst%3DA.%2BE.%26atitle%3DMultifaceted%2520HIV%2520integrase%2520functionalities%2520and%2520therapeutic%2520strategies%2520for%2520their%2520inhibition%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2019%26volume%3D294%26spage%3D15137%26epage%3D15157%26doi%3D10.1074%2Fjbc.REV119.006901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Poeschla, E. M.</span></span> <span> </span><span class="NLM_article-title">Integrase, LEDGF/p75 and HIV replication</span>. <i>Cell. Mol. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">1403</span>– <span class="NLM_lpage">1424</span>, <span class="refDoi"> DOI: 10.1007/s00018-008-7540-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=10.1007%2Fs00018-008-7540-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=18264802" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=1%3ACAS%3A528%3ADC%252BD1cXltFyhu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2008&pages=1403-1424&author=E.+M.+Poeschla&title=Integrase%2C+LEDGF%2Fp75+and+HIV+replication&doi=10.1007%2Fs00018-008-7540-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Integrase, LEDGF/p75 and HIV replication</span></div><div class="casAuthors">Poeschla, E. M.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1403-1424</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Verlag</span>)
        </div><div class="casAbstract">A review.  HIV integrates a DNA copy of its genome into a host cell chromosome in each replication cycle.  The essential DNA cleaving and joining chem. of integration is known, but there is less understanding of the process as it occurs in a cell, where two complex and dynamic macromol. entities are joined: the viral pre-integration complex and chromatin.  Among implicated cellular factors, much recent attention has coalesced around LEDGF/p75, a nuclear protein that may act as a chromatin docking factor or receptor for lentiviral pre-integration complexes.  LEDGF/p75 tethers HIV integrase to chromatin, protects it from degrdn., and strongly influences the genome-wide pattern of HIV integration.  Depleting the protein from cells and/or over-expressing its integrase-binding domain blocks viral replication.  Current goals are to establish the underlying mechanisms and to det. whether this knowledge can be exploited for antiviral therapy or for targeting lentiviral vector integration in human gene therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhiwI_GBCtWrVg90H21EOLACvtfcHk0ljsXW7zun0Qxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXltFyhu7s%253D&md5=87fda953018faed92a13cdc2d1322ce9</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1007%2Fs00018-008-7540-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-008-7540-5%26sid%3Dliteratum%253Aachs%26aulast%3DPoeschla%26aufirst%3DE.%2BM.%26atitle%3DIntegrase%252C%2520LEDGF%252Fp75%2520and%2520HIV%2520replication%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2008%26volume%3D65%26spage%3D1403%26epage%3D1424%26doi%3D10.1007%2Fs00018-008-7540-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emiliani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mousnier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Busschots, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maroun, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Maele, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tempe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandekerckhove, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moisant, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ben-Slama, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witvrouw, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christ, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rain, J.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dargemont, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debyser, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benarous, R.</span></span> <span> </span><span class="NLM_article-title">Integrase mutants defective for interaction with LEDGF/p75 are impaired in chromosome tethering and HIV-1 replication</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">25517</span>– <span class="NLM_lpage">25523</span>, <span class="refDoi"> DOI: 10.1074/jbc.M501378200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=10.1074%2Fjbc.M501378200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=15855167" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlslylurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=25517-25523&author=S.+Emilianiauthor=A.+Mousnierauthor=K.+Busschotsauthor=M.+Marounauthor=B.+Van+Maeleauthor=D.+Tempeauthor=L.+Vandekerckhoveauthor=F.+Moisantauthor=L.+Ben-Slamaauthor=M.+Witvrouwauthor=F.+Christauthor=J.-C.+Rainauthor=C.+Dargemontauthor=Z.+Debyserauthor=R.+Benarous&title=Integrase+mutants+defective+for+interaction+with+LEDGF%2Fp75+are+impaired+in+chromosome+tethering+and+HIV-1+replication&doi=10.1074%2Fjbc.M501378200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Integrase Mutants Defective for Interaction with LEDGF/p75 Are Impaired in Chromosome Tethering and HIV-1 Replication</span></div><div class="casAuthors">Emiliani, Stephane; Mousnier, Aurelie; Busschots, Katrien; Maroun, Marlene; Van Maele, Benedicte; Tempe, Denis; Vandekerckhove, Linos; Moisant, Fanny; Ben-Slama, Lilia; Witvrouw, Myriam; Christ, Frauke; Rain, Jean-Christophe; Dargemont, Catherine; Debyser, Zeger; Benarous, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">25517-25523</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The insertion of a DNA copy of its RNA genome into a chromosome of the host cell is mediated by the viral integrase with the help of mostly uncharacterized cellular cofactors.  The authors have recently described that the transcriptional co-activator LEDGF/p75 strongly interacts with HIV-1 integrase.  Here the authors show that interaction of HIV-1 integrase with LEDGF/p75 is important for viral replication.  Using multiple approaches including two-hybrid interaction studies, random and directed mutagenesis, the authors could demonstrate that HIV-1 virus harboring a single mutation that disrupts integrase-LEDGF/p75 interaction, resulted in defective HIV-1 replication.  Furthermore, the authors found that LEDGF/p75 tethers HIV-1 integrase to chromosomes and that this interaction may be important for the integration process and the replication of HIV-1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzM3afp0-QirVg90H21EOLACvtfcHk0ljiBS6wq0qgYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlslylurs%253D&md5=bfb817b7b839abb70183377eb843ebe2</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M501378200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M501378200%26sid%3Dliteratum%253Aachs%26aulast%3DEmiliani%26aufirst%3DS.%26aulast%3DMousnier%26aufirst%3DA.%26aulast%3DBusschots%26aufirst%3DK.%26aulast%3DMaroun%26aufirst%3DM.%26aulast%3DVan%2BMaele%26aufirst%3DB.%26aulast%3DTempe%26aufirst%3DD.%26aulast%3DVandekerckhove%26aufirst%3DL.%26aulast%3DMoisant%26aufirst%3DF.%26aulast%3DBen-Slama%26aufirst%3DL.%26aulast%3DWitvrouw%26aufirst%3DM.%26aulast%3DChrist%26aufirst%3DF.%26aulast%3DRain%26aufirst%3DJ.-C.%26aulast%3DDargemont%26aufirst%3DC.%26aulast%3DDebyser%26aufirst%3DZ.%26aulast%3DBenarous%26aufirst%3DR.%26atitle%3DIntegrase%2520mutants%2520defective%2520for%2520interaction%2520with%2520LEDGF%252Fp75%2520are%2520impaired%2520in%2520chromosome%2520tethering%2520and%2520HIV-1%2520replication%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D25517%26epage%3D25523%26doi%3D10.1074%2Fjbc.M501378200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Busschots, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voet, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Maeyer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rain, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emiliani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benarous, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desender, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debyser, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christ, F.</span></span> <span> </span><span class="NLM_article-title">Identification of the LEDGF/p75 binding site in HIV-1 integrase</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>365</i></span>,  <span class="NLM_fpage">1480</span>– <span class="NLM_lpage">1492</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2006.10.094</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=10.1016%2Fj.jmb.2006.10.094" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=17137594" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=1%3ACAS%3A528%3ADC%252BD2sXls12nsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=365&publication_year=2007&pages=1480-1492&author=K.+Busschotsauthor=A.+Voetauthor=M.+De+Maeyerauthor=J.+C.+Rainauthor=S.+Emilianiauthor=R.+Benarousauthor=L.+Desenderauthor=Z.+Debyserauthor=F.+Christ&title=Identification+of+the+LEDGF%2Fp75+binding+site+in+HIV-1+integrase&doi=10.1016%2Fj.jmb.2006.10.094"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of the LEDGF/p75 Binding Site in HIV-1 Integrase</span></div><div class="casAuthors">Busschots, Katrien; Voet, Arnout; De Maeyer, Marc; Rain, Jean-Christophe; Emiliani, Stephane; Benarous, Richard; Desender, Linda; Debyser, Zeger; Christ, Frauke</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">365</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1480-1492</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Lens epithelium-derived growth factor (LEDGF)/p75 is an important cellular co-factor for human immunodeficiency virus (HIV) replication.  We originally identified LEDGF/p75 as a binding partner of integrase (IN) in human cells.  The interaction has been mapped to the integrase-binding domain (IBD) of LEDGF/p75 located in the C-terminal part.  We have subsequently shown that IN carrying the Q168A mutation remains enzymically active but is impaired for interaction with LEDGF/p75.  To map the integrase/LEDGF interface in more detail, we have now identified and characterized two regions within the enzyme involved in the interaction with LEDGF/p75.  The first region centers around residues W131 and W132 while the second extends from I161 up to E170.  For the different IN mutants the interaction with LEDGF/p75 and the enzymic activities were detd.  IN(W131A), IN(I161A), IN(R166A), IN(Q168A) and IN(E170A) are impaired for interaction with LEDGF/p75, but retain 3' processing and strand transfer activities.  Due to impaired integration, an HIV-1 strain contg. the W131A mutation in IN displays reduced replication capacity, whereas virus carrying IN(Q168A) is replication defective.  Comparison of the wild-type IN-LEDGF/p75 co-crystal structure with that of the modelled structure of the IN(Q168A) and IN(W131A) mutant integrases corroborated our exptl. data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDwOlPntfkJbVg90H21EOLACvtfcHk0ljiBS6wq0qgYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXls12nsA%253D%253D&md5=6e41029f4dd3d56546d484c33d4549a7</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2006.10.094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2006.10.094%26sid%3Dliteratum%253Aachs%26aulast%3DBusschots%26aufirst%3DK.%26aulast%3DVoet%26aufirst%3DA.%26aulast%3DDe%2BMaeyer%26aufirst%3DM.%26aulast%3DRain%26aufirst%3DJ.%2BC.%26aulast%3DEmiliani%26aufirst%3DS.%26aulast%3DBenarous%26aufirst%3DR.%26aulast%3DDesender%26aufirst%3DL.%26aulast%3DDebyser%26aufirst%3DZ.%26aulast%3DChrist%26aufirst%3DF.%26atitle%3DIdentification%2520of%2520the%2520LEDGF%252Fp75%2520binding%2520site%2520in%2520HIV-1%2520integrase%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2007%26volume%3D365%26spage%3D1480%26epage%3D1492%26doi%3D10.1016%2Fj.jmb.2006.10.094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Rijck, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandekerckhove, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsbers, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hombrouck, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendrix, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vercammen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engelborghs, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christ, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debyser, Z.</span></span> <span> </span><span class="NLM_article-title">Overexpression of the lens epithelium-derived growth factor/p75 integrase binding domain inhibits human immunodeficiency virus replication</span>. <i>J. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">11498</span>– <span class="NLM_lpage">11509</span>, <span class="refDoi"> DOI: 10.1128/JVI.00801-06</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=10.1128%2FJVI.00801-06" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=16987986" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht12hu7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2006&pages=11498-11509&author=J.+De%0ARijckauthor=L.+Vandekerckhoveauthor=R.+Gijsbersauthor=A.+Hombrouckauthor=J.+Hendrixauthor=J.+Vercammenauthor=Y.+Engelborghsauthor=F.+Christauthor=Z.+Debyser&title=Overexpression+of+the+lens+epithelium-derived+growth+factor%2Fp75+integrase+binding+domain+inhibits+human+immunodeficiency+virus+replication&doi=10.1128%2FJVI.00801-06"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpression of the lens epithelium-derived growth factor/p75 integrase binding domain inhibits human immunodeficiency virus replication</span></div><div class="casAuthors">De Rijck, Jan; Vandekerckhove, Linos; Gijsbers, Rik; Hombrouck, Anneleen; Hendrix, Jelle; Vercammen, Jo; Engelborghs, Yves; Christ, Frauke; Debyser, Zeger</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">11498-11509</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">We initially identified lens epithelium-derived growth factor/p75 (LEDGF/p75) as a binding partner of human immunodeficiency virus type 1 (HIV-1) integrase.  To investigate the role of LEDGF/p75 in HIV replication and its potential as a new antiviral target, we stably overexpressed two different fragments contg. the integrase binding domain (IBD) of LEDGF/p75 fused to enhanced green fluorescent protein (eGFP).  HIV-1 replication was severely inhibited by overexpression of the eGFP-IBD fusion proteins, while no inhibition was obsd. in cell lines overexpressing the interaction-deficient D366A mutant.  Quant. PCR pinpointed the block to the integration step, whereas nuclear import was not affected.  Competition of the IBD fusion proteins with endogenous LEDGF/p75 for binding to integrase led to a potent defect in HIV-1 replication in both HeLaP4- and MT-4-derived cell lines.  A previously described diketo acid-resistant HIV-1 strain remained fully susceptible to inhibition, suggesting that this strategy will also work in patients who harbor strains resistant to the current exptl. integrase inhibitors.  These data support LEDGF/p75 as an important cofactor for HIV replication and provide proof of concept for the LEDGF/p75-integrase interaction as a novel target for treating HIV-1 infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzpWZpQsxg27Vg90H21EOLACvtfcHk0lhxU7wQhieNpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht12hu7vJ&md5=1ee6c9f0fa7765de3b41a615e54673f3</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1128%2FJVI.00801-06&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.00801-06%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BRijck%26aufirst%3DJ.%26aulast%3DVandekerckhove%26aufirst%3DL.%26aulast%3DGijsbers%26aufirst%3DR.%26aulast%3DHombrouck%26aufirst%3DA.%26aulast%3DHendrix%26aufirst%3DJ.%26aulast%3DVercammen%26aufirst%3DJ.%26aulast%3DEngelborghs%26aufirst%3DY.%26aulast%3DChrist%26aufirst%3DF.%26aulast%3DDebyser%26aufirst%3DZ.%26atitle%3DOverexpression%2520of%2520the%2520lens%2520epithelium-derived%2520growth%2520factor%252Fp75%2520integrase%2520binding%2520domain%2520inhibits%2520human%2520immunodeficiency%2520virus%2520replication%26jtitle%3DJ.%2520Virol.%26date%3D2006%26volume%3D80%26spage%3D11498%26epage%3D11509%26doi%3D10.1128%2FJVI.00801-06" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Llano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saenz, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meehan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wongthida, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peretz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poeschla, E. M.</span></span> <span> </span><span class="NLM_article-title">An essential role for LEDGF/p75 in HIV integration</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>314</i></span>,  <span class="NLM_fpage">461</span>– <span class="NLM_lpage">464</span>, <span class="refDoi"> DOI: 10.1126/science.1132319</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=10.1126%2Fscience.1132319" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=16959972" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVyqtr3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=314&publication_year=2006&pages=461-464&author=M.+Llanoauthor=D.+T.+Saenzauthor=A.+Meehanauthor=P.+Wongthidaauthor=M.+Peretzauthor=W.+H.+Walkerauthor=W.+Teoauthor=E.+M.+Poeschla&title=An+essential+role+for+LEDGF%2Fp75+in+HIV+integration&doi=10.1126%2Fscience.1132319"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">An Essential Role for LEDGF/p75 in HIV Integration</span></div><div class="casAuthors">Llano, Manuel; Saenz, Dyana T.; Meehan, Anne; Wongthida, Phonphimon; Peretz, Mary; Walker, William H.; Teo, Wulin; Poeschla, Eric M.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">314</span>
        (<span class="NLM_cas:issue">5798</span>),
    <span class="NLM_cas:pages">461-464</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Chromosomal integration enables human immunodeficiency virus (HIV) to establish a permanent reservoir that can be therapeutically suppressed but not eradicated.  Participation of cellular proteins in this obligate replication step is poorly understood.  We used intensified RNA interference and dominant-neg. protein approaches to show that the cellular transcriptional coactivator lens epithelium-derived growth factor (LEDGF)/p75 (p75) is an essential HIV integration cofactor.  The mechanism requires both linkages of a mol. tether that p75 forms between integrase and chromatin.  Fractionally minute levels of endogenous p75 are sufficient to enable integration, showing that cellular factors that engage HIV after entry may elude identification in less intensive knockdowns.  Perturbing the p75-integrase interaction may have therapeutic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRKqlWtCPsYbVg90H21EOLACvtfcHk0lhxU7wQhieNpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVyqtr3O&md5=fe62c3d583b14c92eca29654895c9691</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1126%2Fscience.1132319&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1132319%26sid%3Dliteratum%253Aachs%26aulast%3DLlano%26aufirst%3DM.%26aulast%3DSaenz%26aufirst%3DD.%2BT.%26aulast%3DMeehan%26aufirst%3DA.%26aulast%3DWongthida%26aufirst%3DP.%26aulast%3DPeretz%26aufirst%3DM.%26aulast%3DWalker%26aufirst%3DW.%2BH.%26aulast%3DTeo%26aufirst%3DW.%26aulast%3DPoeschla%26aufirst%3DE.%2BM.%26atitle%3DAn%2520essential%2520role%2520for%2520LEDGF%252Fp75%2520in%2520HIV%2520integration%26jtitle%3DScience%26date%3D2006%26volume%3D314%26spage%3D461%26epage%3D464%26doi%3D10.1126%2Fscience.1132319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jurado, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slaughter, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kessl, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koh, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballandras-Colas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuchs, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kvaratskhelia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engelman, A.</span></span> <span> </span><span class="NLM_article-title">Allosteric integrase inhibitor potency is determined through the inhibition of HIV-1 particle maturation</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">8690</span>– <span class="NLM_lpage">8695</span>, <span class="refDoi"> DOI: 10.1073/pnas.1300703110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=10.1073%2Fpnas.1300703110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=23610442" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFSjt7nO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=8690-8695&author=K.+A.+Juradoauthor=H.+Wangauthor=A.+Slaughterauthor=L.+Fengauthor=J.+J.+Kesslauthor=Y.+Kohauthor=W.+Wangauthor=A.+Ballandras-Colasauthor=P.+A.+Patelauthor=J.+R.+Fuchsauthor=M.+Kvaratskheliaauthor=A.+Engelman&title=Allosteric+integrase+inhibitor+potency+is+determined+through+the+inhibition+of+HIV-1+particle+maturation&doi=10.1073%2Fpnas.1300703110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric integrase inhibitor potency is determined through the inhibition of HIV-1 particle maturation</span></div><div class="casAuthors">Jurado, Kellie A.; Wang, Hao; Slaughter, Alison; Feng, Lei; Kessl, Jacques J.; Koh, Yasuhiro; Wang, Weifeng; Ballandras-Colas, Allison; Patel, Pratiq A.; Fuchs, James R.; Kvaratskhelia, Mamuka; Engelman, Alan</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">8690-8695, S8690/1-S8690/7</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Integration is essential for HIV-1 replication, and the viral integrase (IN) protein is an important therapeutic target.  Allosteric IN inhibitors (ALUNIs) that engage the IN dimer interface at the binding site for the host protein lens epithelium-derived growth factor (LEDGF)/ transcriptional coactivator p75 are an emerging class of small mol. antagonists.  Consistent with the inhibition of a multivalent drug target, ALLINIs display steep antiviral dose-response curves ex vivo.  ALUNIs multimerize IN protein and concordantly block its assembly with viral DNA in vitro, indicating that the disruption of two integration-assocd. functions, IN catalysis and the IN-LEDGF/p75 interaction, dets. the multimode mechanism of ALUNI action.  We now demonstrate that ALLINI potency is unexpectedly accounted for during the late phase of HIV-1 replication.  The compds. promote virion IN multimerization and, reminiscent of class II IN mutations, block the formation of the electron-dense viral core and inhibit reverse transcription and integration in subsequently infected target cells.  Mature virions are recalcitrant to ALLINI treatment and compd. potency during virus prodn. is independent of the level of LEDGF/p75 expression.  We conclude that cooperative multimerization of IN by ALLINIs together with the inability for LEDGF/p75 to effectively engage the virus during its egress from cells underscores the multimodal mechanism of ALLINI action.  Our results highlight the versatile nature of allosteric inhibitors to primarily inhibit viral replication at a step that is distinct from the catalytic requirement for the target enzyme.  The vulnerability of IN to small mols. during the late phase of HIV-1 replication unveils a pharmacol. Achilles' heel for exploitation in clin. ALLINI development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiAzDFbZo0ALVg90H21EOLACvtfcHk0lgxXrkwYA0rcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFSjt7nO&md5=ec563f39468aabeae04685971722b070</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1300703110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1300703110%26sid%3Dliteratum%253Aachs%26aulast%3DJurado%26aufirst%3DK.%2BA.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DSlaughter%26aufirst%3DA.%26aulast%3DFeng%26aufirst%3DL.%26aulast%3DKessl%26aufirst%3DJ.%2BJ.%26aulast%3DKoh%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DBallandras-Colas%26aufirst%3DA.%26aulast%3DPatel%26aufirst%3DP.%2BA.%26aulast%3DFuchs%26aufirst%3DJ.%2BR.%26aulast%3DKvaratskhelia%26aufirst%3DM.%26aulast%3DEngelman%26aufirst%3DA.%26atitle%3DAllosteric%2520integrase%2520inhibitor%2520potency%2520is%2520determined%2520through%2520the%2520inhibition%2520of%2520HIV-1%2520particle%2520maturation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3D8690%26epage%3D8695%26doi%3D10.1073%2Fpnas.1300703110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slaughter, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jena, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koh, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shkriabai, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larue, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitsuya, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kessl, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engelman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuchs, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kvaratskhelia, M.</span></span> <span> </span><span class="NLM_article-title">The A128T resistance mutation reveals aberrant protein multimerization as the primary mechanism of action of allosteric HIV-1integrase inhibitors</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>288</i></span>,  <span class="NLM_fpage">15813</span>– <span class="NLM_lpage">15820</span>, <span class="refDoi"> DOI: 10.1074/jbc.M112.443390</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=10.1074%2Fjbc.M112.443390" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=23615903" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=1%3ACAS%3A528%3ADC%252BC3sXosFyktL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2013&pages=15813-15820&author=L.+Fengauthor=A.+Sharmaauthor=A.+Slaughterauthor=N.+Jenaauthor=Y.+Kohauthor=N.+Shkriabaiauthor=R.+C.+Larueauthor=P.+A.+Patelauthor=H.+Mitsuyaauthor=J.+J.+Kesslauthor=A.+Engelmanauthor=J.+R.+Fuchsauthor=M.+Kvaratskhelia&title=The+A128T+resistance+mutation+reveals+aberrant+protein+multimerization+as+the+primary+mechanism+of+action+of+allosteric+HIV-1integrase+inhibitors&doi=10.1074%2Fjbc.M112.443390"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The A128T Resistance Mutation Reveals Aberrant Protein Multimerization as the Primary Mechanism of Action of Allosteric HIV-1 Integrase Inhibitors</span></div><div class="casAuthors">Feng, Lei; Sharma, Amit; Slaughter, Alison; Jena, Nivedita; Koh, Yasuhiro; Shkriabai, Nikolozi; Larue, Ross C.; Patel, Pratiq A.; Mitsuya, Hiroaki; Kessl, Jacques J.; Engelman, Alan; Fuchs, James R.; Kvaratskhelia, Mamuka</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">288</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">15813-15820</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Allosteric HIV-1 integrase (IN) inhibitors (ALLINIs) are a very promising new class of anti-HIV-1 agents that exhibit a multimodal mechanism of action by allosterically modulating IN multimerization and interfering with IN-lens epithelium-derived growth factor (LEDGF)/p75 binding.  Selection of viral strains under ALLINI pressure has revealed an A128T substitution in HIV-1 IN as a primary mechanism of resistance.  Here, the authors elucidated the structural and mechanistic basis for this resistance.  The A128T substitution did not affect the hydrogen bonding between ALLINI and IN that mimics the IN-LEDGF/p75 interaction but instead altered the positioning of the inhibitor at the IN dimer interface.  Consequently, the A128T substitution had only a minor effect on the ALLINI IC50 values for IN-LEDGF/p75 binding.  Instead, ALLINIs markedly altered the multimerization of IN by promoting aberrant higher order WT (but not A128T) IN oligomers.  Accordingly, WT IN catalytic activities and HIV-1 replication were potently inhibited by ALLINIs, whereas the A128T substitution in IN resulted in significant resistance to the inhibitors both in vitro and in cell culture assays.  The differential multimerization of WT and A128T INs induced by ALLINIs correlated with the differences in infectivity of HIV-1 progeny virions.  The authors conclude that ALLINIs primarily target IN multimerization rather than IN-LEDGF/p75 binding.  The authors' findings provide the structural foundations for developing improved ALLINIs with increased potency and decreased potential to select for drug resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE64Fk1-DKebVg90H21EOLACvtfcHk0ljsRn4QSYvf4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXosFyktL0%253D&md5=f33a3921b5aaa7b2f94a39ccaea84cc8</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M112.443390&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M112.443390%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DL.%26aulast%3DSharma%26aufirst%3DA.%26aulast%3DSlaughter%26aufirst%3DA.%26aulast%3DJena%26aufirst%3DN.%26aulast%3DKoh%26aufirst%3DY.%26aulast%3DShkriabai%26aufirst%3DN.%26aulast%3DLarue%26aufirst%3DR.%2BC.%26aulast%3DPatel%26aufirst%3DP.%2BA.%26aulast%3DMitsuya%26aufirst%3DH.%26aulast%3DKessl%26aufirst%3DJ.%2BJ.%26aulast%3DEngelman%26aufirst%3DA.%26aulast%3DFuchs%26aufirst%3DJ.%2BR.%26aulast%3DKvaratskhelia%26aufirst%3DM.%26atitle%3DThe%2520A128T%2520resistance%2520mutation%2520reveals%2520aberrant%2520protein%2520multimerization%2520as%2520the%2520primary%2520mechanism%2520of%2520action%2520of%2520allosteric%2520HIV-1integrase%2520inhibitors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2013%26volume%3D288%26spage%3D15813%26epage%3D15820%26doi%3D10.1074%2Fjbc.M112.443390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Desimmie, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schrijvers, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demeulemeester, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borrenberghs, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weydert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thys, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vets, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Remoortel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofkens, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Rijck, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendrix, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bannert, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gijsbers, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christ, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debyser, Z.</span></span> <span> </span><span class="NLM_article-title">LEDGINs inhibit late stage HIV-1 replication by modulating integrase multimerization in the virions</span>. <i>Retrovirology</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">57</span>, <span class="refDoi"> DOI: 10.1186/1742-4690-10-57</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=10.1186%2F1742-4690-10-57" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=23721378" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpvFGkur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2013&pages=57&author=B.+A.+Desimmieauthor=R.+Schrijversauthor=J.+Demeulemeesterauthor=D.+Borrenberghsauthor=C.+Weydertauthor=W.+Thysauthor=S.+Vetsauthor=B.+Van+Remoortelauthor=J.+Hofkensauthor=J.+De+Rijckauthor=J.+Hendrixauthor=N.+Bannertauthor=R.+Gijsbersauthor=F.+Christauthor=Z.+Debyser&title=LEDGINs+inhibit+late+stage+HIV-1+replication+by+modulating+integrase+multimerization+in+the+virions&doi=10.1186%2F1742-4690-10-57"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">LEDGINs inhibit late stage HIV-1 replication by modulating integrase multimerization in the virions</span></div><div class="casAuthors">Desimmie, Belete Ayele; Schrijvers, Rik; Demeulemeester, Jonas; Borrenberghs, Doortje; Weydert, Caroline; Thys, Wannes; Vets, Sofie; Van Remoortel, Barbara; Hofkens, Johan; De Rijck, Jan; Hendrix, Jelle; Bannert, Norbert; Gijsbers, Rik; Christ, Frauke; Debyser, Zeger</div><div class="citationInfo"><span class="NLM_cas:title">Retrovirology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">57</span>CODEN:
                <span class="NLM_cas:coden">RETRBO</span>;
        ISSN:<span class="NLM_cas:issn">1742-4690</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">LEDGINs are novel allosteric HIV integrase (IN) inhibitors that target the lens epithelium-derived growth factor (LEDGF)/p75 binding pocket of IN.  They block HIV-1 integration by abrogating the interaction between LEDGF/p75 and IN as well as by allosterically inhibiting the catalytic activity of IN.  Here we demonstrate that LEDGINs reduce the replication capacity of HIV particles produced in their presence.  We systematically studied the mol. basis of this late effect of LEDGINs and demonstrate that HIV virions produced in their presence display a severe replication defect.  Both the late effect and the previously described, early effect on integration contribute to LEDGIN antiviral activity as shown by time-of-addn., qPCR and infectivity assays.  The late effect phenotype requires binding of LEDGINs to integrase without influencing proteolytic cleavage or prodn. of viral particles.  LEDGINs augment IN multimerization during virion assembly or in the released viral particles and severely hamper the infectivity of progeny virions.  About 70% of the particles produced in LEDGIN-treated cells do not form a core or display aberrant empty cores with a mislocalized electron-dense ribonucleoprotein.  The LEDGIN-treated virus displays defective reverse transcription and nuclear import steps in the target cells.  The LEDGIN effect is possibly exerted at the level of the Pol precursor polyprotein.  Our results suggest that LEDGINs modulate IN multimerization in progeny virions and impair the formation of regular cores during the maturation step, resulting in a decreased infectivity of the viral particles in the target cells.  LEDGINs thus profile as unique antivirals with combined early (integration) and late (IN assembly) effects on the HIV replication cycle.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxfs8rqLNsR7Vg90H21EOLACvtfcHk0lhPyX7zeuujxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpvFGkur0%253D&md5=a89a453220c3f8cd51338018b430b9fd</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1186%2F1742-4690-10-57&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1742-4690-10-57%26sid%3Dliteratum%253Aachs%26aulast%3DDesimmie%26aufirst%3DB.%2BA.%26aulast%3DSchrijvers%26aufirst%3DR.%26aulast%3DDemeulemeester%26aufirst%3DJ.%26aulast%3DBorrenberghs%26aufirst%3DD.%26aulast%3DWeydert%26aufirst%3DC.%26aulast%3DThys%26aufirst%3DW.%26aulast%3DVets%26aufirst%3DS.%26aulast%3DVan%2BRemoortel%26aufirst%3DB.%26aulast%3DHofkens%26aufirst%3DJ.%26aulast%3DDe%2BRijck%26aufirst%3DJ.%26aulast%3DHendrix%26aufirst%3DJ.%26aulast%3DBannert%26aufirst%3DN.%26aulast%3DGijsbers%26aufirst%3DR.%26aulast%3DChrist%26aufirst%3DF.%26aulast%3DDebyser%26aufirst%3DZ.%26atitle%3DLEDGINs%2520inhibit%2520late%2520stage%2520HIV-1%2520replication%2520by%2520modulating%2520integrase%2520multimerization%2520in%2520the%2520virions%26jtitle%3DRetrovirology%26date%3D2013%26volume%3D10%26spage%3D57%26doi%3D10.1186%2F1742-4690-10-57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Le
Rouzic, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnard, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chasset, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruneau, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chevreuil, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Strat, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beauvoir, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amadori, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brias, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vomscheid, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eiler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lévy, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delelis, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deprez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saïb, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamborlini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emiliani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruff, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ledoussal, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreau, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benarous, R.</span></span> <span> </span><span class="NLM_article-title">Dual inhibition of HIV-1 replication by integrase-LEDGF allosteric inhibitors is predominant at the post-integration stage</span>. <i>Retrovirology</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">144</span>, <span class="refDoi"> DOI: 10.1186/1742-4690-10-144</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=10.1186%2F1742-4690-10-144" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=24261564" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmvFagtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2013&pages=144&author=E.+Le%0ARouzicauthor=D.+Bonnardauthor=S.+Chassetauthor=J.+M.+Bruneauauthor=F.+Chevreuilauthor=F.+Le+Stratauthor=J.+Nguyenauthor=R.+Beauvoirauthor=C.+Amadoriauthor=J.+Briasauthor=S.+Vomscheidauthor=S.+Eilerauthor=N.+L%C3%A9vyauthor=O.+Delelisauthor=E.+Deprezauthor=A.+Sa%C3%AFbauthor=A.+Zamborliniauthor=S.+Emilianiauthor=M.+Ruffauthor=B.+Ledoussalauthor=F.+Moreauauthor=R.+Benarous&title=Dual+inhibition+of+HIV-1+replication+by+integrase-LEDGF+allosteric+inhibitors+is+predominant+at+the+post-integration+stage&doi=10.1186%2F1742-4690-10-144"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Dual inhibition of HIV-1 replication by integrase-LEDGF allosteric inhibitors is predominant at the post-integration stage</span></div><div class="casAuthors">Le Rouzic, Erwann; Bonnard, Damien; Chasset, Sophie; Bruneau, Jean-Michel; Chevreuil, Francis; Le Strat, Frederic; Nguyen, Juliette; Beauvoir, Roxane; Amadori, Celine; Brias, Julie; Vomscheid, Sophie; Eiler, Sylvia; Levy, Nicolas; Delelis, Olivier; Deprez, Eric; Saib, Ali; Zamborlini, Alessia; Emiliani, Stephane; Ruff, Marc; Ledoussal, Benoit; Moreau, Francois; Benarous, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Retrovirology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">144/1-144/21, 21 pp.</span>CODEN:
                <span class="NLM_cas:coden">RETRBO</span>;
        ISSN:<span class="NLM_cas:issn">1742-4690</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: LEDGF/p75 (LEDGF) is the main cellular cofactor of HIV-1 integrase (IN).  It acts as a tethering factor for IN, and targets the integration of HIV in actively transcribed gene regions of chromatin.  A recently developed class of IN allosteric inhibitors can inhibit the LEDGF-IN interaction.  Results: We describe a new series of IN-LEDGF allosteric inhibitors, the most active of which is Mut101.  We detd. the crystal structure of Mut101 in complex with IN and showed that the compd. binds to the LEDGF-binding pocket, promoting conformational changes of IN which explain at the at. level the allosteric effect of the IN/LEDGF interaction inhibitor on IN functions.  In vitro, Mut101 inhibited both IN-LEDGF interaction and IN strand transfer activity while enhancing IN-IN interaction.  Time of addn. expts. indicated that Mut101 behaved as an integration inhibitor.  Mut101 was fully active on HIV-1 mutants resistant to INSTIs and other classes of anti-HIV drugs, indicative that this compd. has a new mode of action.  However, we found that Mut101 also displayed a more potent antiretroviral activity at a post-integration step.  Infectivity of viral particles produced in presence of Mut101 was severely decreased.  This latter effect also required the binding of the compd. to the LEDGF-binding pocket.  Conclusion: Mut101 has dual anti-HIV-1 activity, at integration and post-integration steps of the viral replication cycle, by binding to a unique target on IN (the LEDGF-binding pocket).  The post-integration block of HIV-1 replication in virus-producer cells is the mechanism by which Mut101 is most active as an antiretroviral.  To explain this difference between Mut101 antiretroviral activity at integration and post-integration stages, we propose the following model: LEDGF is a nuclear, chromatin-bound protein that is absent in the cytoplasm.  Therefore, LEDGF can outcompete compd. binding to IN in the nucleus of target cells lowering its antiretroviral activity at integration, but not in the cytoplasm where post-integration prodn. of infectious viral particles takes place.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryOJ47iOvkx7Vg90H21EOLACvtfcHk0lhPyX7zeuujxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmvFagtLg%253D&md5=44448a2b2a9af9c65759a02295137303</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1186%2F1742-4690-10-144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1742-4690-10-144%26sid%3Dliteratum%253Aachs%26aulast%3DLe%2BRouzic%26aufirst%3DE.%26aulast%3DBonnard%26aufirst%3DD.%26aulast%3DChasset%26aufirst%3DS.%26aulast%3DBruneau%26aufirst%3DJ.%2BM.%26aulast%3DChevreuil%26aufirst%3DF.%26aulast%3DLe%2BStrat%26aufirst%3DF.%26aulast%3DNguyen%26aufirst%3DJ.%26aulast%3DBeauvoir%26aufirst%3DR.%26aulast%3DAmadori%26aufirst%3DC.%26aulast%3DBrias%26aufirst%3DJ.%26aulast%3DVomscheid%26aufirst%3DS.%26aulast%3DEiler%26aufirst%3DS.%26aulast%3DL%25C3%25A9vy%26aufirst%3DN.%26aulast%3DDelelis%26aufirst%3DO.%26aulast%3DDeprez%26aufirst%3DE.%26aulast%3DSa%25C3%25AFb%26aufirst%3DA.%26aulast%3DZamborlini%26aufirst%3DA.%26aulast%3DEmiliani%26aufirst%3DS.%26aulast%3DRuff%26aufirst%3DM.%26aulast%3DLedoussal%26aufirst%3DB.%26aulast%3DMoreau%26aufirst%3DF.%26aulast%3DBenarous%26aufirst%3DR.%26atitle%3DDual%2520inhibition%2520of%2520HIV-1%2520replication%2520by%2520integrase-LEDGF%2520allosteric%2520inhibitors%2520is%2520predominant%2520at%2520the%2520post-integration%2520stage%26jtitle%3DRetrovirology%26date%3D2013%26volume%3D10%26spage%3D144%26doi%3D10.1186%2F1742-4690-10-144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fader, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malenfant, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parisien, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bilodeau, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landry, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pesant, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brochu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chabot, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halmos, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bousquet, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailey, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawai, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coulombe, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaPlante, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakalian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhardwaj, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wernic, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schroeder, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garneau, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cordingley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bethell, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonneau, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poupart, M.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faucher, A.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simoneau, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenwick, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoakim, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsantrizos, Y.</span></span> <span> </span><span class="NLM_article-title">Discovery of BI 224436, a noncatalytic site integrase inhibitor (NCINI) of HIV-1</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">422</span>– <span class="NLM_lpage">427</span>, <span class="refDoi"> DOI: 10.1021/ml500002n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500002n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1eitb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=422-427&author=L.+D.+Faderauthor=E.+Malenfantauthor=M.+Parisienauthor=R.+Carsonauthor=F.+Bilodeauauthor=S.+Landryauthor=M.+Pesantauthor=C.+Brochuauthor=S.+Morinauthor=C.+Chabotauthor=T.+Halmosauthor=Y.+Bousquetauthor=M.+D.+Baileyauthor=S.+H.+Kawaiauthor=R.+Coulombeauthor=S.+LaPlanteauthor=A.+Jakalianauthor=P.+K.+Bhardwajauthor=D.+Wernicauthor=P.+Schroederauthor=M.+Amadauthor=P.+Edwardsauthor=M.+Garneauauthor=J.+Duanauthor=M.+Cordingleyauthor=R.+Bethellauthor=S.+W.+Masonauthor=M.+Bosauthor=P.+Bonneauauthor=M.-A.+Poupartauthor=A.-M.+Faucherauthor=B.+Simoneauauthor=C.+Fenwickauthor=C.+Yoakimauthor=Y.+Tsantrizos&title=Discovery+of+BI+224436%2C+a+noncatalytic+site+integrase+inhibitor+%28NCINI%29+of+HIV-1&doi=10.1021%2Fml500002n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of BI 224436, a Noncatalytic Site Integrase Inhibitor (NCINI) of HIV-1</span></div><div class="casAuthors">Fader, Lee D.; Malenfant, Eric; Parisien, Mathieu; Carson, Rebekah; Bilodeau, Francois; Landry, Serge; Pesant, Marc; Brochu, Christian; Morin, Sebastien; Chabot, Catherine; Halmos, Ted; Bousquet, Yves; Bailey, Murray D.; Kawai, Stephen H.; Coulombe, Rene; LaPlante, Steven; Jakalian, Araz; Bhardwaj, Punit K.; Wernic, Dominik; Schroeder, Patricia; Amad, Ma'an; Edwards, Paul; Garneau, Michel; Duan, Jianmin; Cordingley, Michael; Bethell, Richard; Mason, Stephen W.; Bos, Michael; Bonneau, Pierre; Poupart, Marc-Andre; Faucher, Anne-Marie; Simoneau, Bruno; Fenwick, Craig; Yoakim, Christiane; Tsantrizos, Youla</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">422-427</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An assay recapitulating the 3' processing activity of HIV-1 integrase (IN) was used to screen the Boehringer Ingelheim compd. collection.  Hit-to-lead and lead optimization beginning with compd. I established the importance of the C3 and C4 substituent to antiviral potency against viruses with different aa124/aa125 variants of IN.  The importance of the C7 position on the serum shifted potency was established.  Introduction of a quinoline substituent at the C4 position provided a balance of potency and metabolic stability.  Combination of these findings ultimately led to the discovery of compd. II (BI 224436), the first NCINI to advance into a phase Ia clin. trial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrE57FQpskKLVg90H21EOLACvtfcHk0lhFDNpDlklDDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1eitb8%253D&md5=6df7ddab6dadf569d00d4314a773532c</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fml500002n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500002n%26sid%3Dliteratum%253Aachs%26aulast%3DFader%26aufirst%3DL.%2BD.%26aulast%3DMalenfant%26aufirst%3DE.%26aulast%3DParisien%26aufirst%3DM.%26aulast%3DCarson%26aufirst%3DR.%26aulast%3DBilodeau%26aufirst%3DF.%26aulast%3DLandry%26aufirst%3DS.%26aulast%3DPesant%26aufirst%3DM.%26aulast%3DBrochu%26aufirst%3DC.%26aulast%3DMorin%26aufirst%3DS.%26aulast%3DChabot%26aufirst%3DC.%26aulast%3DHalmos%26aufirst%3DT.%26aulast%3DBousquet%26aufirst%3DY.%26aulast%3DBailey%26aufirst%3DM.%2BD.%26aulast%3DKawai%26aufirst%3DS.%2BH.%26aulast%3DCoulombe%26aufirst%3DR.%26aulast%3DLaPlante%26aufirst%3DS.%26aulast%3DJakalian%26aufirst%3DA.%26aulast%3DBhardwaj%26aufirst%3DP.%2BK.%26aulast%3DWernic%26aufirst%3DD.%26aulast%3DSchroeder%26aufirst%3DP.%26aulast%3DAmad%26aufirst%3DM.%26aulast%3DEdwards%26aufirst%3DP.%26aulast%3DGarneau%26aufirst%3DM.%26aulast%3DDuan%26aufirst%3DJ.%26aulast%3DCordingley%26aufirst%3DM.%26aulast%3DBethell%26aufirst%3DR.%26aulast%3DMason%26aufirst%3DS.%2BW.%26aulast%3DBos%26aufirst%3DM.%26aulast%3DBonneau%26aufirst%3DP.%26aulast%3DPoupart%26aufirst%3DM.-A.%26aulast%3DFaucher%26aufirst%3DA.-M.%26aulast%3DSimoneau%26aufirst%3DB.%26aulast%3DFenwick%26aufirst%3DC.%26aulast%3DYoakim%26aufirst%3DC.%26aulast%3DTsantrizos%26aufirst%3DY.%26atitle%3DDiscovery%2520of%2520BI%2520224436%252C%2520a%2520noncatalytic%2520site%2520integrase%2520inhibitor%2520%2528NCINI%2529%2520of%2520HIV-1%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D422%26epage%3D427%26doi%3D10.1021%2Fml500002n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsantrizos, Y. S.</span>; <span class="NLM_string-name">Bailey, M. D.</span>; <span class="NLM_string-name">Bilodeau, F.</span>; <span class="NLM_string-name">Carson, R. J.</span>; <span class="NLM_string-name">Coulombe, R.</span>; <span class="NLM_string-name">Fader, L.</span>; <span class="NLM_string-name">Halmos, T.</span>; <span class="NLM_string-name">Kawai, S.</span>; <span class="NLM_string-name">Landry, S.</span>; <span class="NLM_string-name">Laplante, S.</span>; <span class="NLM_string-name">Morin, S.</span>; <span class="NLM_string-name">Parisien, M.</span>; <span class="NLM_string-name">Poupart, M.-A.</span>; <span class="NLM_string-name">Simoneau, B.</span></span> <span> </span><span class="NLM_article-title">Preparation of 2-(<i>tert</i>-Butyloxy)-2-(2-methylquinolin-3-yl)acetic Acid Derivatives as Inhibitors of Human Immunodeficiency Virus Replication</span>. World Patent <span class="NLM_patent">WO2009/062285A1</span>, <span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=Y.+S.+Tsantrizos&author=M.+D.+Bailey&author=F.+Bilodeau&author=R.+J.+Carson&author=R.+Coulombe&author=L.+Fader&author=T.+Halmos&author=S.+Kawai&author=S.+Landry&author=S.+Laplante&author=S.+Morin&author=M.+Parisien&author=M.-A.+Poupart&author=B.+Simoneau&title=Preparation+of+2-%28tert-Butyloxy%29-2-%282-methylquinolin-3-yl%29acetic+Acid+Derivatives+as+Inhibitors+of+Human+Immunodeficiency+Virus+Replication"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DTsantrizos%26aufirst%3DY.%2BS.%26atitle%3DPreparation%2520of%25202-%2528tert-Butyloxy%2529-2-%25282-methylquinolin-3-yl%2529acetic%2520Acid%2520Derivatives%2520as%2520Inhibitors%2520of%2520Human%2520Immunodeficiency%2520Virus%2520Replication%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fader, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bilodeau, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chabot, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halmos, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailey, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawai, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coulombe, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laplante, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mekhssian, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakalian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garneau, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simoneau, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenwick, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsantrizos, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoakim, C.</span></span> <span> </span><span class="NLM_article-title">Minimizing the contribution of enterohepatic recirculation to clearance in rat for the NCINI class of inhibitors of HIV</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">711</span>– <span class="NLM_lpage">716</span>, <span class="refDoi"> DOI: 10.1021/ml500110j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500110j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmt1Shu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=711-716&author=L.+D.+Faderauthor=R.+Carsonauthor=S.+Morinauthor=F.+Bilodeauauthor=C.+Chabotauthor=T.+Halmosauthor=M.+D.+Baileyauthor=S.+H.+Kawaiauthor=R.+Coulombeauthor=S.+Laplanteauthor=K.+Mekhssianauthor=A.+Jakalianauthor=M.+Garneauauthor=J.+Duanauthor=S.+W.+Masonauthor=B.+Simoneauauthor=C.+Fenwickauthor=Y.+Tsantrizosauthor=C.+Yoakim&title=Minimizing+the+contribution+of+enterohepatic+recirculation+to+clearance+in+rat+for+the+NCINI+class+of+inhibitors+of+HIV&doi=10.1021%2Fml500110j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Minimizing the Contribution of Enterohepatic Recirculation to Clearance in Rat for the NCINI Class of Inhibitors of HIV</span></div><div class="casAuthors">Fader, Lee D.; Carson, Rebekah; Morin, Sebastien; Bilodeau, Francois; Chabot, Catherine; Halmos, Ted; Bailey, Murray D.; Kawai, Stephen H.; Coulombe, Rene; Laplante, Steven; Mekhssian, Kevork; Jakalian, Araz; Garneau, Michel; Duan, Jianmin; Mason, Stephen W.; Simoneau, Bruno; Fenwick, Craig; Tsantrizos, Youla; Yoakim, Christiane</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">711-716</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A scaffold replacement approach was used to identifying the pyridine series of noncatalytic site integrase inhibitors (NCINIs).  These mols. bind with higher affinity to a tetrameric form compared to a dimeric form of integrase.  Optimization of the C6 and C4 positions revealed that viruses harboring T124 or A124 amino acid substitutions are highly susceptible to these inhibitors, but viruses having the N124 amino acid substitution are about 100-fold less susceptible.  Compd. 20 (I) had EC50 values <10 nM against viruses having T124 or A124 substitutions in IN and >800 nM in viruses having N124 substitutions.  Compd. 20 had an excellent in vitro ADME profile and demonstrated reduced contribution of biliary excretion to in vivo clearance compared to BI 224436, the lead compd. from the quinoline series of NCINIs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDe8rX5yeRo7Vg90H21EOLACvtfcHk0lhFDNpDlklDDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmt1Shu7g%253D&md5=076346757ea2aa73e103f580952a51c9</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fml500110j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500110j%26sid%3Dliteratum%253Aachs%26aulast%3DFader%26aufirst%3DL.%2BD.%26aulast%3DCarson%26aufirst%3DR.%26aulast%3DMorin%26aufirst%3DS.%26aulast%3DBilodeau%26aufirst%3DF.%26aulast%3DChabot%26aufirst%3DC.%26aulast%3DHalmos%26aufirst%3DT.%26aulast%3DBailey%26aufirst%3DM.%2BD.%26aulast%3DKawai%26aufirst%3DS.%2BH.%26aulast%3DCoulombe%26aufirst%3DR.%26aulast%3DLaplante%26aufirst%3DS.%26aulast%3DMekhssian%26aufirst%3DK.%26aulast%3DJakalian%26aufirst%3DA.%26aulast%3DGarneau%26aufirst%3DM.%26aulast%3DDuan%26aufirst%3DJ.%26aulast%3DMason%26aufirst%3DS.%2BW.%26aulast%3DSimoneau%26aufirst%3DB.%26aulast%3DFenwick%26aufirst%3DC.%26aulast%3DTsantrizos%26aufirst%3DY.%26aulast%3DYoakim%26aufirst%3DC.%26atitle%3DMinimizing%2520the%2520contribution%2520of%2520enterohepatic%2520recirculation%2520to%2520clearance%2520in%2520rat%2520for%2520the%2520NCINI%2520class%2520of%2520inhibitors%2520of%2520HIV%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D5%26spage%3D711%26epage%3D716%26doi%3D10.1021%2Fml500110j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fader, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailey, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaulieu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bilodeau, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonneau, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bousquet, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carson, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chabot, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coulombe, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenwick, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garneau, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halmos, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakalian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawai, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landry, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laplante, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rioux, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simoneau, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surprenant, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thavonekham, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thibeault, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trinh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsantrizos, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsoung, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoakim, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wernic, D.</span></span> <span> </span><span class="NLM_article-title">Aligning potency and pharmacokinetic properties for pyridine-based NCINIs</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">797</span>– <span class="NLM_lpage">801</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00194</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00194" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=1%3ACAS%3A528%3ADC%252BC28XpsFaqsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=797-801&author=L.+D.+Faderauthor=M.+D.+Baileyauthor=E.+Beaulieuauthor=F.+Bilodeauauthor=P.+Bonneauauthor=Y.+Bousquetauthor=R.+J.+Carsonauthor=C.+Chabotauthor=R.+Coulombeauthor=J.+Duanauthor=C.+Fenwickauthor=M.+Garneauauthor=T.+Halmosauthor=A.+Jakalianauthor=C.+Jamesauthor=S.+H.+Kawaiauthor=S.+Landryauthor=S.+R.+Laplanteauthor=S.+W.+Masonauthor=S.+Morinauthor=N.+Riouxauthor=B.+Simoneauauthor=S.+Surprenantauthor=B.+Thavonekhamauthor=C.+Thibeaultauthor=T.+Trinhauthor=Y.+Tsantrizosauthor=J.+Tsoungauthor=C.+Yoakimauthor=D.+Wernic&title=Aligning+potency+and+pharmacokinetic+properties+for+pyridine-based+NCINIs&doi=10.1021%2Facsmedchemlett.6b00194"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Aligning Potency and Pharmacokinetic Properties for Pyridine-Based NCINIs</span></div><div class="casAuthors">Fader, Lee D.; Bailey, Murray; Beaulieu, Eric; Bilodeau, Francois; Bonneau, Pierre; Bousquet, Yves; Carson, Rebekah J.; Chabot, Catherine; Coulombe, Rene; Duan, Jianmin; Fenwick, Craig; Garneau, Michel; Halmos, Ted; Jakalian, Araz; James, Clint; Kawai, Stephen H.; Landry, Serge; LaPlante, Steven R.; Mason, Stephen W.; Morin, Sebastien; Rioux, Nathalie; Simoneau, Bruno; Surprenant, Simon; Thavonekham, Bounkham; Thibeault, Carl; Trinh, Thao; Tsantrizos, Youla; Tsoung, Jennifer; Yoakim, Christiane; Wernic, Dominik</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">797-801</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Optimization of pyridine-based noncatalytic site integrase inhibitors (NCINIs) based on compd. (I) has led to the discovery of mols. capable of inhibiting virus harboring N124 variants of HIV integrase (IN) while maintaining minimal contribution of enterohepatic recirculation to clearance in rat.  Structure-activity relationships at the C6 position established chem. space where the extent of enterohepatic recirculation in the rat is minimized.  Desymmetrization of the C4 substituent allowed for potency optimization against virus having the N124 variant of integrase.  Combination of these lessons led to the discovery of compd. (II), having balanced serum-shifted antiviral potency and minimized excretion in to the biliary tract in rat, potentially representing a clin. viable starting point for a new treatment option for individuals infected with HIV.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQtz6e-ThyHLVg90H21EOLACvtfcHk0lhGIDfWpqp6Mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpsFaqsrw%253D&md5=26945fd82b47268403d348233247db01</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00194&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00194%26sid%3Dliteratum%253Aachs%26aulast%3DFader%26aufirst%3DL.%2BD.%26aulast%3DBailey%26aufirst%3DM.%2BD.%26aulast%3DBeaulieu%26aufirst%3DE.%26aulast%3DBilodeau%26aufirst%3DF.%26aulast%3DBonneau%26aufirst%3DP.%26aulast%3DBousquet%26aufirst%3DY.%26aulast%3DCarson%26aufirst%3DR.%2BJ.%26aulast%3DChabot%26aufirst%3DC.%26aulast%3DCoulombe%26aufirst%3DR.%26aulast%3DDuan%26aufirst%3DJ.%26aulast%3DFenwick%26aufirst%3DC.%26aulast%3DGarneau%26aufirst%3DM.%26aulast%3DHalmos%26aufirst%3DT.%26aulast%3DJakalian%26aufirst%3DA.%26aulast%3DJames%26aufirst%3DC.%26aulast%3DKawai%26aufirst%3DS.%2BH.%26aulast%3DLandry%26aufirst%3DS.%26aulast%3DLaplante%26aufirst%3DS.%2BR.%26aulast%3DMason%26aufirst%3DS.%2BW.%26aulast%3DMorin%26aufirst%3DS.%26aulast%3DRioux%26aufirst%3DN.%26aulast%3DSimoneau%26aufirst%3DB.%26aulast%3DSurprenant%26aufirst%3DS.%26aulast%3DThavonekham%26aufirst%3DB.%26aulast%3DThibeault%26aufirst%3DC.%26aulast%3DTrinh%26aufirst%3DT.%26aulast%3DTsantrizos%26aufirst%3DY.%26aulast%3DTsoung%26aufirst%3DJ.%26aulast%3DYoakim%26aufirst%3DC.%26aulast%3DWernic%26aufirst%3DD.%26atitle%3DAligning%2520potency%2520and%2520pharmacokinetic%2520properties%2520for%2520pyridine-based%2520NCINIs%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D797%26epage%3D801%26doi%3D10.1021%2Facsmedchemlett.6b00194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsiang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niedziela-Majka, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lansdon, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hung, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samuel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novikov, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babaoglu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geleziunas, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakowicz, R.</span></span> <span> </span><span class="NLM_article-title">New class of HIV-1 integrase (IN) inhibitors with a dual mode of action</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>287</i></span>,  <span class="NLM_fpage">21189</span>– <span class="NLM_lpage">21203</span>, <span class="refDoi"> DOI: 10.1074/jbc.M112.347534</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=10.1074%2Fjbc.M112.347534" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=22535962" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=1%3ACAS%3A528%3ADC%252BC38Xos1Cksbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=21189-21203&author=M.+Tsiangauthor=G.+S.+Jonesauthor=A.+Niedziela-Majkaauthor=E.+Kanauthor=E.+B.+Lansdonauthor=W.+Huangauthor=M.+Hungauthor=D.+Samuelauthor=N.+Novikovauthor=Y.+Xuauthor=M.+Mitchellauthor=H.+Guoauthor=K.+Babaogluauthor=X.+Liuauthor=R.+Geleziunasauthor=R.+Sakowicz&title=New+class+of+HIV-1+integrase+%28IN%29+inhibitors+with+a+dual+mode+of+action&doi=10.1074%2Fjbc.M112.347534"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">New Class of HIV-1 Integrase (IN) Inhibitors with a Dual Mode of Action</span></div><div class="casAuthors">Tsiang, Manuel; Jones, Gregg S.; Niedziela-Majka, Anita; Kan, Elaine; Lansdon, Eric B.; Huang, Wayne; Hung, Magdeleine; Samuel, Dharmaraj; Novikov, Nikolai; Xu, Yili; Mitchell, Michael; Guo, Hongyan; Babaoglu, Kerim; Liu, Xiaohong; Geleziunas, Romas; Sakowicz, Roman</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">287</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">21189-21203</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Tert-Butoxy-(4-phenyl-quinolin-3-yl)-acetic acids (tBPQA) are a new class of HIV-1 integrase (IN) inhibitors that are structurally distinct from IN strand transfer inhibitors but analogous to LEDGINs.  LEDGINs are a class of potent antiviral compds. that interacts with the lens epithelium-derived growth factor (LEDGF) binding pocket on IN and were identified through competition binding against LEDGF.  LEDGF tethers IN to the host chromatin and enables targeted integration of viral DNA.  The prevailing understanding of the antiviral mechanism of LEDGINs is that they inhibit LEDGF binding to IN, which prevents targeted integration of HIV-1.  We showed that in addn. to the properties already known for LEDGINs, the binding of tBPQAs to the IN dimer interface inhibits IN enzymic activity in a LEDGF-independent manner.  Using the anal. of two long terminal repeat junctions in HIV-infected cells, we showed that the inhibition by tBPQAs occurs at or prior to the viral DNA 3'-processing step.  Biochem. studies revealed that this inhibition operates by compd.-induced conformational changes in the IN dimer that prevent proper assembly of IN onto viral DNA.  For the first time, tBPQAs were demonstrated to be allosteric inhibitors of HIV-1 IN displaying a dual mode of action: inhibition of IN-viral DNA assembly and inhibition of IN-LEDGF interaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9a7vKSwQy6rVg90H21EOLACvtfcHk0lhGIDfWpqp6Mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xos1Cksbc%253D&md5=15268f38a9c9aaf318f94d49ad53054f</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M112.347534&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M112.347534%26sid%3Dliteratum%253Aachs%26aulast%3DTsiang%26aufirst%3DM.%26aulast%3DJones%26aufirst%3DG.%2BS.%26aulast%3DNiedziela-Majka%26aufirst%3DA.%26aulast%3DKan%26aufirst%3DE.%26aulast%3DLansdon%26aufirst%3DE.%2BB.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DHung%26aufirst%3DM.%26aulast%3DSamuel%26aufirst%3DD.%26aulast%3DNovikov%26aufirst%3DN.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DMitchell%26aufirst%3DM.%26aulast%3DGuo%26aufirst%3DH.%26aulast%3DBabaoglu%26aufirst%3DK.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DGeleziunas%26aufirst%3DR.%26aulast%3DSakowicz%26aufirst%3DR.%26atitle%3DNew%2520class%2520of%2520HIV-1%2520integrase%2520%2528IN%2529%2520inhibitors%2520with%2520a%2520dual%2520mode%2520of%2520action%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D21189%26epage%3D21203%26doi%3D10.1074%2Fjbc.M112.347534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brady, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyer, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malani, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Male, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolte, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velthuisen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeffrey, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Duyne, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bushman, F. D.</span></span> <span> </span><span class="NLM_article-title">Allosteric inhibition of human immunodeficiency virus integrase</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>289</i></span>,  <span class="NLM_fpage">20477</span>– <span class="NLM_lpage">20488</span>, <span class="refDoi"> DOI: 10.1074/jbc.M114.551119</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=10.1074%2Fjbc.M114.551119" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=24904063" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1SksLfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=20477-20488&author=K.+Guptaauthor=T.+Bradyauthor=B.+M.+Dyerauthor=N.+Malaniauthor=Y.+Hwangauthor=F.+Maleauthor=R.+T.+Nolteauthor=L.+Wangauthor=E.+Velthuisenauthor=J.+Jeffreyauthor=G.+D.+Van+Duyneauthor=F.+D.+Bushman&title=Allosteric+inhibition+of+human+immunodeficiency+virus+integrase&doi=10.1074%2Fjbc.M114.551119"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric Inhibition of Human Immunodeficiency Virus Integrase</span></div><div class="casAuthors">Gupta, Kushol; Brady, Troy; Dyer, Benjamin M.; Malani, Nirav; Hwang, Young; Male, Frances; Nolte, Robert T.; Wang, Liping; Velthuisen, Emile; Jeffrey, Jerry; Van Duyne, Gregory D.; Bushman, Frederic D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">20477-20488</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">HIV-1 replication in the presence of antiviral agents results in evolution of drug-resistant variants, motivating the search for addnl. drug classes.  Here the authors report studies of GSK1264, which was identified as a compd. that disrupts the interaction between HIV-1 integrase (IN) and the cellular factor lens epithelium-derived growth factor (LEDGF)/p75.  GSK1264 displayed potent antiviral activity and was found to bind at the site occupied by LEDGF/p75 on IN by x-ray crystallog.  Assays of HIV replication in the presence of GSK1264 showed only modest inhibition of the early infection steps and little effect on integration targeting, which is guided by the LEDGF/p75·IN interaction.  In contrast, inhibition of late replication steps was more potent.  Particle prodn. was normal, but particles showed reduced infectivity.  GSK1264 promoted aggregation of IN and preformed LEDGF/p75·IN complexes, suggesting a mechanism of inhibition.  LEDGF/p75 was not displaced from IN during aggregation, indicating trapping of LEDGF/p75 in aggregates.  Aggregation assays with truncated IN variants revealed that a construct with catalytic and C-terminal domains of IN only formed an open polymer assocd. with efficient drug-induced aggregation.  These data suggest that the allosteric inhibitors of IN are promising antiviral agents and provide new information on their mechanism of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfGVxAhaPY-7Vg90H21EOLACvtfcHk0lgHfkoyTaKMww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1SksLfN&md5=a1cadf2734267122e9bc3a6b013f21dc</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M114.551119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M114.551119%26sid%3Dliteratum%253Aachs%26aulast%3DGupta%26aufirst%3DK.%26aulast%3DBrady%26aufirst%3DT.%26aulast%3DDyer%26aufirst%3DB.%2BM.%26aulast%3DMalani%26aufirst%3DN.%26aulast%3DHwang%26aufirst%3DY.%26aulast%3DMale%26aufirst%3DF.%26aulast%3DNolte%26aufirst%3DR.%2BT.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DVelthuisen%26aufirst%3DE.%26aulast%3DJeffrey%26aufirst%3DJ.%26aulast%3DVan%2BDuyne%26aufirst%3DG.%2BD.%26aulast%3DBushman%26aufirst%3DF.%2BD.%26atitle%3DAllosteric%2520inhibition%2520of%2520human%2520immunodeficiency%2520virus%2520integrase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26spage%3D20477%26epage%3D20488%26doi%3D10.1074%2Fjbc.M114.551119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turkki, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherrill-Mix, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eilers, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDanal, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Temelkoff, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolte, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velthuisen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeffrey, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Duyne, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bushman, F. D.</span></span> <span> </span><span class="NLM_article-title">Structural basis for inhibitor-induced aggregation of HIV integrase</span>. <i>PLoS Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">e1002584</span>, <span class="refDoi"> DOI: 10.1371/journal.pbio.1002584</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=10.1371%2Fjournal.pbio.1002584" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=27935939" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=1%3ACAS%3A528%3ADC%252BC2sXosVelu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2016&pages=e1002584&author=K.+Guptaauthor=V.+Turkkiauthor=S.+Sherrill-Mixauthor=Y.+Hwangauthor=G.+Eilersauthor=L.+Taylorauthor=C.+McDanalauthor=P.+Wangauthor=D.+Temelkoffauthor=R.+T.+Nolteauthor=E.+Velthuisenauthor=J.+Jeffreyauthor=G.+D.+Van+Duyneauthor=F.+D.+Bushman&title=Structural+basis+for+inhibitor-induced+aggregation+of+HIV+integrase&doi=10.1371%2Fjournal.pbio.1002584"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for inhibitor-induced aggregation of HIV integrase</span></div><div class="casAuthors">Gupta, Kushol; Turkki, Vesa; Sherrill-Mix, Scott; Hwang, Young; Eilers, Grant; Taylor, Louis; McDanal, Charlene; Wang, Ping; Temelkoff, David; Nolte, Robert T.; Velthuisen, Emile; Jeffrey, Jerry; Van Duyne, Gregory D.; Bushman, Frederic D.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">e1002584/1-e1002584/24</span>CODEN:
                <span class="NLM_cas:coden">PBLIBG</span>;
        ISSN:<span class="NLM_cas:issn">1545-7885</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">The allosteric inhibitors of integrase (termed ALLINIs) interfere with HIV replication by binding to the viral-encoded integrase (IN) protein.  Surprisingly, ALLINIs interfere not with DNA integration but with viral particle assembly late during HIV replication.  To investigate the ALLINI inhibitory mechanism, we crystd. full-length HIV-1 IN bound to the ALLINI GSK1264 and detd. the structure of the complex at 4.4 Å resoln.  The structure shows GSK1264 buried between the IN C-terminal domain (CTD) and the catalytic core domain.  In the crystal lattice, the interacting domains are contributed by two different dimers so that IN forms an open polymer mediated by inhibitor-bridged contacts; the N-terminal domains do not participate and are structurally disordered.  Engineered amino acid substitutions at the inhibitor interface blocked ALLINI-induced multimerization.  HIV escape mutants with reduced sensitivity to ALLINIs commonly altered amino acids at or near the inhibitorbound interface, and these substitutions also diminished IN multimerization.  We propose that ALLINIs inhibit particle assembly by stimulating inappropriate polymn. of IN via interactions between the catalytic core domain and the CTD and that understanding the interface involved offers new routes to inhibitor optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3wrTwfpC_UbVg90H21EOLACvtfcHk0lgHfkoyTaKMww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXosVelu7c%253D&md5=a41f3eb25160c7c02b66ed84307f0e54</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pbio.1002584&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pbio.1002584%26sid%3Dliteratum%253Aachs%26aulast%3DGupta%26aufirst%3DK.%26aulast%3DTurkki%26aufirst%3DV.%26aulast%3DSherrill-Mix%26aufirst%3DS.%26aulast%3DHwang%26aufirst%3DY.%26aulast%3DEilers%26aufirst%3DG.%26aulast%3DTaylor%26aufirst%3DL.%26aulast%3DMcDanal%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DTemelkoff%26aufirst%3DD.%26aulast%3DNolte%26aufirst%3DR.%2BT.%26aulast%3DVelthuisen%26aufirst%3DE.%26aulast%3DJeffrey%26aufirst%3DJ.%26aulast%3DVan%2BDuyne%26aufirst%3DG.%2BD.%26aulast%3DBushman%26aufirst%3DF.%2BD.%26atitle%3DStructural%2520basis%2520for%2520inhibitor-induced%2520aggregation%2520of%2520HIV%2520integrase%26jtitle%3DPLoS%2520Biol.%26date%3D2016%26volume%3D14%26spage%3De1002584%26doi%3D10.1371%2Fjournal.pbio.1002584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cherepanov, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambrosio, A. L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellenberger, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engelman, A.</span></span> <span> </span><span class="NLM_article-title">Structural basis for the recognition between HIV-1 integrase and transcriptional coactivator p75</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>102</i></span>,  <span class="NLM_fpage">17308</span>– <span class="NLM_lpage">17313</span>, <span class="refDoi"> DOI: 10.1073/pnas.0506924102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=10.1073%2Fpnas.0506924102" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=16260736" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlSqtLfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=17308-17313&author=P.+Cherepanovauthor=A.+L.+B.+Ambrosioauthor=S.+Rahmanauthor=T.+Ellenbergerauthor=A.+Engelman&title=Structural+basis+for+the+recognition+between+HIV-1+integrase+and+transcriptional+coactivator+p75&doi=10.1073%2Fpnas.0506924102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for the recognition between HIV-1 integrase and transcriptional coactivator p75</span></div><div class="casAuthors">Cherepanov, Peter; Ambrosio, Andre L. B.; Rahman, Shaila; Ellenberger, Tom; Engelman, Alan</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">17308-17313</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Integrase (IN) is an essential retroviral enzyme, and human transcriptional coactivator p75, which is also referred to as lens epithelium-derived growth factor (LEDGF), is the dominant cellular binding partner of HIV-1 IN.  Here, we report the crystal structure of the dimeric catalytic core domain of HIV-1 IN complexed to the IN-binding domain of LEDGF.  Previously identified LEDGF hotspot residues anchor the protein to both monomers at the IN dimer interface.  The principal structural features of IN that are recognized by the host factor are the backbone conformation of residues 168-171 from one monomer and a hydrophobic patch that is primarily comprised of α-helixes 1 and 3 of the second IN monomer.  Inspection of diverse retroviral primary and secondary sequence elements helps to explain the apparent lentiviral tropism of the LEDGF-IN interaction.  Because the lethal phenotypes of HIV-1 mutant viruses unable to interact with LEDGF indicate that IN function is highly sensitive to perturbations of the structure around the LEDGF-binding site, we propose that small mol. inhibitors of the protein-protein interaction might similarly disrupt HIV-1 replication.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOcJ_wK2p6urVg90H21EOLACvtfcHk0liOnowVAPCFTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlSqtLfE&md5=92b763420ded097aad69decb895f49ab</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0506924102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0506924102%26sid%3Dliteratum%253Aachs%26aulast%3DCherepanov%26aufirst%3DP.%26aulast%3DAmbrosio%26aufirst%3DA.%2BL.%2BB.%26aulast%3DRahman%26aufirst%3DS.%26aulast%3DEllenberger%26aufirst%3DT.%26aulast%3DEngelman%26aufirst%3DA.%26atitle%3DStructural%2520basis%2520for%2520the%2520recognition%2520between%2520HIV-1%2520integrase%2520and%2520transcriptional%2520coactivator%2520p75%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2005%26volume%3D102%26spage%3D17308%26epage%3D17313%26doi%3D10.1073%2Fpnas.0506924102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davis, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vishwakarma, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billmers, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finn, J.</span></span> <span> </span><span class="NLM_article-title">Synthesis of α-hydroxycarbonyl compounds (acyloins): direct oxidation of enolates using 2-sulfonyloxaziridine</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">3241</span>– <span class="NLM_lpage">3243</span>, <span class="refDoi"> DOI: 10.1021/jo00191a048</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00191a048" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=1%3ACAS%3A528%3ADyaL2cXkvV2ru7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1984&pages=3241-3243&author=F.+A.+Davisauthor=L.+C.+Vishwakarmaauthor=J.+G.+Billmersauthor=J.+Finn&title=Synthesis+of+%CE%B1-hydroxycarbonyl+compounds+%28acyloins%29%3A+direct+oxidation+of+enolates+using+2-sulfonyloxaziridine&doi=10.1021%2Fjo00191a048"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of α-hydroxycarbonyl compounds (acyloins):  direct oxidation of enolates using 2-sulfonyloxaziridines</span></div><div class="casAuthors">Davis, Franklin A.; Vishwakarma, Lal C.; Billmers, Joanne G.; Finn, John</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">3241-3</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">Direct oxidn. of ketone and ester enolates with oxaziridine I affords α-hydroxycarbonyl compds. in higher yield, with fewer side reactions, and with superior stereoselectivity than similar oxidns. using Mo peroxide-pyridine-(Me2N)3PO or O2.  Competitive addn. of enolates to sulfonimide PhSO2:CHPh is unimportant.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIHYbwSFWMmrVg90H21EOLACvtfcHk0liOnowVAPCFTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXkvV2ru7Y%253D&md5=7a9c0eea5d2ca9135823cc4417705d07</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjo00191a048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00191a048%26sid%3Dliteratum%253Aachs%26aulast%3DDavis%26aufirst%3DF.%2BA.%26aulast%3DVishwakarma%26aufirst%3DL.%2BC.%26aulast%3DBillmers%26aufirst%3DJ.%2BG.%26aulast%3DFinn%26aufirst%3DJ.%26atitle%3DSynthesis%2520of%2520%25CE%25B1-hydroxycarbonyl%2520compounds%2520%2528acyloins%2529%253A%2520direct%2520oxidation%2520of%2520enolates%2520using%25202-sulfonyloxaziridine%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1984%26volume%3D49%26spage%3D3241%26epage%3D3243%26doi%3D10.1021%2Fjo00191a048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Corey, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Link, J. O.</span></span> <span> </span><span class="NLM_article-title">A general, catalytic, and enantioselective synthesis of α-amino acids</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">1906</span>– <span class="NLM_lpage">1908</span>, <span class="refDoi"> DOI: 10.1021/ja00031a069</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00031a069" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=1%3ACAS%3A528%3ADyaK38Xht12msbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=1992&pages=1906-1908&author=E.+J.+Coreyauthor=J.+O.+Link&title=A+general%2C+catalytic%2C+and+enantioselective+synthesis+of+%CE%B1-amino+acids&doi=10.1021%2Fja00031a069"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">A general, catalytic, and enantioselective synthesis of α-amino acids</span></div><div class="casAuthors">Corey, E. J.; Link, John O.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1906-8</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">A useful and general new synthesis of chiral α-amino acids is reported which produces these valuable substances from inexpensive achiral precursors by an enantioselective catalytic process.  The synthesis of enantiomerically pure (S)-α-amino acids, n-amylglycine, homophenylalanine, p-phenylphenylalanine, β-naphthylalanine, cyclohexylglycine, and tert-butylglycine, from trichloromethyl ketones in good yield using three simple steps is reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovJJRXiDv2WrVg90H21EOLACvtfcHk0liOnowVAPCFTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xht12msbk%253D&md5=363811ba776e2ac646a1cbedfd7bd97b</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fja00031a069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00031a069%26sid%3Dliteratum%253Aachs%26aulast%3DCorey%26aufirst%3DE.%2BJ.%26aulast%3DLink%26aufirst%3DJ.%2BO.%26atitle%3DA%2520general%252C%2520catalytic%252C%2520and%2520enantioselective%2520synthesis%2520of%2520%25CE%25B1-amino%2520acids%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1992%26volume%3D114%26spage%3D1906%26epage%3D1908%26doi%3D10.1021%2Fja00031a069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carlens, G.</span>; <span class="NLM_string-name">Chaltin, P.</span>; <span class="NLM_string-name">Christ, F.</span>; <span class="NLM_string-name">Debyser, Z.</span>; <span class="NLM_string-name">Marchand, A.</span>; <span class="NLM_string-name">Marchand, D.</span>; <span class="NLM_string-name">Voet, A.</span>; <span class="NLM_string-name">De
Maeyer, M.</span></span> <span> </span><span class="NLM_article-title">Novel Antiviral Compounds</span>. World Patent <span class="NLM_patent">WO2011/076765A1</span>, <span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=G.+Carlens&author=P.+Chaltin&author=F.+Christ&author=Z.+Debyser&author=A.+Marchand&author=D.+Marchand&author=A.+Voet&author=M.+De%0AMaeyer&title=Novel+Antiviral+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCarlens%26aufirst%3DG.%26atitle%3DNovel%2520Antiviral%2520Compounds%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peese, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allard, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connolly, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorensen, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McAuliffe, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minassian, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krystal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kish, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolte, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simmermacher, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenkins, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cianci, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naidu, B. N.</span></span> <span> </span><span class="NLM_article-title">5,6,7,8-Tetrahydro-1,6-naphthyridine derivatives as potent HIV-1-integrase-allosteric-site inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">1348</span>– <span class="NLM_lpage">1361</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01473</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01473" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=1%3ACAS%3A528%3ADC%252BC1MXkslOktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=1348-1361&author=K.+M.+Peeseauthor=C.+W.+Allardauthor=T.+Connollyauthor=B.+L.+Johnsonauthor=C.+Liauthor=M.+Patelauthor=M.+E.+Sorensenauthor=M.+A.+Walkerauthor=N.+A.+Meanwellauthor=B.+McAuliffeauthor=B.+Minassianauthor=M.+Krystalauthor=D.+D.+Parkerauthor=H.+A.+Lewisauthor=K.+Kishauthor=P.+Zhangauthor=R.+T.+Nolteauthor=J.+Simmermacherauthor=S.+Jenkinsauthor=C.+Cianciauthor=B.+N.+Naidu&title=5%2C6%2C7%2C8-Tetrahydro-1%2C6-naphthyridine+derivatives+as+potent+HIV-1-integrase-allosteric-site+inhibitors&doi=10.1021%2Facs.jmedchem.8b01473"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">5,6,7,8-Tetrahydro-1,6-naphthyridine Derivatives as Potent HIV-1-Integrase-Allosteric-Site Inhibitors</span></div><div class="casAuthors">Peese, Kevin M.; Allard, Christopher W.; Connolly, Timothy; Johnson, Barry L.; Li, Chen; Patel, Manoj; Sorensen, Margaret E.; Walker, Michael A.; Meanwell, Nicholas A.; McAuliffe, Brian; Minassian, Beatrice; Krystal, Mark; Parker, Dawn D.; Lewis, Hal A.; Kish, Kevin; Zhang, Ping; Nolte, Robert T.; Simmermacher, Jean; Jenkins, Susan; Cianci, Christopher; Naidu, B. Narasimhulu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1348-1361</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of 5,6,7,8-tetrahydro-1,6-naphthyridine derivs. targeting the allosteric lens-epithelium-derived-growth-factor-p75 (LEDGF/p75)-binding site on HIV-1 integrase, an attractive target for antiviral chemotherapy, was prepd. and screened for activity against HIV-1 infection in cell culture.  Small mols. that bind within the LEDGF/p75-binding site promote aberrant multimerization of the integrase enzyme and are of significant interest as HIV-1-replication inhibitors.  Structure-activity-relationship studies and rat pharmacokinetic studies of lead compds. are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxfRugKDl9IbVg90H21EOLACvtfcHk0lhNyxUG3eSEIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXkslOktw%253D%253D&md5=23f771095384ab88b0edce6f12704fc0</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01473&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01473%26sid%3Dliteratum%253Aachs%26aulast%3DPeese%26aufirst%3DK.%2BM.%26aulast%3DAllard%26aufirst%3DC.%2BW.%26aulast%3DConnolly%26aufirst%3DT.%26aulast%3DJohnson%26aufirst%3DB.%2BL.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DPatel%26aufirst%3DM.%26aulast%3DSorensen%26aufirst%3DM.%2BE.%26aulast%3DWalker%26aufirst%3DM.%2BA.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DMcAuliffe%26aufirst%3DB.%26aulast%3DMinassian%26aufirst%3DB.%26aulast%3DKrystal%26aufirst%3DM.%26aulast%3DParker%26aufirst%3DD.%2BD.%26aulast%3DLewis%26aufirst%3DH.%2BA.%26aulast%3DKish%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DNolte%26aufirst%3DR.%2BT.%26aulast%3DSimmermacher%26aufirst%3DJ.%26aulast%3DJenkins%26aufirst%3DS.%26aulast%3DCianci%26aufirst%3DC.%26aulast%3DNaidu%26aufirst%3DB.%2BN.%26atitle%3D5%252C6%252C7%252C8-Tetrahydro-1%252C6-naphthyridine%2520derivatives%2520as%2520potent%2520HIV-1-integrase-allosteric-site%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D1348%26epage%3D1361%26doi%3D10.1021%2Facs.jmedchem.8b01473" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosse-Kunstleve, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winn, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storoni, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, R. J.</span></span> <span> </span><span class="NLM_article-title">Phaser crystallographic software</span>. <i>J. Appl. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">658</span>– <span class="NLM_lpage">674</span>, <span class="refDoi"> DOI: 10.1107/S0021889807021206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=10.1107%2FS0021889807021206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=19461840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2007&pages=658-674&author=A.+J.+McCoyauthor=R.+W.+Grosse-Kunstleveauthor=P.+D.+Adamsauthor=M.+D.+Winnauthor=L.+C.+Storoniauthor=R.+J.+Read&title=Phaser+crystallographic+software&doi=10.1107%2FS0021889807021206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Phaser crystallographic software</span></div><div class="casAuthors">McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.; Winn, Martyn D.; Storoni, Laurent C.; Read, Randy J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">658-674</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Phaser is a program for phasing macromol. crystal structures by both mol. replacement and exptl. phasing methods.  The novel phasing algorithms implemented in Phaser have been developed using max. likelihood and multivariate statistics.  For mol. replacement, the new algorithms have proved to be significantly better than traditional methods in discriminating correct solns. from noise, and for single-wavelength anomalous dispersion exptl. phasing, the new algorithms, which account for correlations between F+ and F-, give better phases (lower mean phase error with respect to the phases given by the refined structure) than those that use mean F and anomalous differences ΔF.  One of the design concepts of Phaser was that it be capable of a high degree of automation.  To this end, Phaser (written in C++) can be called directly from Python, although it can also be called using traditional CCP4 keyword-style input.  Phaser is a platform for future development of improved phasing methods and their release, including source code, to the crystallog. community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPeVyjN_FMGbVg90H21EOLACvtfcHk0lhNyxUG3eSEIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D&md5=c63b722ae97e0a74e6a5a079d388f09f</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1107%2FS0021889807021206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889807021206%26sid%3Dliteratum%253Aachs%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DStoroni%26aufirst%3DL.%2BC.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26atitle%3DPhaser%2520crystallographic%2520software%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2007%26volume%3D40%26spage%3D658%26epage%3D674%26doi%3D10.1107%2FS0021889807021206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emsley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohkamp, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowtan, K.</span></span> <span> </span><span class="NLM_article-title">Features and development of Coot</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">486</span>– <span class="NLM_lpage">501</span>, <span class="refDoi"> DOI: 10.1107/S0907444910007493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=10.1107%2FS0907444910007493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=20383002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=486-501&author=P.+Emsleyauthor=B.+Lohkampauthor=W.+G.+Scottauthor=K.+Cowtan&title=Features+and+development+of+Coot&doi=10.1107%2FS0907444910007493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Features and development of Coot</span></div><div class="casAuthors">Emsley, P.; Lohkamp, B.; Scott, W. G.; Cowtan, K.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">486-501</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Coot is a mol.-graphics application for model building and validation of biol. macromols.  The program displays electron-d. maps and at. models and allows model manipulations such as idealization, real-space refinement, manual rotation/translation, rigid-body fitting, ligand search, solvation, mutations, rotamers and Ramachandran idealization.  Furthermore, tools are provided for model validation as well as interfaces to external programs for refinement, validation and graphics.  The software is designed to be easy to learn for novice users, which is achieved by ensuring that tools for common tasks are 'discoverable' through familiar user-interface elements (menus and toolbars) or by intuitive behavior (mouse controls).  Recent developments have focused on providing tools for expert users, with customisable key bindings, extensions and an extensive scripting interface.  The software is under rapid development, but has already achieved very widespread use within the crystallog. community.  The current state of the software is presented, with a description of the facilities available and of some of the underlying methods employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAKBKszbqb_7Vg90H21EOLACvtfcHk0lhNyxUG3eSEIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D&md5=67262cbfc60004de5ef962d5c043c910</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1107%2FS0907444910007493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910007493%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DLohkamp%26aufirst%3DB.%26aulast%3DScott%26aufirst%3DW.%2BG.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DFeatures%2520and%2520development%2520of%2520Coot%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D486%26epage%3D501%26doi%3D10.1107%2FS0907444910007493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, V. A.</span>; <span class="NLM_string-name">Byington, R. T.</span></span> <span> </span><span class="NLM_article-title">Infectivity Assay</span>. In  <i>Techniques in HIV Research</i>; <span class="NLM_publisher-name">Stockton Press</span>: <span class="NLM_publisher-loc">New York, NY</span>, <span class="NLM_year">1990</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=10.1007%2F978-1-349-11888-5_4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1990&author=V.+A.+Johnson&author=R.+T.+Byington&title=Techniques+in+HIV+Research"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1007%2F978-1-349-11888-5_4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-1-349-11888-5_4%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DV.%2BA.%26atitle%3DInfectivity%2520Assay%26btitle%3DTechniques%2520in%2520HIV%2520Research%26pub%3DStockton%2520Press%26date%3D1990" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weislow, O. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiser, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fine, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bader, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoemaker, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyd, M. R.</span></span> <span> </span><span class="NLM_article-title">New soluble-formazan assay for HIV-1 cytopathic effects: application to high-flux screening of synthetic and natural products for AIDS-antiviral activity</span>. <i>J. Natl. Cancer Inst.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">577</span>– <span class="NLM_lpage">586</span>, <span class="refDoi"> DOI: 10.1093/jnci/81.8.577</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=10.1093%2Fjnci%2F81.8.577" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=2495366" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=1%3ACAS%3A528%3ADyaL1MXkvV2lt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=1989&pages=577-586&author=O.+S.+Weislowauthor=R.+Kiserauthor=D.+L.+Fineauthor=J.+Baderauthor=R.+H.+Shoemakerauthor=M.+R.+Boyd&title=New+soluble-formazan+assay+for+HIV-1+cytopathic+effects%3A+application+to+high-flux+screening+of+synthetic+and+natural+products+for+AIDS-antiviral+activity&doi=10.1093%2Fjnci%2F81.8.577"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">New soluble-formazan assay for HIV-1 cytopathic effects:  application to high-flux screening of synthetic and natural products for AIDS-antiviral activity</span></div><div class="casAuthors">Weislow, Owen S.; Kiser, Rebecca; Fine, Donald L.; Bader, John; Shoemaker, Robert H.; Boyd, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">577-86</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    </div><div class="casAbstract">An effective and optimally safe microculture method was developed for the rapid and convenient assay of the in vitro cytopathic effects of human immunodeficiency virus (HIV-1) on human lymphoblastoid or other suitable host cells.  The assay procedure is applicable to the evaluation of drug effects on in vitro infections induced directly in cultured host cells by cell-free HIV-1 or by coculture with H9 cells chronically infected with HIV-1.  The assay uses a newly developed tetrazolium reagent that is metabolically reduced by viable cells to yield a sol., colored formazan product measureable by conventional colorimetric techniques.  This simple microassay minimizes the no. of plate manipulations typically required with other assay methods and, coupled with computerized data collection and anal., facilitates large-scale screening of agents for potential antiviral activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDJZMdwKZfgbVg90H21EOLACvtfcHk0lgk5bQtQmL8kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXkvV2lt78%253D&md5=c39a027f4ddc6bb5d7b1108c1b128be6</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F81.8.577&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F81.8.577%26sid%3Dliteratum%253Aachs%26aulast%3DWeislow%26aufirst%3DO.%2BS.%26aulast%3DKiser%26aufirst%3DR.%26aulast%3DFine%26aufirst%3DD.%2BL.%26aulast%3DBader%26aufirst%3DJ.%26aulast%3DShoemaker%26aufirst%3DR.%2BH.%26aulast%3DBoyd%26aufirst%3DM.%2BR.%26atitle%3DNew%2520soluble-formazan%2520assay%2520for%2520HIV-1%2520cytopathic%2520effects%253A%2520application%2520to%2520high-flux%2520screening%2520of%2520synthetic%2520and%2520natural%2520products%2520for%2520AIDS-antiviral%2520activity%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D1989%26volume%3D81%26spage%3D577%26epage%3D586%26doi%3D10.1093%2Fjnci%2F81.8.577" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kieltyka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vath, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baglieri, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferraro, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zvyaga, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drexler, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weller, H. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shou, W. Z.</span></span> <span> </span><span class="NLM_article-title">A high-throughput bioanalytical platform using automated infusion for tandem mass spectrometric method optimization and its application in a metabolic stability screen</span>. <i>Rapid Commun. Mass Spectrom.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">1579</span>– <span class="NLM_lpage">1597</span>, <span class="refDoi"> DOI: 10.1002/rcm.4037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=10.1002%2Frcm.4037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=19399765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtVKmt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2009&pages=1579-1597&author=K.+Kieltykaauthor=J.+Zhangauthor=S.+Liauthor=M.+Vathauthor=C.+Baglieriauthor=C.+Ferraroauthor=T.+A.+Zvyagaauthor=D.+M.+Drexlerauthor=H.+N.+Wellerauthor=W.+Z.+Shou&title=A+high-throughput+bioanalytical+platform+using+automated+infusion+for+tandem+mass+spectrometric+method+optimization+and+its+application+in+a+metabolic+stability+screen&doi=10.1002%2Frcm.4037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">A high-throughput bioanalytical platform using automated infusion for tandem mass spectrometric method optimization and its application in a metabolic stability screen</span></div><div class="casAuthors">Kieltyka, Kasia; Zhang, Jun; Li, Shu; Vath, Marianne; Baglieri, Chris; Ferraro, Cheryl; Zvyaga, Tatyana A.; Drexler, Dieter M.; Weller, Harold N.; Shou, Wilson Z.</div><div class="citationInfo"><span class="NLM_cas:title">Rapid Communications in Mass Spectrometry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1579-1591</span>CODEN:
                <span class="NLM_cas:coden">RCMSEF</span>;
        ISSN:<span class="NLM_cas:issn">0951-4198</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Liq. chromatog./tandem mass spectrometry (LC/MS/MS) is the bioanal. method of choice to support plate-based, in vitro early ADME (Absorption, Distribution, Metab. and Excretion) screens such as metabolic stability (Metstab) assessment.  MS/MS method optimization has historically been the bottleneck in this environment, where samples from thousands of discrete compds. are analyzed on a monthly basis, mainly due to the lack of a high-quality com. available platform to handle the necessary MS/MS method optimization steps for sample anal. by selected reaction monitoring (SRM) on triple quadrupole mass spectrometers.  To address this challenge, we recently developed a highly automated bioanal. platform by successfully integrating QuickQuan 2.0, a unique high-throughput soln. featuring MS/MS method optimization by automated infusion, with a customized inhouse software tool in support of a Metstab screen.  In this platform, a dual-column setup running parallel chromatog. was also implemented to reduce the bioanal. cycle time for LC/MS/MS sample anal.  A set of 45 validation compds. was used to demonstrate the speed, quality and reproducibility of MS/MS method optimization, sample anal., and data processing using this automated platform.  Metstab results for the validation compds. in microsomes from multiple species (human, rat, mouse) showed good consistency within each batch, and also between batches conducted on different days.  We have achieved and maintained a monthly throughput of 1300 compd. assays representing 500 discrete compds. per instrument per mo on this platform, and it has been used to generate metabolic stability data for more than 25 000 compds. to date with an overall success rate of more than 95%.  Copyright © 2009 John Wiley & Sons, Ltd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8W1PNTqYnALVg90H21EOLACvtfcHk0lgVuj_ZM6ujzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtVKmt70%253D&md5=57977322942dc41955c1d9cf015e5b05</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1002%2Frcm.4037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Frcm.4037%26sid%3Dliteratum%253Aachs%26aulast%3DKieltyka%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DVath%26aufirst%3DM.%26aulast%3DBaglieri%26aufirst%3DC.%26aulast%3DFerraro%26aufirst%3DC.%26aulast%3DZvyaga%26aufirst%3DT.%2BA.%26aulast%3DDrexler%26aufirst%3DD.%2BM.%26aulast%3DWeller%26aufirst%3DH.%2BN.%26aulast%3DShou%26aufirst%3DW.%2BZ.%26atitle%3DA%2520high-throughput%2520bioanalytical%2520platform%2520using%2520automated%2520infusion%2520for%2520tandem%2520mass%2520spectrometric%2520method%2520optimization%2520and%2520its%2520application%2520in%2520a%2520metabolic%2520stability%2520screen%26jtitle%3DRapid%2520Commun.%2520Mass%2520Spectrom.%26date%3D2009%26volume%3D23%26spage%3D1579%26epage%3D1597%26doi%3D10.1002%2Frcm.4037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6NCJ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6NCJ','PDB','6NCJ'); return false;">PDB: 6NCJ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6UM8" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6UM8','PDB','6UM8'); return false;">PDB: 6UM8</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i75"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01681">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_51536"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.9b01681?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01681</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Crystallography data for compounds (<i>S</i>,<i>S</i> and <i>R</i>,<i>R</i>)-<b>14</b> and (<i>S</i>,<i>R</i> and <i>R</i>,<i>S</i>)-<b>15</b>; crystallization, data collection, and structure refinement results for the HIV-1 integrase CCD:(<i>S</i>,<i>S</i>)-<b>14</b> complex (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01681/suppl_file/jm9b01681_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01681/suppl_file/jm9b01681_si_002.xlsx">XLSX</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01681/suppl_file/jm9b01681_si_001.pdf">jm9b01681_si_001.pdf (358.37 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01681/suppl_file/jm9b01681_si_002.xlsx">jm9b01681_si_002.xlsx (11.21 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The coordinates of the HIV-1 integrase CCD:(<i>S</i>,<i>S</i>)-<b>14</b> complex have been deposited in the PDB under PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6UM8">6UM8</a>. Single crystal structures for (<i>S</i>,<i>S</i> and <i>R</i>,<i>R</i>)-<b>14</b> and (<i>S</i>,<i>R</i> and <i>R</i>,<i>S</i>)-<b>15</b> have been deposited in the CCDC database under CCDC deposition numbers 1862636 and 1862637, respectively.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b01681&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b01681%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-5" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b01681" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799c82c6f233d06","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
